vulvar carcinoma: A carcinoma that arises from epithelial cells of the mammalian vulva
Haemangioma and lymphangioma, any site
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
3572 |
4. Check minimum number of eventsNone |
3572 |
5. Include endpoints |
4001 |
6. Filter based on genotype QC (FinnGen only) |
3856 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Haemangioma sive lymphangioma, quovis loco
Haemangioma and lymphangioma, any site
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 31154 | 18400 | 12629 |
| Only index persons | 26146 | 15515 | 10631 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.45 | 0.53 | 0.35 |
| Only index persons | 0.50 | 0.57 | 0.41 |
| Median age at first event (years) | |||
| Whole population | 37.79 | 37.79 | 37.66 |
| Only index persons | 42.29 | 42.73 | 41.64 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3856 | 2482 | 1374 |
| Unadjusted period prevalence (%) | 0.79 | 0.88 | 0.63 |
| Median age at first event (years) | 52.45 | 50.10 | 56.70 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4001
- Matched controls
- 40009
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D18.0
ICD-10 Finland
Haemangioma, any site
1194.0
307.7
3338
168
22700
ICD-8 Finland
Haemangioma and lymphangioma, Haemangioma
+∞
264.6
251
*
D18.1
ICD-10 Finland
Lymphangioma, any site
2459.9
252.6
242
*
2280A
ICD-9 Finland
Haemangioma and lymphangioma, any site, Haemangioma, any site
+∞
223.0
212
*
D18
ICD-10 Finland
Haemangioma and lymphangioma, any site
84.6
171.9
91
11
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
48.9
123.8
72
15
Q27.4
ICD-10 Finland
Congenital phlebectasia
65.0
116.1
64
10
EAA10
NOMESCO Finland
Excision of lesion of lip
8.0
104.4
143
184
ZXC12
NOMESCO Finland
Pulse colorlaser
21.2
102.5
77
37
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
17.8
94.8
77
44
QX3LT
NOMESCO Finland
Subcutaneous sclerotherapy
42.2
83.0
50
12
Q82.50
ICD-10 Finland
Naevus flammeus
22.2
77.4
57
26
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
6.0
66.0
118
202
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.5
57.4
408
1765
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.0
55.2
161
416
Q82.51
ICD-10 Finland
Naevus portwine
18.9
54.4
43
23
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
11.9
45.4
46
39
Q27.9
ICD-10 Finland
Congenital malformation of peripheral vascular system, unspecified
73.9
45.0
51
7
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
3.3
41.5
163
513
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
40.1
404
2013
22701
ICD-8 Finland
Haemangioma and lymphangioma, Lymphangioma
+∞
37.6
36
*
2281A
ICD-9 Finland
Haemangioma and lymphangioma, any site, Lymphangioma, any site
+∞
37.6
36
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
36.9
1496
11109
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
3.5
35.4
124
363
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
35.0
1125
7903
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.2
34.1
294
1375
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.7
33.1
77
167
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
32.1
871
5856
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
5.0
31.7
68
138
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.1
31.0
303
1489
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
5.2
30.5
62
120
D13.4
ICD-10 Finland
Benign neoplasm: Liver
6.0
29.9
53
90
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
29.3
108
327
XX6KT
NOMESCO Finland
Other sclerotherapy
32.0
29.0
38
12
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
4.4
27.8
70
162
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
3.3
26.5
100
308
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.6
25.4
151
597
UJF32
NOMESCO Finland
Coloscopy
1.5
25.0
948
6820
Q27.88
ICD-10 Finland
Other specified congenital malformation of peripheral vascular system
34.7
24.2
31
9
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
23.8
373
2148
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.8
23.6
123
456
S18
ICPC
Laceration/cut
1.4
23.0
1753
14319
L82
ICD-10 Finland
Seborrhoeic keratosis
1.5
22.3
701
4830
SPAT1153
SPAT
Removal of sutures
1.4
20.8
1096
8359
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
20.7
795
5707
EP1LT
NOMESCO Finland
Percutaneous sclerotherapy of vascular malformation of head and neck
77.2
20.7
23
*
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
8.2
20.5
27
33
ZXC50
NOMESCO Finland
Cryotherapy
2.5
20.4
124
497
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.1
20.2
184
879
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
2.0
20.0
218
1114
K76.80
ICD-10 Finland
Hepatic cyst
4.6
19.8
46
100
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
19.7
506
3322
XQ848
NOMESCO Finland
Dermatological photography
2.5
19.7
126
517
XX4BW, ,
NOMESCO Finland
8.4
19.3
25
30
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
18.9
847
6250
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.9
18.8
249
1359
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.6
18.7
62
176
J01MA02
ATC
ciprofloxacin; systemic
1.4
18.6
1346
10790
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
18.5
1003
7659
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
2.1
18.0
171
831
ZQX00
NOMESCO Finland
0-4% of the skin
20.1
17.7
26
13
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.8
17.7
87
313
N02BE01
ATC
paracetamol; systemic, rectal
1.5
17.6
3440
32112
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
17.3
229
1250
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
17.3
339
2077
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
16.9
926
7071
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.7
16.8
93
356
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
16.7
910
6936
9744, ,
FHL
+∞
16.7
16
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.7
16.7
92
352
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
3.1
16.4
67
217
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
16.3
1383
11303
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
16.1
1317
10704
J01DB01
ATC
cefalexin; oral
1.4
15.8
3145
29014
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
15.8
317
1954
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
4.9
15.7
34
70
A02BC02
ATC
pantoprazole; systemic
1.3
15.6
2528
22579
XQ845
NOMESCO Finland
Dermatoscopy
2.7
15.6
83
312
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
15.5
2569
23007
A02BC01
ATC
omeprazole; systemic
1.4
15.4
922
7124
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.8
15.4
75
269
A02BC05
ATC
esomeprazole; systemic
1.3
15.2
1439
11918
N03AX16
ATC
[U] pregabalin
1.4
14.9
796
6031
ZXC10
NOMESCO Finland
Use of laser
2.5
14.9
89
355
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
14.5
376
2468
N02AX02
ATC
tramadol; systemic, rectal
1.3
14.4
1489
12463
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
14.2
888
6902
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
14.2
608
4430
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
14.0
461
3187
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
14.0
1650
14035
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.2
13.7
109
494
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
2.4
13.6
94
401
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
13.5
1447
12138
R52.9
ICD-10 Finland
Pain, unspecified
1.5
13.5
376
2510
S04
ICPC
Lump/swelling localized
1.5
13.5
413
2814
WX704
NOMESCO Finland
Intubation
1.6
13.4
290
1821
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
13.4
654
4871
9749
FHL
Other measure in this category
5.2
13.4
27
52
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.0
13.3
134
666
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
4.7
13.3
30
64
ZXA00
NOMESCO Finland
Right side
1.4
13.1
855
6676
WX402
NOMESCO Finland
General anaesthesia
1.4
13.0
805
6238
A02BC03
ATC
lansoprazole; oral
1.3
12.9
949
7543
M03BX02
ATC
tizanidine; oral
1.3
12.9
2272
20257
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
2.1
12.8
123
602
TEA00
NOMESCO Finland
Biopsy of lip
3.3
12.7
46
139
S82
ICPC
Naevus/mole
1.4
12.6
511
3677
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
12.6
1495
12672
K76.89
ICD-10 Finland
Other specified diseases of liver
6.0
12.6
22
37
9733
FHL
Excision of skin change in operating room or anesthesia
2.9
12.4
56
193
Z31.5
ICD-10 Finland
Genetic counselling
1.7
12.4
205
1198
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
12.4
319
2091
EJB10
NOMESCO Finland
Excision of tumor or other lesion of apex or body of tongue
4.6
12.3
29
64
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
4.1
12.3
33
81
R42
ICD-10 Finland
Dizziness and giddiness
1.4
12.3
780
6060
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
4.4
12.1
30
69
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
3.2
12.0
46
144
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.1
12.0
118
583
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.0
11.9
52
176
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
11.7
1670
14446
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.6
11.7
66
257
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
11.6
1485
12675
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
11.5
2721
24967
Q82.5
ICD-10 Finland
Congenital non-neoplastic naevus
5.3
11.5
23
44
I78.8
ICD-10 Finland
Other diseases of capillaries
11.1
11.5
21
19
ZXA05
NOMESCO Finland
Left side
1.3
11.5
773
6053
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
11.4
2698
24747
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
11.4
290
1896
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
11.3
525
3868
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
11.3
611
4624
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.4
11.2
74
310
N03AX12
ATC
[U] gabapentin; oral
1.4
11.2
544
4041
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.8
11.2
160
897
ZXA10
NOMESCO Finland
Bilateral
1.4
11.1
591
4459
K30
ICD-10 Finland
Functional dyspepsia
1.5
11.0
403
2842
L57.0
ICD-10 Finland
Actinic keratosis
1.5
10.9
320
2157
C05AA08
ATC
fluocortolone; rectal, topical
1.4
10.8
434
3118
P01AB01
ATC
metronidazole; oral, rectal
1.3
10.8
1408
12019
SAA04
NOMESCO Finland
Special examination of mouth
1.7
10.8
189
1125
CBB30
NOMESCO Finland
Excision of lesion of eyelid
2.1
10.7
99
478
AA1AD
NOMESCO Finland
CT of head and brain
1.3
10.7
929
7535
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
10.6
1900
16802
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
10.6
234
1479
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.4
10.6
69
288
R03BA08
ATC
ciclesonide; inhalant
1.5
10.4
303
2039
PG1HT
NOMESCO Finland
Extensive endovascular embolisation of arterio-venous malformation not elsewhere classified
110.3
10.4
11
*
JN5LT
NOMESCO Finland
Sclerotherapy with direct puncture body area
+∞
10.4
10
*
G44.2
ICD-10 Finland
Tension-type headache
1.4
10.4
490
3619
S29
ICPC
Skin symptom/complaint other
1.3
10.4
712
5580
R51.80
ICD-10 Finland
Headache
1.4
10.3
570
4322
9734
FHL
Excision and local plastic or associated free skin grafting
3.9
10.3
29
74
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
10.3
265
1737
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.7
10.2
52
192
4704
FHL
Neck tumor removal
13.1
10.1
17
13
Z71.8
ICD-10 Finland
Other specified counselling
1.3
10.1
1235
10437
R01AD09
ATC
mometasone; nasal
1.2
10.1
1637
14289
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.3
10.1
1056
8758
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
10.1
449
3284
SPAT1263
SPAT
Sampling
1.3
10.0
1424
12250
Q87.21
ICD-10 Finland
Klippel-Trénaunay-Weber syndrome
40.2
10.0
12
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
10.0
323
2225
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
9.9
195
1197
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
3.7
9.9
30
81
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
9.8
1524
13226
QBA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of trunk
12.2
9.8
17
14
R03BA02
ATC
budesonide; inhalant
1.3
9.8
609
4700
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
1.9
9.8
127
691
TQW99
NOMESCO Finland
Other minor procedure on skin
1.7
9.8
162
949
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
9.8
650
5070
B01AB05
ATC
enoxaparin; parenteral
1.3
9.7
1024
8495
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
9.7
413
2996
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
2.3
9.7
74
332
N28.1
ICD-10 Finland
Cyst of kidney
2.7
9.7
49
181
R03AC02
ATC
salbutamol; inhalant
1.2
9.6
1997
17871
M01AH05
ATC
etoricoxib; oral
1.2
9.6
2249
20387
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
9.6
277
1863
J02AC01
ATC
fluconazole; systemic
1.2
9.6
1399
12054
ZXE00
NOMESCO Finland
One hour or less
1.3
9.5
1317
11273
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
9.4
1506
13096
PG1JT
NOMESCO Finland
Very extensive endovascular embolisation of arterio-venous malformation not elsewhere classified
100.3
9.4
10
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.3
9.4
72
323
Q28.8
ICD-10 Finland
Other specified congenital malformations of circulatory system
17.6
9.4
14
8
R74
ICPC
Upper respiratory infection acute
1.3
9.4
1204
10217
M79.6
ICD-10 Finland
Pain in limb
1.2
9.4
1582
13837
QX3KT, ,
NOMESCO Finland
+∞
9.4
9
*
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
9.4
241
1580
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.6
9.4
188
1161
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
9.3
618
4815
M54.5
ICD-10 Finland
Low back pain
1.2
9.3
1303
11164
M25.5
ICD-10 Finland
Pain in joint
1.3
9.1
1194
10149
S21
ICPC
Skin texture symptom/complaint
1.4
9.1
517
3934
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
9.1
187
1163
WX002
NOMESCO Finland
Sedation and analgesia
1.3
9.0
606
4731
SFA10
NOMESCO Finland
One-surface restoration
1.2
9.0
2001
17986
Z01.2
ICD-10 Finland
Dental examination
1.2
9.0
1704
15069
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
8.9
136
780
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.9
8.9
111
598
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.0
8.9
92
465
Z2221
NOMESCO Finland
Medical doctor
1.3
8.8
905
7469
WX400
NOMESCO Finland
Inhalation anesthesy
1.7
8.8
141
819
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.4
8.8
339
2415
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
2.1
8.8
77
366
J01EA01
ATC
trimethoprim; systemic
1.3
8.7
854
7007
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
1.9
8.7
114
623
G04CA02
ATC
tamsulosin; oral
1.3
8.7
593
4637
UDC00
NOMESCO Finland
Ear microscopy
1.5
8.7
235
1559
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
8.6
297
2071
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
8.2
8.6
18
22
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
8.6
251
1694
SFA30
NOMESCO Finland
Three-surface restoration
1.2
8.5
1466
12812
ZXE10
NOMESCO Finland
More than one and less than three hours
1.2
8.5
1168
9966
WX702
NOMESCO Finland
Supraglottic ventilation device
1.6
8.5
191
1215
J01AA02
ATC
doxycycline; systemic
1.2
8.4
2817
26311
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.0
8.4
82
405
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.7
8.4
161
982
Z00.8
ICD-10 Finland
Other general examinations
1.5
8.4
264
1806
I86.8
ICD-10 Finland
Varicose veins of other specified sites
7.3
8.4
19
26
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
2.6
8.4
47
183
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
8.4
635
5038
J01DA09
ATC
[U] cefadroxil
1.3
8.3
863
7127
QAE30
NOMESCO Finland
Excision and repair of surgical scar in head or neck
10.7
8.3
15
14
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.1
8.3
76
368
A02BC04
ATC
rabeprazole; oral
1.5
8.2
292
2048
A07AA02
ATC
nystatin; oral
1.6
8.2
178
1122
B02AA02
ATC
tranexamic acid; systemic
1.3
8.1
504
3884
R01AD08
ATC
fluticasone; nasal
1.3
8.1
981
8244
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
8.1
249
1697
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
8.1
403
3003
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
8.0
669
5375
R53
ICD-10 Finland
Malaise and fatigue
1.3
8.0
866
7184
R21
ICPC
Throat symptom/complaint
1.3
8.0
748
6099
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.5
8.0
47
188
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
7.9
854
7078
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
7.9
369
2718
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
4.1
7.8
21
52
DM1CM
NOMESCO Finland
Paranasal sinuses extensive MRI examination with 3 Tesla magnet
45.1
7.7
9
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
1.9
7.7
86
448
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
7.7
362
2674
L98.0
ICD-10 Finland
Pyogenic granuloma
3.3
7.6
27
81
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
7.6
210
1399
PA5AC
NOMESCO Finland
Angiography of arteries to the face with X-ray
18.4
7.6
11
6
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
8.0
7.6
16
20
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.6
7.6
193
1264
K11.69
ICD-10 Finland
Mukocele UNS
3.1
7.5
30
97
9474
FHL
Soft tissue tumor removal (subcutaneous tumor 9736 skin tumor 9733)
8.9
7.5
15
17
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
7.5
1955
17717
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.5
7.5
244
1683
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.6
7.5
190
1244
D21.0
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of head, face and neck
4.2
7.5
19
45
SPAT1312
SPAT
General health counselling
1.2
7.5
1049
8951
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
7.4
273
1929
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
7.4
320
2327
KMAK, ,
NOMESCO Finland
1.2
7.4
1759
15804
A03
ICPC
Fever
1.3
7.4
596
4767
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
3.7
7.3
22
59
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
7.3
1041
8888
D23.0
ICD-10 Finland
Benign neoplasm: Skin of lip
4.0
7.3
20
50
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
7.3
455
3509
SPAT1301
SPAT
No procedures
1.2
7.3
989
8403
UJD02
NOMESCO Finland
Gastroscopy
1.6
7.3
145
896
JN1AE, ,
SPAT
1.7
7.2
136
828
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.5
7.2
188
1238
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
7.2
1874
16956
E0000UV, ,
ATC
1.2
7.2
1455
12868
EAW99
NOMESCO Finland
Other operation on lip
20.0
7.1
10
5
J01DA01
ATC
[U] cefalexin
1.2
7.1
2137
19581
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.9
7.1
83
439
K86.2
ICD-10 Finland
Cyst of pancreas
2.6
7.1
40
157
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
7.1
108
621
N03AF02
ATC
oxcarbazepine; oral
1.8
7.1
105
599
L17
ICPC
Foot/toe symptom/complaint
1.2
7.1
1050
9004
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
1.8
7.0
92
505
J01FA10
ATC
azithromycin; systemic
1.2
7.0
2073
18957
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.0
626
5068
Z3226
NOMESCO Finland
Physiotherapist
1.3
7.0
572
4579
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
3.9
7.0
20
52
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.8
7.0
100
565
R03BA05
ATC
fluticasone; inhalant
1.3
6.9
597
4812
6266A
ICD-9 Finland
Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia
1.9
6.9
88
479
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
6.9
1440
12758
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
6.9
521
4129
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
6.9
126
763
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.2
6.8
1002
8576
R60.0
ICD-10 Finland
Localized oedema
1.3
6.8
391
2978
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
1.9
6.8
80
425
L03
ICPC
Low back symptom/complaint
1.2
6.8
1020
8754
N05BA04
ATC
oxazepam; oral
1.2
6.8
851
7167
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
6.7
176
1162
R01AD58
ATC
fluticasone, combinations; nasal
1.2
6.7
875
7397
Z3231
NOMESCO Finland
Registered nurse
1.2
6.7
873
7380
SFA20
NOMESCO Finland
Two-surface restoration
1.2
6.7
2099
19263
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
6.7
339
2534
C07AB02
ATC
metoprolol; systemic
1.3
6.7
559
4489
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.4
6.6
243
1716
WX720
NOMESCO Finland
Own respiration
1.6
6.6
153
981
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.4
6.6
303
2228
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
12.3
6.6
11
9
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
6.5
159
1032
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
6.5
338
2539
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.3
6.5
408
3153
K14.9
ICD-10 Finland
Disease of tongue, unspecified
3.5
6.4
21
60
Q28.9
ICD-10 Finland
Congenital malformation of circulatory system, unspecified
70.0
6.4
7
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
6.4
210
1452
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
6.4
1076
9323
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.4
637
5220
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.5
6.4
179
1198
J05AB01
ATC
aciclovir; systemic
1.2
6.4
725
6032
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
6.4
920
7851
ZXD20
NOMESCO Finland
Day surgery
1.3
6.4
396
3051
N02BF01
ATC
gabapentin; oral
1.4
6.4
341
2571
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
2.1
6.4
59
288
S06.0
ICD-10 Finland
Concussion
1.4
6.4
342
2580
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
4.1
6.3
17
42
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.2
6.3
1232
10825
R4120
NOMESCO Finland
Occupational therapy
1.5
6.3
208
1441
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.6
6.3
152
986
PG1GT
NOMESCO Finland
Endovascular embolisation of arterio-venous malformation with radiological guidance not elsewhere classified
18.0
6.3
9
5
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.3
2119
19524
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
26.7
6.2
8
*
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.4
6.2
335
2529
J01CA04
ATC
amoxicillin; systemic
1.2
6.2
3061
29139
XCD10
NOMESCO Finland
Electrophysiological examination of eye
1.9
6.2
68
353
UKC02
NOMESCO Finland
Cystoscopy
1.3
6.2
433
3394
N62
ICD-10 Finland
Hypertrophy of breast
1.6
6.2
136
863
H53.1
ICD-10 Finland
Subjective visual disturbances
1.4
6.2
223
1572
SPAT1260
SPAT
Consultation of another employee
1.3
6.2
534
4304
N64.5
ICD-10 Finland
Other signs and symptoms in breast
1.8
6.1
86
483
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
3.3
6.1
22
67
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
6.1
451
3560
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
6.1
348
2650
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.4
6.1
230
1636
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
3.0
6.1
25
83
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
6.0
323
2436
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
6.0e-01
1.3e+00
2.3e+00
5.6e+00
2.0e+00
1.8e+00
1.1e+00
cases:4.66%
controls:2.61%
cases:3.64%
controls:1.03%
cases:1.86%
controls:0.20%
cases:5.82%
controls:0.02%
cases:1.36%
controls:0.19%
cases:5.82%
controls:1.01%
cases:7.71%
controls:2.65%
165
921
3373
34336
129
364
3412
34919
66
69
3475
35214
206
8
3335
35275
48
68
3486
35132
200
344
3239
33875
232
785
2776
28893
Haemangioma, any site
D18.0 [45586089]
D18.0 [45586089]
1.8e+00
—
1.0e+50
1.0e+50
—
7.4e+00
5.3e+00
cases:0.34%
controls:0.05%
—
—
cases:0.85%
controls:0.00%
cases:88.08%
controls:0.00%
—
—
cases:24.43%
controls:0.02%
cases:12.37%
controls:0.07%
12
19
3526
35238
—
30
0
3511
35283
3119
0
422
35283
—
840
7
2599
34212
372
21
2636
29657
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
5.0e-01
9.0e-01
1.9e+00
6.9e+00
1.6e+00
1.3e+00
7.0e-01
cases:10.12%
controls:6.41%
cases:6.47%
controls:2.73%
cases:2.63%
controls:0.39%
cases:14.88%
controls:0.02%
cases:2.41%
controls:0.49%
cases:9.04%
controls:2.56%
cases:12.60%
controls:6.68%
358
2259
3180
32998
229
964
3312
34319
93
137
3448
35146
527
6
3014
35277
85
171
3449
35029
311
876
3128
33343
379
1983
2629
27695
Otolaryngology
4 [38004449]
4 [38004449]
4.0e-01
9.2e-01
1.9e+00
6.3e+00
1.9e+00
1.1e+00
6.4e-01
cases:14.19%
controls:9.98%
cases:8.73%
controls:3.68%
cases:3.42%
controls:0.52%
cases:11.44%
controls:0.02%
cases:3.34%
controls:0.51%
cases:10.58%
controls:3.64%
cases:17.95%
controls:10.30%
502
3518
3036
31739
309
1299
3232
33984
121
184
3420
35099
405
8
3136
35275
118
181
3416
35019
364
1244
3075
32975
540
3057
2468
26621
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
3.8e-01
1.1e+00
1.8e+00
6.1e+00
1.5e+00
9.8e-01
5.9e-01
cases:11.02%
controls:7.83%
cases:8.67%
controls:3.09%
cases:2.43%
controls:0.41%
cases:11.92%
controls:0.03%
cases:1.87%
controls:0.44%
cases:7.56%
controls:2.98%
cases:14.30%
controls:8.43%
390
2761
3148
32496
307
1089
3234
34194
86
143
3455
35140
422
11
3119
35272
66
156
3468
35044
260
1021
3179
33198
430
2501
2578
27177
Gastroenterology
10 [38004455]
10 [38004455]
4.9e-01
1.0e+00
1.9e+00
5.7e+00
1.5e+00
1.1e+00
7.4e-01
cases:7.18%
controls:4.51%
cases:5.25%
controls:1.95%
cases:2.17%
controls:0.35%
cases:7.00%
controls:0.03%
cases:1.61%
controls:0.37%
cases:5.47%
controls:1.93%
cases:10.31%
controls:5.18%
254
1590
3284
33667
186
687
3355
34596
77
122
3464
35161
248
9
3293
35274
57
131
3477
35069
188
662
3251
33557
310
1537
2698
28141
General Surgery
2 [38004447]
2 [38004447]
3.2e-01
8.3e-01
1.5e+00
6.1e+00
1.5e+00
8.8e-01
5.0e-01
cases:22.13%
controls:17.07%
cases:11.13%
controls:5.16%
cases:3.16%
controls:0.69%
cases:12.51%
controls:0.03%
cases:2.94%
controls:0.70%
cases:11.17%
controls:4.96%
cases:21.97%
controls:14.61%
783
6017
2755
29240
394
1820
3147
33463
112
244
3429
35039
443
11
3098
35272
104
247
3430
34953
384
1698
3055
32521
661
4335
2347
25343
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
D37.6 [45586102]
D37.6 [45586102]
1.7e+00
3.7e+00
—
1.0e+50
—
3.4e+00
1.8e+00
cases:0.34%
controls:0.06%
cases:1.16%
controls:0.03%
—
—
cases:0.23%
controls:0.00%
—
—
cases:0.70%
controls:0.02%
cases:0.53%
controls:0.08%
12
22
3526
35235
41
10
3500
35273
—
8
0
3533
35283
—
24
8
3415
34211
16
25
2992
29653
Outpatient Hospital
22 [8756]
22 [8756]
2.6e-01
7.4e-01
1.1e+00
5.4e+00
1.2e+00
9.6e-01
4.6e-01
cases:27.56%
controls:22.60%
cases:12.09%
controls:6.16%
cases:2.51%
controls:0.82%
cases:5.14%
controls:0.03%
cases:2.46%
controls:0.72%
cases:13.49%
controls:5.61%
cases:24.90%
controls:17.34%
975
7968
2563
27289
428
2175
3113
33108
89
288
3452
34995
182
9
3359
35274
87
253
3447
34947
464
1920
2975
32299
749
5146
2259
24532
Pediatric Surgery
OMOP4822020 [45756819]
OMOP4822020 [45756819]
7.0e-01
1.8e+00
2.1e+00
1.0e+50
3.1e+00
1.9e+00
1.2e+00
cases:0.73%
controls:0.37%
cases:0.76%
controls:0.13%
cases:0.25%
controls:0.03%
cases:0.71%
controls:0.00%
cases:0.40%
controls:0.02%
cases:0.79%
controls:0.12%
cases:1.23%
controls:0.36%
26
129
3512
35128
27
46
3514
35237
9
11
3532
35272
25
0
3516
35283
14
6
3520
35194
27
40
3412
34179
37
108
2971
29570
Outpatient Visit
OP [9202]
OP [9202]
2.7e-01
6.1e-01
9.0e-01
5.7e+00
9.7e-01
9.4e-01
6.0e-01
cases:72.64%
controls:66.92%
cases:60.97%
controls:45.79%
cases:21.12%
controls:9.79%
cases:58.54%
controls:0.49%
cases:22.58%
controls:9.91%
cases:68.51%
controls:45.90%
cases:83.21%
controls:73.06%
2570
23594
968
11663
2159
16157
1382
19126
748
3455
2793
31828
2073
173
1468
35110
798
3489
2736
31711
2356
15707
1083
18512
2503
21683
505
7995
Inpatient Visit
IP [9201]
IP [9201]
1.6e-01
4.6e-01
1.5e+00
5.0e+00
1.3e+00
7.7e-01
4.1e-01
cases:7.63%
controls:6.59%
cases:3.67%
controls:2.34%
cases:1.10%
controls:0.26%
cases:2.99%
controls:0.02%
cases:0.99%
controls:0.27%
cases:4.65%
controls:2.21%
cases:9.38%
controls:6.40%
270
2324
3268
32933
130
826
3411
34457
39
91
3502
35192
106
7
3435
35276
35
96
3499
35104
160
755
3279
33464
282
1899
2726
27779
Oral Surgery
19 [38004464]
19 [38004464]
4.1e-01
9.1e-01
2.4e+00
1.0e+50
2.9e+00
1.9e+00
9.4e-01
cases:1.19%
controls:0.79%
cases:0.71%
controls:0.29%
cases:0.45%
controls:0.04%
cases:2.57%
controls:0.00%
cases:0.85%
controls:0.05%
cases:1.69%
controls:0.26%
cases:1.89%
controls:0.75%
42
280
3496
34977
25
101
3516
35182
16
15
3525
35268
91
0
3450
35283
30
17
3504
35183
58
89
3381
34130
57
222
2951
29456
Inpatient Hospital
21 [8717]
21 [8717]
2.1e-01
6.8e-01
8.8e-01
5.0e+00
1.1e+00
7.0e-01
3.7e-01
cases:33.92%
controls:29.36%
cases:16.27%
controls:8.94%
cases:3.02%
controls:1.28%
cases:6.50%
controls:0.05%
cases:3.37%
controls:1.19%
cases:15.30%
controls:8.26%
cases:30.29%
controls:23.13%
1200
10350
2338
24907
576
3153
2965
32130
107
450
3434
34833
230
16
3311
35267
119
419
3415
34781
526
2827
2913
31392
911
6866
2097
22812
Neurology
13 [38004458]
13 [38004458]
2.4e-01
7.6e-01
9.5e-01
4.1e+00
1.1e+00
7.6e-01
5.2e-01
cases:11.25%
controls:9.06%
cases:7.82%
controls:3.81%
cases:1.78%
controls:0.70%
cases:1.86%
controls:0.03%
cases:1.92%
controls:0.67%
cases:7.85%
controls:3.83%
cases:15.19%
controls:9.59%
398
3196
3140
32061
277
1343
3264
33940
63
246
3478
35037
66
11
3475
35272
68
237
3466
34963
270
1312
3169
32907
457
2846
2551
26832
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
D48.0 [45586112]
D48.0 [45586112]
1.7e+00
2.8e+00
—
—
—
2.0e+00
1.8e+00
cases:0.31%
controls:0.06%
cases:0.37%
controls:0.02%
—
—
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.33%
controls:0.05%
11
21
3527
35236
13
8
3528
35275
—
—
—
6
8
3433
34211
10
16
2998
29662
Emergency Room Visit
ER [9203]
ER [9203]
3.0e-01
7.6e-01
1.1e+00
4.2e+00
8.0e-01
5.1e-01
4.3e-01
cases:35.92%
controls:29.44%
cases:18.58%
controls:9.61%
cases:3.39%
controls:1.15%
cases:3.16%
controls:0.05%
cases:2.55%
controls:1.16%
cases:14.74%
controls:9.39%
cases:37.10%
controls:27.69%
1271
10381
2267
24876
658
3391
2883
31892
120
405
3421
34878
112
18
3429
35265
90
410
3444
34790
507
3214
2932
31005
1116
8217
1892
21461
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
ZY020 [2001311600]
4.6e-01
9.9e-01
2.0e+00
—
2.3e+00
1.6e+00
8.3e-01
cases:1.02%
controls:0.64%
cases:0.51%
controls:0.19%
cases:0.17%
controls:0.02%
—
—
cases:0.31%
controls:0.03%
cases:0.81%
controls:0.16%
cases:1.06%
controls:0.47%
36
227
3502
35030
18
67
3523
35216
6
8
3535
35275
—
11
11
3523
35189
28
56
3411
34163
32
139
2976
29539
Dentistry
C5 [903277]
C5 [903277]
3.7e-01
7.3e-01
1.3e+00
1.0e+50
3.0e+00
1.7e+00
6.3e-01
cases:2.97%
controls:2.07%
cases:1.58%
controls:0.77%
cases:0.59%
controls:0.16%
cases:6.55%
controls:0.00%
cases:1.90%
controls:0.10%
cases:4.07%
controls:0.80%
cases:3.96%
controls:2.15%
105
730
3433
34527
56
270
3485
35013
21
58
3520
35225
232
0
3309
35283
67
34
3467
35166
140
275
3299
33944
119
639
2889
29039
Neurosurgery
14 [38004459]
14 [38004459]
4.8e-01
1.0e+00
1.0e+00
—
2.2e+00
1.7e+00
1.0e+00
cases:3.73%
controls:2.35%
cases:2.51%
controls:0.94%
cases:0.45%
controls:0.16%
—
—
cases:1.19%
controls:0.13%
cases:4.42%
controls:0.83%
cases:6.05%
controls:2.31%
132
827
3406
34430
89
332
3452
34951
16
56
3525
35227
—
42
45
3492
35155
152
285
3287
33934
182
686
2826
28992
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
5.0e-01
7.6e-01
2.1e+00
—
2.5e+00
1.0e+00
5.3e-01
cases:6.84%
controls:4.25%
cases:2.49%
controls:1.18%
cases:0.96%
controls:0.12%
—
—
cases:1.22%
controls:0.10%
cases:2.76%
controls:1.04%
cases:6.78%
controls:4.11%
242
1500
3296
33757
88
415
3453
34868
34
43
3507
35240
—
43
35
3491
35165
95
355
3344
33864
204
1220
2804
28458
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
2.7e-01
8.2e-01
1.3e+00
3.8e+00
6.8e-01
5.8e-01
6.0e-01
cases:8.45%
controls:6.58%
cases:5.54%
controls:2.51%
cases:1.02%
controls:0.29%
cases:0.65%
controls:0.01%
cases:0.59%
controls:0.30%
cases:4.10%
controls:2.33%
cases:12.40%
controls:7.23%
299
2321
3239
32936
196
884
3345
34399
36
103
3505
35180
23
5
3518
35278
21
106
3513
35094
141
799
3298
33420
373
2147
2635
27531
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
3.1e-01
1.2e+00
2.0e+00
—
1.7e+00
1.3e+00
8.1e-01
cases:5.48%
controls:4.08%
cases:3.59%
controls:1.11%
cases:1.10%
controls:0.15%
—
—
cases:0.91%
controls:0.16%
cases:3.61%
controls:1.04%
cases:6.25%
controls:2.88%
194
1439
3344
33818
127
392
3414
34891
39
54
3502
35229
—
32
56
3502
35144
124
355
3315
33864
188
856
2820
28822
Internal Medicine
11 [38004456]
11 [38004456]
2.8e-01
5.2e-01
5.8e-01
4.4e+00
7.4e-01
5.0e-01
2.9e-01
cases:23.88%
controls:19.12%
cases:12.06%
controls:7.51%
cases:2.37%
controls:1.34%
cases:5.62%
controls:0.07%
cases:2.55%
controls:1.24%
cases:11.46%
controls:7.27%
cases:23.11%
controls:18.30%
845
6741
2693
28516
427
2651
3114
32632
84
472
3457
34811
199
26
3342
35257
90
435
3444
34765
394
2488
3045
31731
695
5430
2313
24248
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
QAE10 [2001309784]
8.6e-01
1.3e+00
—
—
2.5e+00
1.8e+00
8.1e-01
cases:1.55%
controls:0.66%
cases:0.82%
controls:0.23%
—
—
—
—
cases:0.31%
controls:0.03%
cases:1.16%
controls:0.19%
cases:1.53%
controls:0.69%
55
233
3483
35024
29
80
3512
35203
—
—
11
9
3523
35191
40
65
3399
34154
46
204
2962
29474
Pulmonary Disease
29 [38004472]
29 [38004472]
3.1e-01
5.5e-01
7.2e-01
3.8e+00
8.3e-01
5.3e-01
5.1e-01
cases:10.18%
controls:7.68%
cases:6.81%
controls:4.05%
cases:1.61%
controls:0.79%
cases:0.90%
controls:0.02%
cases:1.61%
controls:0.71%
cases:6.60%
controls:4.01%
cases:13.03%
controls:8.24%
360
2706
3178
32551
241
1430
3300
33853
57
280
3484
35003
32
7
3509
35276
57
250
3477
34950
227
1373
3212
32846
392
2446
2616
27232
Orthopedic Surgery
20 [38004465]
20 [38004465]
3.1e-01
5.7e-01
6.5e-01
4.8e+00
4.6e-01
4.6e-01
4.1e-01
cases:16.79%
controls:12.86%
cases:8.25%
controls:4.85%
cases:1.67%
controls:0.88%
cases:3.47%
controls:0.03%
cases:1.27%
controls:0.80%
cases:7.88%
controls:5.14%
cases:20.35%
controls:14.50%
594
4533
2944
30724
292
1711
3249
33572
59
310
3482
34973
123
10
3418
35273
45
283
3489
34917
271
1760
3168
32459
612
4304
2396
25374
Nephrology
39 [38004479]
39 [38004479]
5.9e-01
6.6e-01
1.1e+00
2.3e+00
1.0e+00
8.0e-01
7.3e-01
cases:1.38%
controls:0.77%
cases:1.19%
controls:0.62%
cases:0.73%
controls:0.25%
cases:0.28%
controls:0.03%
cases:0.54%
controls:0.20%
cases:1.31%
controls:0.59%
cases:1.80%
controls:0.87%
49
272
3489
34985
42
217
3499
35066
26
89
3515
35194
10
10
3531
35273
19
70
3515
35130
45
203
3394
34016
54
259
2954
29419
Ophthalmology
18 [38004463]
18 [38004463]
1.6e-01
3.7e-01
6.7e-01
4.4e+00
8.2e-01
4.9e-01
2.6e-01
cases:15.15%
controls:13.19%
cases:8.05%
controls:5.73%
cases:1.92%
controls:0.99%
cases:3.19%
controls:0.04%
cases:2.18%
controls:0.97%
cases:9.22%
controls:5.84%
cases:19.65%
controls:15.91%
536
4652
3002
30605
285
2020
3256
33263
68
349
3473
34934
113
14
3428
35269
77
342
3457
34858
317
1997
3122
32222
591
4722
2417
24956
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
D48.1 [45566694]
D48.1 [45566694]
1.1e+00
3.0e+00
—
—
—
2.5e+00
1.5e+00
cases:0.34%
controls:0.12%
cases:0.65%
controls:0.03%
—
—
—
—
—
—
cases:0.38%
controls:0.03%
cases:0.53%
controls:0.11%
12
41
3526
35216
23
12
3518
35271
—
—
—
13
11
3426
34208
16
34
2992
29644
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
4.7e-01
1.2e+00
1.6e+00
—
1.6e+00
1.2e+00
8.6e-01
cases:3.00%
controls:1.89%
cases:1.61%
controls:0.49%
cases:0.25%
controls:0.05%
—
—
cases:0.31%
controls:0.07%
cases:1.42%
controls:0.45%
cases:3.52%
controls:1.52%
106
667
3432
34590
57
172
3484
35111
9
18
3532
35265
—
11
23
3523
35177
49
154
3390
34065
106
452
2902
29226
Melanocytic naevi, unspecified
D22.9 [45571603]
D22.9 [45571603]
9.1e-01
1.8e+00
2.8e+00
1.0e+50
—
1.3e+00
5.5e-01
cases:0.90%
controls:0.37%
cases:0.56%
controls:0.09%
cases:0.31%
controls:0.02%
cases:0.42%
controls:0.00%
—
—
cases:0.49%
controls:0.13%
cases:0.90%
controls:0.52%
32
129
3506
35128
20
33
3521
35250
11
7
3530
35276
15
0
3526
35283
—
17
46
3422
34173
27
154
2981
29524
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
6.4e-01
2.0e+00
1.9e+00
1.0e+50
—
1.3e+00
8.8e-01
cases:1.30%
controls:0.69%
cases:1.92%
controls:0.26%
cases:0.25%
controls:0.04%
cases:0.85%
controls:0.00%
—
—
cases:0.90%
controls:0.25%
cases:1.80%
controls:0.75%
46
244
3492
35013
68
93
3473
35190
9
13
3532
35270
30
0
3511
35283
—
31
87
3408
34132
54
223
2954
29455
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
2.3e-01
4.8e-01
3.7e-01
3.9e+00
1.2e+00
5.7e-01
3.0e-01
cases:9.84%
controls:8.01%
cases:3.76%
controls:2.37%
cases:0.54%
controls:0.37%
cases:1.10%
controls:0.02%
cases:1.02%
controls:0.30%
cases:3.87%
controls:2.23%
cases:9.01%
controls:6.83%
348
2825
3190
32432
133
835
3408
34448
19
131
3522
35152
39
8
3502
35275
36
106
3498
35094
133
763
3306
33456
271
2026
2737
27652
Neoplasm of uncertain or unknown behaviour: Other digestive organs
D37.7 [45552349]
D37.7 [45552349]
1.1e+00
1.5e+00
2.6e+00
1.0e+50
—
1.5e+00
8.3e-01
cases:0.40%
controls:0.13%
cases:0.37%
controls:0.09%
cases:0.23%
controls:0.02%
cases:0.17%
controls:0.00%
—
—
cases:0.44%
controls:0.10%
cases:0.43%
controls:0.19%
14
46
3524
35211
13
30
3528
35253
8
6
3533
35277
6
0
3535
35283
—
15
34
3424
34185
13
56
2995
29622
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
3.8e-01
7.3e-01
1.2e+00
—
1.9e+00
1.5e+00
8.2e-01
cases:8.03%
controls:5.61%
cases:3.11%
controls:1.52%
cases:0.62%
controls:0.18%
—
—
cases:0.88%
controls:0.13%
cases:4.27%
controls:1.03%
cases:8.61%
controls:3.98%
284
1978
3254
33279
110
536
3431
34747
22
64
3519
35219
—
31
47
3503
35153
147
352
3292
33867
259
1181
2749
28497
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
3.4e-01
7.4e-01
2.3e+00
—
1.4e+00
1.1e+00
6.0e-01
cases:3.48%
controls:2.50%
cases:1.72%
controls:0.83%
cases:0.73%
controls:0.07%
—
—
cases:0.31%
controls:0.08%
cases:2.47%
controls:0.81%
cases:5.22%
controls:2.94%
123
882
3415
34375
61
292
3480
34991
26
26
3515
35257
—
11
27
3523
35173
85
278
3354
33941
157
874
2851
28804
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
83084-4 [42529201]
3.0e-01
1.0e+00
4.1e+00
—
—
1.5e+00
8.7e-01
cases:0.28%
controls:0.21%
cases:0.37%
controls:0.14%
cases:1.16%
controls:0.02%
—
—
—
—
cases:0.73%
controls:0.16%
cases:0.66%
controls:0.28%
10
74
3528
35183
13
48
3528
35235
41
7
3500
35276
—
—
25
54
3414
34165
20
83
2988
29595
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-7.7e-01
-5.8e-01
-4.1e-01
—
2.6e+00
2.4e+00
2.8e+00
cases:14.70%
controls:27.14%
cases:4.57%
controls:7.86%
cases:0.54%
controls:0.81%
—
—
cases:0.79%
controls:0.06%
cases:4.54%
controls:0.44%
cases:14.53%
controls:1.01%
520
9568
3018
25689
162
2773
3379
32510
19
285
3522
34998
—
28
21
3506
35179
156
152
3283
34067
437
300
2571
29378
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
3.9e-01
1.4e+00
2.2e+00
—
1.2e+00
5.9e-01
6.3e-01
cases:6.92%
controls:4.82%
cases:5.73%
controls:1.53%
cases:1.33%
controls:0.15%
—
—
cases:0.57%
controls:0.17%
cases:2.85%
controls:1.60%
cases:9.71%
controls:5.41%
245
1698
3293
33559
203
541
3338
34742
47
53
3494
35230
—
20
60
3514
35140
98
548
3341
33671
292
1607
2716
28071
Extirpation of intracranial lesion
AAB00 [2001300256]
AAB00 [2001300256]
5.4e-01
2.6e+00
—
1.0e+50
—
3.8e+00
1.2e+00
cases:0.17%
controls:0.10%
cases:0.23%
controls:0.02%
—
—
cases:0.14%
controls:0.00%
—
—
cases:0.76%
controls:0.02%
cases:0.27%
controls:0.08%
6
35
3532
35222
8
6
3533
35277
—
5
0
3536
35283
—
26
6
3413
34213
8
24
3000
29654
Hepatic cyst
K76.80 [2000502934]
K76.80 [2000502934]
1.4e+00
2.0e+00
—
1.0e+50
—
2.1e+00
2.3e+00
cases:0.20%
controls:0.05%
cases:0.23%
controls:0.03%
—
—
cases:0.51%
controls:0.00%
—
—
cases:0.23%
controls:0.03%
cases:0.33%
controls:0.03%
7
18
3531
35239
8
11
3533
35272
—
18
0
3523
35283
—
8
10
3431
34209
10
10
2998
29668
Emergency Medicine
93 [38004510]
93 [38004510]
1.9e-01
6.8e-01
1.1e+00
3.1e+00
6.7e-01
4.3e-01
2.4e-01
cases:13.45%
controls:11.37%
cases:10.65%
controls:5.72%
cases:2.09%
controls:0.74%
cases:0.62%
controls:0.03%
cases:1.50%
controls:0.77%
cases:9.22%
controls:6.22%
cases:20.55%
controls:16.89%
476
4009
3062
31248
377
2018
3164
33265
74
261
3467
35022
22
10
3519
35273
53
272
3481
34928
317
2128
3122
32091
618
5014
2390
24664
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
24108-3 [3022914]
2.1e-01
5.7e-01
3.2e+00
—
2.3e+00
7.6e-01
7.0e-01
cases:0.54%
controls:0.44%
cases:0.54%
controls:0.30%
cases:1.41%
controls:0.06%
—
—
cases:0.25%
controls:0.03%
cases:0.64%
controls:0.30%
cases:1.16%
controls:0.58%
19
154
3519
35103
19
107
3522
35176
50
21
3491
35262
—
9
9
3525
35191
22
103
3417
34116
35
173
2973
29505
Malignant melanoma of the trunk other or unspecified histology
C43.59 [2000500754]
C43.59 [2000500754]
1.8e+00
2.3e+00
—
—
—
1.5e+00
2.1e+00
cases:0.20%
controls:0.03%
cases:0.20%
controls:0.02%
—
—
—
—
—
—
cases:0.15%
controls:0.03%
cases:0.27%
controls:0.03%
7
12
3531
35245
7
7
3534
35276
—
—
—
5
11
3434
34208
8
10
3000
29668
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
4.1e-01
1.1e+00
1.5e+00
—
1.6e+00
8.9e-01
7.1e-01
cases:5.60%
controls:3.79%
cases:2.94%
controls:1.03%
cases:0.42%
controls:0.10%
—
—
cases:0.57%
controls:0.12%
cases:2.56%
controls:1.07%
cases:7.15%
controls:3.65%
198
1337
3340
33920
104
365
3437
34918
15
35
3526
35248
—
20
42
3514
35158
88
365
3351
33854
215
1083
2793
28595
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
4.5e-01
1.4e+00
2.5e+00
—
1.3e+00
1.2e+00
5.0e-01
cases:2.04%
controls:1.30%
cases:1.69%
controls:0.41%
cases:0.51%
controls:0.04%
—
—
cases:0.14%
controls:0.04%
cases:1.02%
controls:0.30%
cases:2.13%
controls:1.30%
72
460
3466
34797
60
145
3481
35138
18
15
3523
35268
—
5
14
3529
35186
35
104
3404
34115
64
387
2944
29291
Dermatological photography
XQ848 [2001310110]
XQ848 [2001310110]
1.0e+00
2.0e+00
—
—
—
1.8e+00
1.2e+00
cases:0.65%
controls:0.23%
cases:0.42%
controls:0.06%
—
—
—
—
—
—
cases:0.26%
controls:0.04%
cases:0.66%
controls:0.20%
23
81
3515
35176
15
20
3526
35263
—
—
—
9
15
3430
34204
20
60
2988
29618
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
D48.9 [45532986]
D48.9 [45532986]
—
2.3e+00
—
—
—
2.3e+00
1.4e+00
—
—
cases:0.37%
controls:0.04%
—
—
—
—
—
—
cases:0.29%
controls:0.03%
cases:0.43%
controls:0.10%
—
13
13
3528
35270
—
—
—
10
10
3429
34209
13
31
2995
29647
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
20483-4 [3034770]
5.8e-01
1.4e+00
3.3e+00
—
—
1.3e+00
3.3e-01
cases:0.71%
controls:0.40%
cases:0.56%
controls:0.14%
cases:0.37%
controls:0.01%
—
—
—
—
cases:0.47%
controls:0.13%
cases:0.66%
controls:0.48%
25
140
3513
35117
20
48
3521
35235
13
5
3528
35278
—
—
16
44
3423
34175
20
142
2988
29536
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
1.6e-01
5.6e-01
2.8e+00
—
1.7e+00
7.0e-01
5.9e-01
cases:1.61%
controls:1.38%
cases:1.16%
controls:0.66%
cases:0.99%
controls:0.06%
—
—
cases:0.40%
controls:0.07%
cases:1.08%
controls:0.53%
cases:2.53%
controls:1.41%
57
487
3481
34770
41
234
3500
35049
35
22
3506
35261
—
14
26
3520
35174
37
183
3402
34036
76
419
2932
29259
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
3.1e-01
8.1e-01
2.4e+00
—
1.3e+00
7.4e-01
5.2e-01
cases:2.26%
controls:1.66%
cases:1.58%
controls:0.71%
cases:1.21%
controls:0.11%
—
—
cases:0.34%
controls:0.10%
cases:1.25%
controls:0.60%
cases:3.32%
controls:2.00%
80
587
3458
34670
56
250
3485
35033
43
39
3498
35244
—
12
34
3522
35166
43
206
3396
34013
100
593
2908
29085
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
3.1e-01
6.6e-01
1.3e+00
—
1.5e+00
1.2e+00
7.5e-01
cases:7.43%
controls:5.56%
cases:2.91%
controls:1.53%
cases:0.51%
controls:0.14%
—
—
cases:0.65%
controls:0.15%
cases:3.69%
controls:1.10%
cases:8.31%
controls:4.11%
263
1959
3275
33298
103
539
3438
34744
18
50
3523
35233
—
23
52
3511
35148
127
375
3312
33844
250
1219
2758
28459
Actinic keratosis
L57.0 [45591640]
L57.0 [45591640]
6.8e-01
1.2e+00
2.1e+00
1.0e+50
8.4e-01
9.5e-01
8.1e-01
cases:1.89%
controls:0.97%
cases:1.58%
controls:0.48%
cases:0.65%
controls:0.08%
cases:0.73%
controls:0.00%
cases:0.20%
controls:0.09%
cases:1.48%
controls:0.58%
cases:2.83%
controls:1.28%
67
342
3471
34915
56
170
3485
35113
23
29
3518
35254
26
0
3515
35283
7
30
3527
35170
51
199
3388
34020
85
380
2923
29298
Other and unspecified skin changes
R23.8 [45573020]
R23.8 [45573020]
4.4e-01
1.4e+00
2.8e+00
1.0e+50
1.2e+00
5.9e-01
4.4e-01
cases:2.69%
controls:1.74%
cases:2.77%
controls:0.69%
cases:1.27%
controls:0.08%
cases:0.23%
controls:0.00%
cases:0.34%
controls:0.10%
cases:1.57%
controls:0.88%
cases:4.65%
controls:3.06%
95
615
3443
34642
98
245
3443
35038
45
28
3496
35255
8
0
3533
35283
12
36
3522
35164
54
300
3385
33919
140
907
2868
28771
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
TQX10 [2001310152]
8.5e-01
2.0e+00
—
1.0e+50
—
1.5e+00
1.3e+00
cases:1.81%
controls:0.78%
cases:1.64%
controls:0.24%
—
—
cases:2.12%
controls:0.00%
—
—
cases:0.99%
controls:0.21%
cases:2.56%
controls:0.71%
64
275
3474
34982
58
83
3483
35200
—
75
0
3466
35283
—
34
73
3405
34146
77
212
2931
29466
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
2.3e-01
4.3e-01
3.5e-01
3.6e+00
6.8e-01
3.4e-01
3.2e-01
cases:18.03%
controls:14.92%
cases:8.67%
controls:5.82%
cases:1.41%
controls:1.00%
cases:1.36%
controls:0.04%
cases:1.78%
controls:0.91%
cases:7.50%
controls:5.45%
cases:17.79%
controls:13.55%
638
5259
2900
29998
307
2053
3234
33230
50
353
3491
34930
48
13
3493
35270
63
321
3471
34879
258
1865
3181
32354
535
4022
2473
25656
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
1.5e-01
4.8e-01
1.3e+00
2.0e+00
7.3e-01
5.9e-01
4.2e-01
cases:8.82%
controls:7.70%
cases:6.50%
controls:4.10%
cases:4.35%
controls:1.19%
cases:0.48%
controls:0.06%
cases:2.35%
controls:1.14%
cases:7.15%
controls:4.11%
cases:14.23%
controls:9.80%
312
2716
3226
32541
230
1448
3311
33835
154
419
3387
34864
17
22
3524
35261
83
403
3451
34797
246
1406
3193
32813
428
2909
2580
26769
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
19176-7 [3015916]
4.7e-01
1.0e+00
4.6e+00
—
1.0e+50
1.0e+00
9.4e-01
cases:0.25%
controls:0.16%
cases:0.28%
controls:0.10%
cases:1.69%
controls:0.02%
—
—
cases:0.17%
controls:0.00%
cases:0.32%
controls:0.11%
cases:0.57%
controls:0.22%
9
56
3529
35201
10
35
3531
35248
60
6
3481
35277
—
6
0
3528
35200
11
39
3428
34180
17
66
2991
29612
Excision of other lesion extending through all layers of skin in lower limb
QDE10 [2001309980]
QDE10 [2001309980]
8.4e-01
1.8e+00
—
—
—
2.2e+00
1.5e+00
cases:0.42%
controls:0.18%
cases:0.37%
controls:0.06%
—
—
—
—
—
—
cases:0.41%
controls:0.04%
cases:0.83%
controls:0.18%
15
65
3523
35192
13
22
3528
35261
—
—
—
14
15
3425
34204
25
53
2983
29625
Localized swelling, mass and lump, unspecified
R22.9 [45577788]
R22.9 [45577788]
4.6e-01
1.6e+00
2.3e+00
—
—
1.1e+00
5.3e-01
cases:1.02%
controls:0.64%
cases:1.04%
controls:0.20%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.47%
controls:0.16%
cases:1.56%
controls:0.92%
36
227
3502
35030
37
72
3504
35211
10
10
3531
35273
—
—
16
55
3423
34164
47
274
2961
29404
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
3.0e-01
7.0e-01
2.3e+00
—
8.4e-01
8.1e-01
5.3e-01
cases:9.61%
controls:7.33%
cases:4.86%
controls:2.47%
cases:2.12%
controls:0.21%
—
—
cases:0.62%
controls:0.27%
cases:4.71%
controls:2.15%
cases:11.34%
controls:6.99%
340
2586
3198
32671
172
870
3369
34413
75
74
3466
35209
—
22
95
3512
35105
162
734
3277
33485
341
2075
2667
27603
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
JN1CG [2001305527]
8.0e-01
2.2e+00
—
1.0e+50
—
2.0e+00
1.2e+00
cases:0.42%
controls:0.19%
cases:0.56%
controls:0.06%
—
—
cases:1.36%
controls:0.00%
—
—
cases:0.38%
controls:0.05%
cases:0.57%
controls:0.18%
15
67
3523
35190
20
22
3521
35261
—
48
0
3493
35283
—
13
17
3426
34202
17
52
2991
29626
Laceration/cut
S18 [2002000983]
S18 [2002000983]
3.0e-01
6.5e-01
1.5e+00
—
1.8e+00
7.3e-01
3.5e-01
cases:8.42%
controls:6.37%
cases:4.18%
controls:2.22%
cases:1.27%
controls:0.28%
—
—
cases:1.73%
controls:0.29%
cases:4.51%
controls:2.23%
cases:11.00%
controls:8.00%
298
2245
3240
33012
148
784
3393
34499
45
100
3496
35183
—
61
101
3473
35099
155
763
3284
33456
331
2375
2677
27303
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
1.6e-01
5.2e-01
1.2e+00
2.1e+00
6.5e-01
5.5e-01
2.7e-01
cases:11.48%
controls:9.97%
cases:7.31%
controls:4.48%
cases:1.89%
controls:0.57%
cases:0.23%
controls:0.03%
cases:1.13%
controls:0.59%
cases:7.39%
controls:4.41%
cases:16.62%
controls:13.16%
406
3515
3132
31742
259
1580
3282
33703
67
200
3474
35083
8
10
3533
35273
40
209
3494
34991
254
1508
3185
32711
500
3905
2508
25773
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
2.3e-01
4.6e-01
8.0e-01
2.3e+00
8.2e-01
5.0e-01
3.0e-01
cases:6.11%
controls:4.93%
cases:3.98%
controls:2.54%
cases:0.82%
controls:0.37%
cases:0.17%
controls:0.02%
cases:0.79%
controls:0.35%
cases:4.30%
controls:2.65%
cases:9.47%
controls:7.18%
216
1739
3322
33518
141
897
3400
34386
29
130
3512
35153
6
6
3535
35277
28
123
3506
35077
148
907
3291
33312
285
2131
2723
27547
Coloscopy
UJF32 [2001305029]
UJF32 [2001305029]
4.0e-01
8.4e-01
1.4e+00
1.0e+50
1.2e+00
7.9e-01
4.9e-01
cases:5.00%
controls:3.40%
cases:2.17%
controls:0.95%
cases:0.37%
controls:0.09%
cases:0.40%
controls:0.00%
cases:0.34%
controls:0.10%
cases:1.89%
controls:0.87%
cases:5.82%
controls:3.66%
177
1200
3361
34057
77
335
3464
34948
13
31
3528
35252
14
0
3527
35283
12
35
3522
35165
65
297
3374
33922
175
1085
2833
28593
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
-2.4e-02
1.4e-01
2.7e+00
—
1.2e+00
7.0e-01
5.2e-01
cases:1.36%
controls:1.39%
cases:1.10%
controls:0.96%
cases:2.49%
controls:0.17%
—
—
cases:0.51%
controls:0.15%
cases:1.80%
controls:0.90%
cases:2.86%
controls:1.73%
48
490
3490
34767
39
338
3502
34945
88
59
3453
35224
—
18
53
3516
35147
62
309
3377
33910
86
512
2922
29166
Extensive MRI examination of soft tissue of neck with high intesity magnet
EP1CG [2001302289]
EP1CG [2001302289]
—
2.6e+00
—
1.0e+50
—
—
2.5e+00
—
—
cases:0.31%
controls:0.02%
—
—
cases:0.23%
controls:0.00%
—
—
—
—
cases:0.33%
controls:0.03%
—
11
8
3530
35275
—
8
0
3533
35283
—
—
10
8
2998
29670
Destruction of lesion of head or neck
QAA25 [2001309763]
QAA25 [2001309763]
4.9e-01
1.7e+00
—
1.0e+50
—
2.1e+00
1.2e+00
cases:0.34%
controls:0.21%
cases:0.34%
controls:0.06%
—
—
cases:0.79%
controls:0.00%
—
—
cases:0.70%
controls:0.08%
cases:0.76%
controls:0.23%
12
73
3526
35184
12
21
3529
35262
—
28
0
3513
35283
—
24
28
3415
34191
23
67
2985
29611
Neoplasm of uncertain or unknown behaviour: Skin
D48.5 [45586113]
D48.5 [45586113]
8.7e-01
1.8e+00
—
—
—
1.5e+00
9.1e-01
cases:1.13%
controls:0.48%
cases:0.99%
controls:0.16%
—
—
—
—
—
—
cases:0.81%
controls:0.19%
cases:1.50%
controls:0.61%
40
168
3498
35089
35
57
3506
35226
—
—
—
28
65
3411
34154
45
180
2963
29498
General Practice
1 [38004446]
1 [38004446]
8.5e-02
4.4e-01
8.6e-01
3.5e+00
1.7e-01
2.5e-01
2.6e-01
cases:11.28%
controls:10.45%
cases:5.96%
controls:3.94%
cases:1.30%
controls:0.55%
cases:0.56%
controls:0.02%
cases:0.74%
controls:0.62%
cases:5.35%
controls:4.20%
cases:15.63%
controls:12.54%
399
3685
3139
31572
211
1389
3330
33894
46
195
3495
35088
20
6
3521
35277
26
219
3508
34981
184
1437
3255
32782
470
3722
2538
25956
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
3.6e-01
8.7e-01
1.3e+00
—
1.3e+00
8.0e-01
3.8e-01
cases:6.44%
controls:4.60%
cases:2.77%
controls:1.17%
cases:0.34%
controls:0.09%
—
—
cases:0.34%
controls:0.09%
cases:2.33%
controls:1.06%
cases:5.72%
controls:3.99%
228
1623
3310
33634
98
414
3443
34869
12
33
3529
35250
—
12
32
3522
35168
80
364
3359
33855
172
1184
2836
28494
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
-1.3e-02
8.6e-01
1.9e+00
—
1.6e+00
1.4e+00
8.1e-01
cases:1.24%
controls:1.26%
cases:0.93%
controls:0.40%
cases:0.28%
controls:0.04%
—
—
cases:0.14%
controls:0.03%
cases:1.19%
controls:0.28%
cases:1.83%
controls:0.82%
44
444
3494
34813
33
140
3508
35143
10
15
3531
35268
—
5
10
3529
35190
41
97
3398
34122
55
244
2953
29434
Destruction of lesion of skin, site unspecified
QXA25 [2001310041]
QXA25 [2001310041]
8.6e-01
1.6e+00
1.0e+50
1.0e+50
—
2.0e+00
1.4e+00
cases:0.40%
controls:0.17%
cases:0.45%
controls:0.09%
cases:0.23%
controls:0.00%
cases:0.34%
controls:0.00%
—
—
cases:0.55%
controls:0.08%
cases:1.03%
controls:0.25%
14
59
3524
35198
16
32
3525
35251
8
0
3533
35283
12
0
3529
35283
—
19
27
3420
34192
31
73
2977
29605
Excision of other lesion extending through all layers of skin in upper limb
QCE10 [2001309914]
QCE10 [2001309914]
9.5e-01
1.9e+00
—
1.0e+50
—
2.1e+00
1.0e+00
cases:0.45%
controls:0.18%
cases:0.31%
controls:0.05%
—
—
cases:0.73%
controls:0.00%
—
—
cases:0.35%
controls:0.04%
cases:0.43%
controls:0.15%
16
62
3522
35195
11
16
3530
35267
—
26
0
3515
35283
—
12
15
3427
34204
13
46
2995
29632
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
2.7e-01
9.0e-01
7.1e-01
—
1.8e+00
1.4e+00
6.0e-01
cases:6.53%
controls:5.05%
cases:2.85%
controls:1.18%
cases:0.31%
controls:0.15%
—
—
cases:0.62%
controls:0.11%
cases:3.23%
controls:0.85%
cases:6.38%
controls:3.61%
231
1780
3307
33477
101
418
3440
34865
11
54
3530
35229
—
22
38
3512
35162
111
291
3328
33928
192
1071
2816
28607
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
8.7e-02
6.6e-01
1.8e+00
—
1.2e+00
6.8e-01
5.5e-01
cases:1.92%
controls:1.76%
cases:1.69%
controls:0.88%
cases:0.71%
controls:0.12%
—
—
cases:0.40%
controls:0.12%
cases:1.86%
controls:0.96%
cases:4.22%
controls:2.48%
68
622
3470
34635
60
311
3481
34972
25
43
3516
35240
—
14
41
3520
35159
64
327
3375
33892
127
737
2881
28941
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
D17.0 [45561897]
D17.0 [45561897]
6.1e-01
2.4e+00
—
—
—
2.5e+00
8.7e-01
cases:0.20%
controls:0.11%
cases:0.28%
controls:0.03%
—
—
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.23%
controls:0.10%
7
38
3531
35219
10
9
3531
35274
—
—
—
7
6
3432
34213
7
29
3001
29649
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
4.0e-02
1.8e-01
5.2e-01
3.6e+00
4.1e-01
1.8e-01
8.8e-02
cases:56.33%
controls:55.35%
cases:53.57%
controls:49.09%
cases:30.02%
controls:20.30%
cases:29.85%
controls:1.20%
cases:27.73%
controls:20.28%
cases:55.68%
controls:51.27%
cases:70.31%
controls:68.44%
1993
19514
1545
15743
1897
17320
1644
17963
1063
7161
2478
28122
1057
425
2484
34858
980
7138
2554
28062
1915
17545
1524
16674
2115
20311
893
9367
Naevus/mole
S82 [2002001046]
S82 [2002001046]
5.3e-01
5.7e-01
1.7e+00
—
2.2e+00
6.5e-01
4.5e-01
cases:2.20%
controls:1.31%
cases:0.71%
controls:0.40%
cases:0.25%
controls:0.05%
—
—
cases:0.25%
controls:0.03%
cases:0.84%
controls:0.44%
cases:2.69%
controls:1.74%
78
463
3460
34794
25
142
3516
35141
9
17
3532
35266
—
9
10
3525
35190
29
151
3410
34068
81
515
2927
29163
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
2.4e-01
4.1e-01
4.9e-01
3.4e+00
6.9e-01
3.0e-01
3.6e-01
cases:4.80%
controls:3.82%
cases:3.61%
controls:2.43%
cases:0.76%
controls:0.47%
cases:0.56%
controls:0.02%
cases:0.88%
controls:0.44%
cases:3.34%
controls:2.49%
cases:6.68%
controls:4.75%
170
1347
3368
33910
128
859
3413
34424
27
165
3514
35118
20
7
3521
35276
31
156
3503
35044
115
852
3324
33367
201
1409
2807
28269
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
7.3e-02
5.4e-01
9.3e-01
1.7e+00
7.8e-01
4.0e-01
3.9e-01
cases:8.68%
controls:8.12%
cases:7.40%
controls:4.46%
cases:1.64%
controls:0.65%
cases:0.23%
controls:0.04%
cases:1.41%
controls:0.66%
cases:6.46%
controls:4.43%
cases:15.39%
controls:10.93%
307
2862
3231
32395
262
1575
3279
33708
58
230
3483
35053
8
14
3533
35269
50
231
3484
34969
222
1516
3217
32703
463
3243
2545
26435
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
7.1e-02
1.9e-01
4.3e-01
3.5e+00
5.4e-01
4.3e-01
2.4e-01
cases:17.35%
controls:16.35%
cases:7.77%
controls:6.52%
cases:1.16%
controls:0.76%
cases:1.04%
controls:0.03%
cases:1.44%
controls:0.85%
cases:9.22%
controls:6.18%
cases:23.14%
controls:19.13%
614
5766
2924
29491
275
2300
3266
32983
41
268
3500
35015
37
11
3504
35272
51
299
3483
34901
317
2114
3122
32105
696
5677
2312
24001
Excision of other lesion extending through all layers of skin of trunk
QBE10 [2001309853]
QBE10 [2001309853]
8.3e-01
1.5e+00
—
1.0e+50
—
1.4e+00
9.5e-01
cases:1.27%
controls:0.56%
cases:0.65%
controls:0.14%
—
—
cases:0.76%
controls:0.00%
—
—
cases:0.70%
controls:0.17%
cases:1.30%
controls:0.51%
45
197
3493
35060
23
49
3518
35234
—
27
0
3514
35283
—
24
59
3415
34160
39
150
2969
29528
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
8.4e-02
5.1e-01
2.1e+00
—
9.6e-01
6.2e-01
5.1e-01
cases:4.69%
controls:4.33%
cases:3.39%
controls:2.06%
cases:2.01%
controls:0.25%
—
—
cases:0.68%
controls:0.26%
cases:3.14%
controls:1.72%
cases:7.28%
controls:4.52%
166
1526
3372
33731
120
728
3421
34555
71
87
3470
35196
—
24
92
3510
35108
108
587
3331
33632
219
1342
2789
28336
Seborrhoeic keratosis
L82 [45548208]
L82 [45548208]
5.3e-01
6.4e-01
2.2e+00
1.0e+50
—
8.6e-01
4.7e-01
cases:2.71%
controls:1.61%
cases:1.16%
controls:0.62%
cases:0.56%
controls:0.06%
cases:1.27%
controls:0.00%
—
—
cases:1.69%
controls:0.72%
cases:4.32%
controls:2.76%
96
569
3442
34688
41
217
3500
35066
20
22
3521
35261
45
0
3496
35283
—
58
247
3381
33972
130
818
2878
28860
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.3e-01
5.0e-01
1.0e+00
1.8e+00
6.1e-01
4.1e-01
3.0e-01
cases:27.13%
controls:24.66%
cases:22.90%
controls:15.22%
cases:7.31%
controls:2.78%
cases:0.90%
controls:0.15%
cases:4.87%
controls:2.70%
cases:21.58%
controls:15.42%
cases:39.39%
controls:32.51%
960
8696
2578
26561
811
5369
2730
29914
259
982
3282
34301
32
53
3509
35230
172
950
3362
34250
742
5275
2697
28944
1185
9647
1823
20031
Localized swelling, mass and lump, neck
R22.1 [45592412]
R22.1 [45592412]
4.2e-01
2.1e+00
2.6e+00
—
—
9.7e-01
7.7e-01
cases:0.42%
controls:0.28%
cases:0.68%
controls:0.09%
cases:0.25%
controls:0.02%
—
—
—
—
cases:0.26%
controls:0.10%
cases:0.63%
controls:0.29%
15
98
3523
35159
24
30
3517
35253
9
7
3532
35276
—
—
9
34
3430
34185
19
87
2989
29591
Other therap proced/minor surg NEC
-59 [2002000130]
-59 [2002000130]
1.4e+00
1.8e+00
—
—
—
—
1.4e+00
cases:0.57%
controls:0.14%
cases:0.23%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.13%
20
48
3518
35209
8
13
3533
35270
—
—
—
—
15
38
2993
29640
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
1.1e-01
5.6e-01
1.7e+00
—
1.3e+00
5.5e-01
5.7e-01
cases:2.15%
controls:1.92%
cases:1.67%
controls:0.96%
cases:0.68%
controls:0.13%
—
—
cases:0.42%
controls:0.12%
cases:1.83%
controls:1.07%
cases:4.75%
controls:2.75%
76
678
3462
34579
59
338
3482
34945
24
46
3517
35237
—
15
42
3519
35158
63
366
3376
33853
143
815
2865
28863
Other specified intervertebral disc degeneration
M51.3 [45591865]
M51.3 [45591865]
4.9e-01
1.1e+00
1.2e+00
—
2.0e+00
7.9e-01
6.8e-01
cases:1.19%
controls:0.73%
cases:0.68%
controls:0.23%
cases:0.17%
controls:0.05%
—
—
cases:0.20%
controls:0.03%
cases:0.70%
controls:0.32%
cases:1.60%
controls:0.82%
42
258
3496
34999
24
82
3517
35201
6
18
3535
35265
—
7
9
3527
35191
24
109
3415
34110
48
243
2960
29435
Benign neoplasm: Choroid
D31.3 [45566680]
D31.3 [45566680]
8.4e-01
1.6e+00
—
—
—
1.6e+00
1.4e+00
cases:0.20%
controls:0.09%
cases:0.28%
controls:0.06%
—
—
—
—
—
—
cases:0.35%
controls:0.07%
cases:0.66%
controls:0.17%
7
30
3531
35227
10
20
3531
35263
—
—
—
12
24
3427
34195
20
51
2988
29627
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
1.7e-01
5.3e-01
1.7e+00
—
1.2e+00
6.0e-01
5.7e-01
cases:2.52%
controls:2.12%
cases:1.72%
controls:1.02%
cases:0.71%
controls:0.14%
—
—
cases:0.42%
controls:0.13%
cases:2.04%
controls:1.13%
cases:5.25%
controls:3.04%
89
748
3449
34509
61
361
3480
34922
25
48
3516
35235
—
15
44
3519
35156
70
387
3369
33832
158
902
2850
28776
Use of laser
ZXC10 [2001311360]
ZXC10 [2001311360]
7.9e-01
2.0e+00
—
1.0e+50
—
2.7e+00
1.8e+00
cases:0.31%
controls:0.14%
cases:0.14%
controls:0.02%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.41%
controls:0.03%
cases:0.47%
controls:0.08%
11
50
3527
35207
5
7
3536
35276
—
14
0
3527
35283
—
14
9
3425
34210
14
23
2994
29655
Neck ultrasound examination
EP1AE [2001302284]
EP1AE [2001302284]
6.2e-01
1.5e+00
—
—
—
1.8e+00
1.3e+00
cases:0.82%
controls:0.44%
cases:0.68%
controls:0.16%
—
—
—
—
—
—
cases:0.76%
controls:0.13%
cases:1.43%
controls:0.40%
29
156
3509
35101
24
55
3517
35228
—
—
—
26
44
3413
34175
43
120
2965
29558
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
1.8e-01
6.5e-01
2.3e+00
—
1.0e+00
1.1e+00
4.4e-01
cases:2.35%
controls:1.97%
cases:1.33%
controls:0.70%
cases:0.45%
controls:0.05%
—
—
cases:0.17%
controls:0.06%
cases:1.60%
controls:0.53%
cases:2.56%
controls:1.66%
83
694
3455
34563
47
246
3494
35037
16
16
3525
35267
—
6
21
3528
35179
55
180
3384
34039
77
493
2931
29185
dronedarone; oral
C01BD07 [40253900]
C01BD07 [40253900]
2.0e+00
2.5e+00
—
—
—
1.8e+00
1.4e+00
cases:0.25%
controls:0.03%
cases:0.17%
controls:0.01%
—
—
—
—
—
—
cases:0.15%
controls:0.02%
cases:0.20%
controls:0.05%
9
12
3529
35245
6
5
3535
35278
—
—
—
5
8
3434
34211
6
15
3002
29663
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
JN1DG [2001305530]
4.8e-01
2.2e+00
—
1.0e+50
—
2.2e+00
8.8e-01
cases:0.17%
controls:0.10%
cases:0.48%
controls:0.05%
—
—
cases:0.96%
controls:0.00%
—
—
cases:0.47%
controls:0.05%
cases:0.37%
controls:0.15%
6
37
3532
35220
17
19
3524
35264
—
34
0
3507
35283
—
16
18
3423
34201
11
45
2997
29633
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
3.3e-01
8.1e-01
1.1e+00
—
9.0e-01
7.5e-01
5.1e-01
cases:8.37%
controls:6.14%
cases:4.52%
controls:2.06%
cases:1.13%
controls:0.40%
—
—
cases:1.08%
controls:0.44%
cases:4.57%
controls:2.20%
cases:10.54%
controls:6.59%
296
2164
3242
33093
160
727
3381
34556
40
140
3501
35143
—
38
155
3496
35045
157
754
3282
33465
317
1957
2691
27721
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
6.8e-02
3.9e-01
5.0e-01
3.0e+00
4.3e-01
2.5e-01
2.2e-01
cases:14.92%
controls:14.08%
cases:10.17%
controls:7.11%
cases:1.98%
controls:1.21%
cases:2.17%
controls:0.11%
cases:1.73%
controls:1.13%
cases:9.36%
controls:7.47%
cases:22.31%
controls:18.77%
528
4964
3010
30293
360
2510
3181
32773
70
427
3471
34856
77
39
3464
35244
61
396
3473
34804
322
2556
3117
31663
671
5571
2337
24107
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
-6.7e-01
6.9e-01
2.3e+00
1.0e+50
—
1.2e+00
8.1e-01
cases:0.23%
controls:0.44%
cases:0.34%
controls:0.17%
cases:0.17%
controls:0.02%
cases:0.54%
controls:0.00%
—
—
cases:0.47%
controls:0.14%
cases:0.80%
controls:0.36%
8
155
3530
35102
12
60
3529
35223
6
6
3535
35277
19
0
3522
35283
—
16
48
3423
34171
24
106
2984
29572
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
4.9e-01
1.2e+00
1.3e+00
—
8.3e-01
7.0e-01
5.0e-01
cases:3.19%
controls:1.97%
cases:2.43%
controls:0.75%
cases:0.51%
controls:0.14%
—
—
cases:0.31%
controls:0.14%
cases:1.72%
controls:0.86%
cases:4.29%
controls:2.65%
113
696
3425
34561
86
265
3455
35018
18
48
3523
35235
—
11
48
3523
35152
59
293
3380
33926
129
785
2879
28893
Benign neoplasm: Liver
D13.4 [45561892]
D13.4 [45561892]
2.4e+00
—
—
1.0e+50
—
—
1.7e+00
cases:0.23%
controls:0.02%
—
—
—
—
cases:0.28%
controls:0.00%
—
—
—
—
cases:0.27%
controls:0.05%
8
7
3530
35250
—
—
10
0
3531
35283
—
—
8
14
3000
29664
CR(E)ST syndrome
M34.1 [45582129]
M34.1 [45582129]
2.2e+00
1.9e+00
—
—
—
1.7e+00
1.5e+00
cases:0.23%
controls:0.03%
cases:0.20%
controls:0.03%
—
—
—
—
—
—
cases:0.17%
controls:0.03%
cases:0.23%
controls:0.05%
8
9
3530
35248
7
10
3534
35273
—
—
—
6
11
3433
34208
7
15
3001
29663
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
2.6e-02
4.7e-01
1.4e+00
—
1.1e+00
7.2e-01
4.4e-01
cases:5.46%
controls:5.32%
cases:3.05%
controls:1.94%
cases:0.79%
controls:0.20%
—
—
cases:0.68%
controls:0.22%
cases:3.14%
controls:1.55%
cases:7.51%
controls:4.97%
193
1876
3345
33381
108
683
3433
34600
28
71
3513
35212
—
24
79
3510
35121
108
530
3331
33689
226
1476
2782
28202
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.2e-01
3.7e-01
9.8e-01
1.7e+00
5.4e-01
3.1e-01
2.5e-01
cases:30.02%
controls:27.57%
cases:23.86%
controls:17.75%
cases:7.74%
controls:3.06%
cases:0.88%
controls:0.17%
cases:4.95%
controls:2.94%
cases:22.10%
controls:17.26%
cases:40.49%
controls:34.65%
1062
9721
2476
25536
845
6261
2696
29022
274
1080
3267
34203
31
59
3510
35224
175
1035
3359
34165
760
5906
2679
28313
1218
10283
1790
19395
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
3.2e-01
5.6e-01
3.8e-01
—
1.8e+00
1.0e+00
4.0e-01
cases:4.35%
controls:3.19%
cases:1.21%
controls:0.69%
cases:0.14%
controls:0.10%
—
—
cases:0.37%
controls:0.06%
cases:1.74%
controls:0.62%
cases:4.22%
controls:2.87%
154
1124
3384
34133
43
245
3498
35038
5
34
3536
35249
—
13
22
3521
35178
60
213
3379
34006
127
851
2881
28827
Benign neoplasm: Colon, unspecified
D12.6 [45576377]
D12.6 [45576377]
7.0e-01
1.1e+00
—
—
2.3e+00
9.1e-01
6.0e-01
cases:0.82%
controls:0.41%
cases:0.48%
controls:0.16%
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.44%
controls:0.18%
cases:0.93%
controls:0.52%
29
144
3509
35113
17
57
3524
35226
—
—
6
6
3528
35194
15
60
3424
34159
28
153
2980
29525
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
3.1e-01
5.3e-01
1.3e+00
—
1.7e+00
1.4e+00
6.9e-01
cases:4.41%
controls:3.29%
cases:1.27%
controls:0.75%
cases:0.20%
controls:0.05%
—
—
cases:0.28%
controls:0.05%
cases:2.24%
controls:0.54%
cases:4.16%
controls:2.13%
156
1159
3382
34098
45
266
3496
35017
7
19
3534
35264
—
10
19
3524
35181
77
186
3362
34033
125
631
2883
29047
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
1.8e-01
6.1e-01
2.0e+00
—
7.5e-01
3.9e-01
3.5e-01
cases:7.09%
controls:5.99%
cases:4.83%
controls:2.69%
cases:2.26%
controls:0.32%
—
—
cases:0.71%
controls:0.34%
cases:3.75%
controls:2.56%
cases:10.41%
controls:7.59%
251
2112
3287
33145
171
948
3370
34335
80
113
3461
35170
—
25
118
3509
35082
129
877
3310
33342
313
2253
2695
27425
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
7.2e-01
1.3e+00
-1.0e+50
—
—
7.9e-01
1.2e+00
cases:2.74%
controls:1.35%
cases:1.55%
controls:0.43%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.79%
controls:0.36%
cases:2.99%
controls:0.90%
97
477
3441
34780
55
150
3486
35133
0
14
3541
35269
—
—
27
122
3412
34097
90
267
2918
29411
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
7.2e-01
1.3e+00
-1.0e+50
—
—
7.9e-01
1.2e+00
cases:2.74%
controls:1.35%
cases:1.55%
controls:0.43%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.79%
controls:0.36%
cases:2.99%
controls:0.90%
97
477
3441
34780
55
150
3486
35133
0
14
3541
35269
—
—
27
122
3412
34097
90
267
2918
29411
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
7.2e-01
1.3e+00
-1.0e+50
—
—
7.9e-01
1.2e+00
cases:2.74%
controls:1.35%
cases:1.55%
controls:0.43%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.79%
controls:0.36%
cases:2.99%
controls:0.90%
97
477
3441
34780
55
150
3486
35133
0
14
3541
35269
—
—
27
122
3412
34097
90
267
2918
29411
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
7.2e-01
1.3e+00
-1.0e+50
—
—
7.9e-01
1.2e+00
cases:2.74%
controls:1.35%
cases:1.55%
controls:0.43%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.79%
controls:0.36%
cases:2.99%
controls:0.90%
97
477
3441
34780
55
150
3486
35133
0
14
3541
35269
—
—
27
122
3412
34097
90
267
2918
29411
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
7.2e-01
1.3e+00
-1.0e+50
—
—
7.9e-01
1.2e+00
cases:2.74%
controls:1.35%
cases:1.55%
controls:0.43%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.79%
controls:0.36%
cases:2.99%
controls:0.90%
97
477
3441
34780
55
150
3486
35133
0
14
3541
35269
—
—
27
122
3412
34097
90
267
2918
29411
Malignant melanoma on the torso: 'superficial spreading' type
C43.52 [2000500751]
C43.52 [2000500751]
1.5e+00
1.8e+00
—
—
—
2.3e+00
1.7e+00
cases:0.14%
controls:0.03%
cases:0.14%
controls:0.02%
—
—
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.40%
controls:0.07%
5
11
3533
35246
5
8
3536
35275
—
—
—
9
9
3430
34210
12
21
2996
29657
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
3.1e-01
1.2e+00
1.4e+00
—
5.1e-01
5.2e-01
5.8e-01
cases:3.76%
controls:2.77%
cases:2.65%
controls:0.84%
cases:0.31%
controls:0.07%
—
—
cases:0.17%
controls:0.10%
cases:1.51%
controls:0.91%
cases:5.39%
controls:3.08%
133
978
3405
34279
94
296
3447
34987
11
26
3530
35257
—
6
36
3528
35164
52
310
3387
33909
162
915
2846
28763
Headache
R51.80 [2000503603]
R51.80 [2000503603]
4.2e-01
6.7e-01
1.6e+00
—
1.2e+00
7.2e-01
6.1e-01
cases:2.37%
controls:1.58%
cases:1.04%
controls:0.54%
cases:0.31%
controls:0.06%
—
—
cases:0.14%
controls:0.04%
cases:1.08%
controls:0.53%
cases:3.39%
controls:1.87%
84
557
3454
34700
37
190
3504
35093
11
22
3530
35261
—
5
15
3529
35185
37
180
3402
34039
102
556
2906
29122
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
7.9e-02
9.3e-01
2.1e+00
1.0e+50
1.0e+00
9.9e-01
4.7e-01
cases:0.90%
controls:0.84%
cases:0.79%
controls:0.31%
cases:0.31%
controls:0.04%
cases:0.37%
controls:0.00%
cases:0.14%
controls:0.05%
cases:0.76%
controls:0.28%
cases:1.86%
controls:1.17%
32
295
3506
34962
28
111
3513
35172
11
14
3530
35269
13
0
3528
35283
5
18
3529
35182
26
97
3413
34122
56
348
2952
29330
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
3.8e-02
2.5e-01
8.7e-01
2.2e+00
4.3e-01
1.9e-01
1.0e-01
cases:36.63%
controls:35.75%
cases:38.89%
controls:33.11%
cases:20.70%
controls:9.82%
cases:4.57%
controls:0.53%
cases:14.18%
controls:9.71%
cases:38.24%
controls:33.88%
cases:51.33%
controls:48.75%
1296
12606
2242
22651
1377
11681
2164
23602
733
3465
2808
31818
162
186
3379
35097
501
3419
3033
31781
1315
11594
2124
22625
1544
14469
1464
15209
Other minor procedure on skin
TQW99 [2001310150]
TQW99 [2001310150]
1.0e+00
1.3e+00
2.3e+00
1.0e+50
2.3e+00
1.6e+00
8.0e-01
cases:0.79%
controls:0.28%
cases:0.37%
controls:0.10%
cases:0.14%
controls:0.01%
cases:0.56%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.49%
controls:0.10%
cases:0.70%
controls:0.31%
28
100
3510
35157
13
37
3528
35246
5
5
3536
35278
20
0
3521
35283
5
5
3529
35195
17
33
3422
34186
21
93
2987
29585
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.3e-01
5.6e-01
1.3e+00
—
9.3e-01
6.9e-01
3.9e-01
cases:8.93%
controls:7.91%
cases:5.03%
controls:2.93%
cases:1.30%
controls:0.34%
—
—
cases:0.85%
controls:0.34%
cases:4.89%
controls:2.51%
cases:11.04%
controls:7.72%
316
2790
3222
32467
178
1033
3363
34250
46
120
3495
35163
—
30
119
3504
35081
168
858
3271
33361
332
2290
2676
27388
fusidic acid
D09AA02 [21602265]
D09AA02 [21602265]
3.3e-01
4.3e-01
1.6e+00
—
1.5e+00
4.1e-01
4.4e-01
cases:4.35%
controls:3.17%
cases:1.30%
controls:0.85%
cases:0.45%
controls:0.09%
—
—
cases:0.40%
controls:0.09%
cases:1.40%
controls:0.93%
cases:5.19%
controls:3.39%
154
1116
3384
34141
46
300
3495
34983
16
31
3525
35252
—
14
31
3520
35169
48
318
3391
33901
156
1006
2852
28672
fusidic acid; ointment
D06AX01 [21602062]
D06AX01 [21602062]
3.3e-01
4.3e-01
1.6e+00
—
1.5e+00
4.1e-01
4.4e-01
cases:4.35%
controls:3.17%
cases:1.30%
controls:0.85%
cases:0.45%
controls:0.09%
—
—
cases:0.40%
controls:0.09%
cases:1.40%
controls:0.93%
cases:5.19%
controls:3.39%
154
1116
3384
34141
46
300
3495
34983
16
31
3525
35252
—
14
31
3520
35169
48
318
3391
33901
156
1006
2852
28672
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
2.9e-01
1.3e+00
1.9e+00
1.0e+50
1.5e+00
6.7e-01
3.6e-01
cases:2.46%
controls:1.84%
cases:2.15%
controls:0.58%
cases:0.42%
controls:0.06%
cases:0.28%
controls:0.00%
cases:0.20%
controls:0.04%
cases:1.37%
controls:0.70%
cases:3.32%
controls:2.34%
87
650
3451
34607
76
204
3465
35079
15
22
3526
35261
10
0
3531
35283
7
15
3527
35185
47
240
3392
33979
100
695
2908
28983
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
9.8e-02
3.5e-01
1.1e+00
1.6e+00
4.0e-01
2.8e-01
2.1e-01
cases:31.37%
controls:29.31%
cases:29.96%
controls:23.25%
cases:12.51%
controls:4.49%
cases:1.07%
controls:0.22%
cases:6.56%
controls:4.48%
cases:29.05%
controls:23.71%
cases:46.01%
controls:40.93%
1110
10333
2428
24924
1061
8202
2480
27081
443
1585
3098
33698
38
79
3503
35204
232
1578
3302
33622
999
8113
2440
26106
1384
12147
1624
17531
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
1.3e-01
6.4e-01
1.9e+00
—
1.0e+00
8.7e-01
4.8e-01
cases:2.29%
controls:2.01%
cases:1.61%
controls:0.86%
cases:0.48%
controls:0.07%
—
—
cases:0.23%
controls:0.08%
cases:2.04%
controls:0.86%
cases:3.99%
controls:2.50%
81
708
3457
34549
57
303
3484
34980
17
25
3524
35258
—
8
28
3526
35172
70
295
3369
33924
120
741
2888
28937
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
3.5e-01
8.4e-01
1.5e+00
—
8.7e-01
7.1e-01
4.8e-01
cases:3.19%
controls:2.27%
cases:1.67%
controls:0.72%
cases:0.31%
controls:0.07%
—
—
cases:0.17%
controls:0.07%
cases:1.37%
controls:0.68%
cases:3.96%
controls:2.49%
113
802
3425
34455
59
255
3482
35028
11
24
3530
35259
—
6
25
3528
35175
47
231
3392
33988
119
740
2889
28938
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
7.0e-01
1.1e+00
—
—
1.2e+00
8.1e-01
1.2e+00
cases:3.11%
controls:1.57%
cases:1.64%
controls:0.53%
—
—
—
—
cases:0.17%
controls:0.05%
cases:0.99%
controls:0.44%
cases:3.42%
controls:1.01%
110
552
3428
34705
58
186
3483
35097
—
—
6
18
3528
35182
34
152
3405
34067
103
300
2905
29378
FEV1
20150-9 [3024653]
20150-9 [3024653]
7.0e-01
1.1e+00
—
—
1.2e+00
8.1e-01
1.2e+00
cases:3.11%
controls:1.57%
cases:1.64%
controls:0.53%
—
—
—
—
cases:0.17%
controls:0.05%
cases:0.99%
controls:0.44%
cases:3.42%
controls:1.01%
110
552
3428
34705
58
186
3483
35097
—
—
6
18
3528
35182
34
152
3405
34067
103
300
2905
29378
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
7.0e-01
1.1e+00
—
—
1.2e+00
8.1e-01
1.2e+00
cases:3.11%
controls:1.57%
cases:1.64%
controls:0.53%
—
—
—
—
cases:0.17%
controls:0.05%
cases:0.99%
controls:0.44%
cases:3.42%
controls:1.01%
110
552
3428
34705
58
186
3483
35097
—
—
6
18
3528
35182
34
152
3405
34067
103
300
2905
29378
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
1.9e-01
3.6e-01
4.7e-01
1.8e+00
5.5e-01
3.1e-01
2.2e-01
cases:37.56%
controls:33.29%
cases:20.22%
controls:15.02%
cases:3.25%
controls:2.06%
cases:0.40%
controls:0.07%
cases:3.54%
controls:2.08%
cases:19.54%
controls:15.18%
cases:38.93%
controls:33.78%
1329
11737
2209
23520
716
5298
2825
29985
115
728
3426
34555
14
23
3527
35260
125
731
3409
34469
672
5193
2767
29026
1171
10024
1837
19654
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
1.9e-01
3.6e-01
4.7e-01
1.8e+00
5.5e-01
3.1e-01
2.2e-01
cases:37.56%
controls:33.29%
cases:20.22%
controls:15.02%
cases:3.25%
controls:2.06%
cases:0.40%
controls:0.07%
cases:3.54%
controls:2.08%
cases:19.54%
controls:15.18%
cases:38.93%
controls:33.78%
1329
11737
2209
23520
716
5298
2825
29985
115
728
3426
34555
14
23
3527
35260
125
731
3409
34469
672
5193
2767
29026
1171
10024
1837
19654
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
2.8e-01
9.5e-01
1.5e+00
1.0e+50
5.3e-01
5.8e-01
5.4e-01
cases:6.16%
controls:4.73%
cases:4.80%
controls:1.92%
cases:1.36%
controls:0.29%
cases:0.20%
controls:0.00%
cases:0.42%
controls:0.25%
cases:3.63%
controls:2.07%
cases:10.34%
controls:6.31%
218
1667
3320
33590
170
678
3371
34605
48
103
3493
35180
7
0
3534
35283
15
88
3519
35112
125
710
3314
33509
311
1874
2697
27804
Hand Surgery
40 [38004480]
40 [38004480]
5.3e-01
9.5e-01
8.6e-01
—
1.0e+00
7.4e-01
6.0e-01
cases:4.07%
controls:2.43%
cases:2.06%
controls:0.81%
cases:0.40%
controls:0.17%
—
—
cases:0.51%
controls:0.18%
cases:1.83%
controls:0.88%
cases:4.79%
controls:2.69%
144
856
3394
34401
73
286
3468
34997
14
59
3527
35224
—
18
63
3516
35137
63
301
3376
33918
144
799
2864
28879
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.1e-01
3.8e-01
8.9e-01
1.7e+00
4.2e-01
2.6e-01
2.5e-01
cases:28.75%
controls:26.50%
cases:26.40%
controls:19.68%
cases:7.99%
controls:3.45%
cases:1.04%
controls:0.20%
cases:5.21%
controls:3.49%
cases:24.60%
controls:20.12%
cases:43.28%
controls:37.26%
1017
9343
2521
25914
935
6943
2606
28340
283
1217
3258
34066
37
70
3504
35213
184
1229
3350
33971
846
6885
2593
27334
1302
11057
1706
18621
Ultrsound examination of soft tissue not elsewhere classified
QX2XE [2001310033]
QX2XE [2001310033]
-1.3e-01
1.6e+00
—
—
—
2.3e+00
6.4e-01
cases:0.17%
controls:0.19%
cases:0.31%
controls:0.06%
—
—
—
—
—
—
cases:0.58%
controls:0.06%
cases:0.50%
controls:0.26%
6
68
3532
35189
11
22
3530
35261
—
—
—
20
21
3419
34198
15
78
2993
29600
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
3.0e-01
3.5e-01
6.5e-01
2.6e+00
9.7e-01
2.6e-01
1.6e-01
cases:4.61%
controls:3.47%
cases:2.60%
controls:1.84%
cases:0.48%
controls:0.25%
cases:0.23%
controls:0.02%
cases:0.57%
controls:0.22%
cases:2.56%
controls:1.99%
cases:7.15%
controls:6.17%
163
1222
3375
34035
92
648
3449
34635
17
89
3524
35194
8
6
3533
35277
20
76
3514
35124
88
681
3351
33538
215
1831
2793
27847
Benign neoplasm: Skin of eyelid, including canthus
D23.1 [45600585]
D23.1 [45600585]
5.2e-01
1.3e+00
2.8e+00
—
—
1.3e+00
1.0e+00
cases:0.37%
controls:0.22%
cases:0.23%
controls:0.06%
cases:0.23%
controls:0.01%
—
—
—
—
cases:0.29%
controls:0.08%
cases:0.60%
controls:0.21%
13
77
3525
35180
8
21
3533
35262
8
5
3533
35278
—
—
10
27
3429
34192
18
63
2990
29615
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.2e-01
3.8e-01
8.7e-01
1.6e+00
4.0e-01
2.6e-01
2.5e-01
cases:29.06%
controls:26.74%
cases:26.57%
controls:19.89%
cases:8.05%
controls:3.55%
cases:1.02%
controls:0.20%
cases:5.26%
controls:3.59%
cases:24.89%
controls:20.38%
cases:43.65%
controls:37.53%
1028
9427
2510
25830
941
7018
2600
28265
285
1251
3256
34032
36
70
3505
35213
186
1264
3348
33936
856
6973
2583
27246
1313
11138
1695
18540
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
2.3e-01
8.0e-01
1.7e+00
1.5e+00
5.1e-01
6.0e-01
4.9e-01
cases:10.83%
controls:8.82%
cases:9.69%
controls:4.59%
cases:4.97%
controls:0.96%
cases:0.20%
controls:0.04%
cases:1.44%
controls:0.87%
cases:8.20%
controls:4.68%
cases:17.49%
controls:11.51%
383
3109
3155
32148
343
1621
3198
33662
176
340
3365
34943
7
15
3534
35268
51
307
3483
34893
282
1602
3157
32617
526
3415
2482
26263
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
3.8e-01
6.8e-01
7.6e-01
—
7.8e-01
7.0e-01
5.0e-01
cases:9.44%
controls:6.68%
cases:4.66%
controls:2.43%
cases:1.02%
controls:0.48%
—
—
cases:1.16%
controls:0.54%
cases:4.77%
controls:2.43%
cases:10.17%
controls:6.41%
334
2356
3204
32901
165
856
3376
34427
36
168
3505
35115
—
41
189
3493
35011
164
830
3275
33389
306
1903
2702
27775
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
6.7e-02
3.2e-01
1.1e+00
1.6e+00
3.2e-01
2.4e-01
2.4e-01
cases:21.59%
controls:20.48%
cases:21.21%
controls:16.29%
cases:8.67%
controls:3.19%
cases:0.65%
controls:0.13%
cases:4.27%
controls:3.14%
cases:20.30%
controls:16.64%
cases:34.64%
controls:29.48%
764
7222
2774
28035
751
5747
2790
29536
307
1124
3234
34159
23
47
3518
35236
151
1107
3383
34093
698
5693
2741
28526
1042
8750
1966
20928
Benign neoplasm: Kidney
D30.0 [45542695]
D30.0 [45542695]
—
—
—
—
—
1.9e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.20%
controls:0.03%
cases:0.27%
controls:0.04%
—
—
—
—
—
7
10
3432
34209
8
13
3000
29665
Localized swelling, mass and lump, head
R22.0 [45548955]
R22.0 [45548955]
8.4e-01
2.1e+00
1.0e+50
1.0e+50
—
1.6e+00
5.4e-01
cases:0.45%
controls:0.20%
cases:0.62%
controls:0.08%
cases:0.59%
controls:0.00%
cases:0.17%
controls:0.00%
—
—
cases:0.44%
controls:0.08%
cases:0.50%
controls:0.29%
16
69
3522
35188
22
27
3519
35256
21
0
3520
35283
6
0
3535
35283
—
15
29
3424
34190
15
86
2993
29592
Urology
34 [38004474]
34 [38004474]
3.4e-01
4.4e-01
1.1e+00
—
8.5e-01
5.9e-01
4.5e-01
cases:6.30%
controls:4.56%
cases:3.76%
controls:2.45%
cases:1.19%
controls:0.41%
—
—
cases:0.88%
controls:0.38%
cases:4.19%
controls:2.38%
cases:8.01%
controls:5.27%
223
1609
3315
33648
133
866
3408
34417
42
144
3499
35139
—
31
133
3503
35067
144
813
3295
33406
241
1563
2767
28115
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
AA1CG [2001300116]
3.8e-01
1.5e+00
—
1.0e+50
—
1.3e+00
8.7e-01
cases:1.27%
controls:0.87%
cases:1.04%
controls:0.23%
—
—
cases:0.45%
controls:0.00%
—
—
cases:0.84%
controls:0.23%
cases:1.80%
controls:0.76%
45
307
3493
34950
37
80
3504
35203
—
16
0
3525
35283
—
29
77
3410
34142
54
225
2954
29453
Rheumatology
66 [38004491]
66 [38004491]
3.7e-01
4.6e-01
7.8e-01
—
8.2e-01
6.8e-01
6.2e-01
cases:4.47%
controls:3.12%
cases:2.74%
controls:1.75%
cases:0.71%
controls:0.33%
—
—
cases:0.79%
controls:0.35%
cases:3.29%
controls:1.69%
cases:5.82%
controls:3.20%
158
1100
3380
34157
97
618
3444
34665
25
115
3516
35168
—
28
123
3506
35077
113
580
3326
33639
175
951
2833
28727
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
2.7e-01
7.1e-01
1.4e+00
—
1.3e+00
4.1e-01
3.5e-01
cases:3.67%
controls:2.84%
cases:2.06%
controls:1.02%
cases:0.45%
controls:0.11%
—
—
cases:0.37%
controls:0.10%
cases:1.60%
controls:1.06%
cases:5.32%
controls:3.82%
130
1000
3408
34257
73
360
3468
34923
16
40
3525
35243
—
13
36
3521
35164
55
364
3384
33855
160
1133
2848
28545
Localized swelling, mass and lump, upper limb
R22.3 [45548956]
R22.3 [45548956]
1.1e+00
2.6e+00
—
—
—
—
2.1e-01
cases:0.37%
controls:0.12%
cases:0.59%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.20%
controls:0.16%
13
44
3525
35213
21
15
3520
35268
—
—
—
—
6
48
3002
29630
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
Z03.89 [2000503757]
2.0e-01
8.5e-01
1.6e+00
—
—
7.7e-01
4.9e-01
cases:1.61%
controls:1.32%
cases:0.93%
controls:0.40%
cases:0.23%
controls:0.05%
—
—
—
—
cases:0.87%
controls:0.41%
cases:2.63%
controls:1.63%
57
467
3481
34790
33
141
3508
35142
8
16
3533
35267
—
—
30
139
3409
34080
79
483
2929
29195
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
D17.2 [45561898]
D17.2 [45561898]
2.8e-01
1.7e+00
—
—
—
2.0e+00
1.2e+00
cases:0.20%
controls:0.15%
cases:0.25%
controls:0.05%
—
—
—
—
—
—
cases:0.20%
controls:0.03%
cases:0.37%
controls:0.11%
7
53
3531
35204
9
17
3532
35266
—
—
—
7
9
3432
34210
11
32
2997
29646
Other and unspecified ovarian cysts
N83.2 [45539066]
N83.2 [45539066]
3.1e-01
6.6e-01
—
—
2.3e+00
8.2e-01
5.9e-01
cases:1.30%
controls:0.96%
cases:0.68%
controls:0.35%
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.70%
controls:0.31%
cases:1.83%
controls:1.02%
46
339
3492
34918
24
124
3517
35159
—
—
7
7
3527
35193
24
106
3415
34113
55
303
2953
29375
Sicca syndrome [Sjögren]
M35.0 [45562711]
M35.0 [45562711]
6.0e-01
1.3e+00
—
—
—
1.3e+00
1.1e+00
cases:0.40%
controls:0.22%
cases:0.40%
controls:0.11%
—
—
—
—
—
—
cases:0.47%
controls:0.13%
cases:0.73%
controls:0.25%
14
77
3524
35180
14
39
3527
35244
—
—
—
16
43
3423
34176
22
73
2986
29605
Clinical photography of mouth and teeth
SBB00 [2001310298]
SBB00 [2001310298]
6.2e-01
1.6e+00
1.9e+00
1.0e+50
—
2.0e+00
6.1e-01
cases:0.65%
controls:0.35%
cases:0.34%
controls:0.07%
cases:0.17%
controls:0.03%
cases:0.28%
controls:0.00%
—
—
cases:0.47%
controls:0.06%
cases:0.53%
controls:0.29%
23
124
3515
35133
12
24
3529
35259
6
9
3535
35274
10
0
3531
35283
—
16
21
3423
34198
16
86
2992
29592
hydrocortisone aceponate
D07AC16 [21602135]
D07AC16 [21602135]
1.6e-01
4.3e-01
6.8e-01
2.5e+00
5.9e-01
3.8e-01
3.5e-01
cases:8.08%
controls:6.98%
cases:3.33%
controls:2.19%
cases:0.48%
controls:0.24%
cases:0.17%
controls:0.01%
cases:0.37%
controls:0.20%
cases:3.26%
controls:2.26%
cases:9.91%
controls:7.21%
286
2460
3252
32797
118
772
3423
34511
17
86
3524
35197
6
5
3535
35278
13
72
3521
35128
112
773
3327
33446
298
2141
2710
27537
hydrocortisone buteprate
D07AB11 [21602115]
D07AB11 [21602115]
1.6e-01
4.3e-01
6.8e-01
2.5e+00
5.9e-01
3.8e-01
3.5e-01
cases:8.08%
controls:6.98%
cases:3.33%
controls:2.19%
cases:0.48%
controls:0.24%
cases:0.17%
controls:0.01%
cases:0.37%
controls:0.20%
cases:3.26%
controls:2.26%
cases:9.91%
controls:7.21%
286
2460
3252
32797
118
772
3423
34511
17
86
3524
35197
6
5
3535
35278
13
72
3521
35128
112
773
3327
33446
298
2141
2710
27537
hydrocortisone
D07AA02 [21602102]
D07AA02 [21602102]
1.6e-01
4.3e-01
6.8e-01
2.5e+00
5.9e-01
3.8e-01
3.5e-01
cases:8.08%
controls:6.98%
cases:3.33%
controls:2.19%
cases:0.48%
controls:0.24%
cases:0.17%
controls:0.01%
cases:0.37%
controls:0.20%
cases:3.26%
controls:2.26%
cases:9.91%
controls:7.21%
286
2460
3252
32797
118
772
3423
34511
17
86
3524
35197
6
5
3535
35278
13
72
3521
35128
112
773
3327
33446
298
2141
2710
27537
hydrocortisone butyrate
D07AB02 [21602106]
D07AB02 [21602106]
1.6e-01
4.3e-01
6.8e-01
2.5e+00
5.9e-01
3.8e-01
3.5e-01
cases:8.08%
controls:6.98%
cases:3.33%
controls:2.19%
cases:0.48%
controls:0.24%
cases:0.17%
controls:0.01%
cases:0.37%
controls:0.20%
cases:3.26%
controls:2.26%
cases:9.91%
controls:7.21%
286
2460
3252
32797
118
772
3423
34511
17
86
3524
35197
6
5
3535
35278
13
72
3521
35128
112
773
3327
33446
298
2141
2710
27537
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
1.5e-01
4.7e-01
6.4e-01
3.2e+00
8.3e-01
2.7e-01
4.9e-02
cases:2.91%
controls:2.52%
cases:2.17%
controls:1.37%
cases:0.51%
controls:0.27%
cases:0.59%
controls:0.03%
cases:0.54%
controls:0.24%
cases:2.01%
controls:1.53%
cases:4.89%
controls:4.66%
103
889
3435
34368
77
483
3464
34800
18
95
3523
35188
21
9
3520
35274
19
83
3515
35117
69
525
3370
33694
147
1384
2861
28294
hydrocortisone
C05AA01 [21601608]
C05AA01 [21601608]
1.7e-01
4.2e-01
6.8e-01
2.5e+00
5.6e-01
3.7e-01
3.5e-01
cases:8.31%
controls:7.08%
cases:3.33%
controls:2.22%
cases:0.48%
controls:0.24%
cases:0.17%
controls:0.01%
cases:0.37%
controls:0.21%
cases:3.29%
controls:2.28%
cases:9.97%
controls:7.26%
294
2497
3244
32760
118
783
3423
34500
17
86
3524
35197
6
5
3535
35278
13
74
3521
35126
113
781
3326
33438
300
2156
2708
27522
hydrocortisone
A07EA02 [21600654]
A07EA02 [21600654]
1.7e-01
4.2e-01
6.8e-01
2.5e+00
5.6e-01
3.7e-01
3.5e-01
cases:8.31%
controls:7.08%
cases:3.33%
controls:2.22%
cases:0.48%
controls:0.24%
cases:0.17%
controls:0.01%
cases:0.37%
controls:0.21%
cases:3.29%
controls:2.28%
cases:9.97%
controls:7.26%
294
2497
3244
32760
118
783
3423
34500
17
86
3524
35197
6
5
3535
35278
13
74
3521
35126
113
781
3326
33438
300
2156
2708
27522
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
K44.9 [45533596]
3.8e-01
9.2e-01
2.1e+00
1.0e+50
1.3e+00
4.9e-01
6.1e-01
cases:0.96%
controls:0.66%
cases:0.56%
controls:0.23%
cases:0.23%
controls:0.03%
cases:0.23%
controls:0.00%
cases:0.14%
controls:0.04%
cases:0.38%
controls:0.23%
cases:1.40%
controls:0.76%
34
233
3504
35024
20
80
3521
35203
8
10
3533
35273
8
0
3533
35283
5
13
3529
35187
13
79
3426
34140
42
226
2966
29452
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
5.9e-01
1.1e+00
2.0e+00
—
—
1.1e+00
7.6e-01
cases:1.07%
controls:0.60%
cases:0.54%
controls:0.18%
cases:0.14%
controls:0.02%
—
—
—
—
cases:0.61%
controls:0.20%
cases:1.20%
controls:0.56%
38
210
3500
35047
19
64
3522
35219
5
7
3536
35276
—
—
21
67
3418
34152
36
167
2972
29511
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
1.9e-01
5.8e-01
1.0e+00
—
1.1e+00
5.1e-01
2.6e-01
cases:6.67%
controls:5.60%
cases:4.29%
controls:2.45%
cases:0.88%
controls:0.31%
—
—
cases:0.96%
controls:0.31%
cases:4.07%
controls:2.49%
cases:10.21%
controls:8.08%
236
1976
3302
33281
152
866
3389
34417
31
109
3510
35174
—
34
108
3500
35092
140
852
3299
33367
307
2399
2701
27279
Cells panel - Urine sediment
58434-2 [40761535]
58434-2 [40761535]
1.4e-01
7.6e-01
1.4e+00
—
1.5e+00
8.5e-01
4.6e-01
cases:1.58%
controls:1.38%
cases:1.16%
controls:0.55%
cases:0.20%
controls:0.05%
—
—
cases:0.28%
controls:0.07%
cases:1.19%
controls:0.51%
cases:2.36%
controls:1.51%
56
487
3482
34770
41
193
3500
35090
7
18
3534
35265
—
10
23
3524
35177
41
176
3398
34043
71
448
2937
29230
Chronic superficial gastritis
K29.3 [45596316]
K29.3 [45596316]
7.9e-01
1.7e+00
—
—
—
1.8e+00
9.1e-01
cases:0.51%
controls:0.23%
cases:0.28%
controls:0.05%
—
—
—
—
—
—
cases:0.26%
controls:0.04%
cases:0.47%
controls:0.19%
18
82
3520
35175
10
18
3531
35265
—
—
—
9
15
3430
34204
14
56
2994
29622
Pediatric Medicine
37 [38004477]
37 [38004477]
-2.7e-01
-5.1e-02
-3.6e-03
3.5e+00
5.6e-01
-1.8e-01
-2.0e-01
cases:1.84%
controls:2.40%
cases:1.24%
controls:1.31%
cases:0.37%
controls:0.37%
cases:0.65%
controls:0.02%
cases:0.57%
controls:0.32%
cases:1.02%
controls:1.21%
cases:1.50%
controls:1.83%
65
845
3473
34412
44
461
3497
34822
13
130
3528
35153
23
7
3518
35276
20
114
3514
35086
35
415
3404
33804
45
543
2963
29135
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
7.5e-02
3.2e-01
8.7e-01
1.5e+00
3.7e-01
2.4e-01
1.7e-01
cases:34.03%
controls:32.37%
cases:33.01%
controls:26.29%
cases:12.14%
controls:5.46%
cases:1.30%
controls:0.29%
cases:7.47%
controls:5.30%
cases:31.81%
controls:26.76%
cases:48.40%
controls:44.26%
1204
11413
2334
23844
1169
9275
2372
26008
430
1926
3111
33357
46
103
3495
35180
264
1865
3270
33335
1094
9158
2345
25061
1456
13135
1552
16543
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
7.3e-02
3.2e-01
8.8e-01
1.5e+00
3.6e-01
2.5e-01
1.6e-01
cases:33.89%
controls:32.28%
cases:33.01%
controls:26.26%
cases:12.17%
controls:5.44%
cases:1.27%
controls:0.29%
cases:7.44%
controls:5.30%
cases:31.78%
controls:26.71%
cases:48.27%
controls:44.18%
1199
11380
2339
23877
1169
9266
2372
26017
431
1918
3110
33365
45
103
3496
35180
263
1864
3271
33336
1093
9141
2346
25078
1452
13112
1556
16566
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
25907-7 [3000570]
1.1e-01
1.2e+00
—
—
2.3e+00
8.4e-01
6.6e-01
cases:0.45%
controls:0.41%
cases:0.40%
controls:0.12%
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.29%
controls:0.13%
cases:0.83%
controls:0.43%
16
143
3522
35114
14
44
3527
35239
—
—
6
6
3528
35194
10
43
3429
34176
25
128
2983
29550
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
7.4e-02
3.2e-01
8.8e-01
1.5e+00
3.6e-01
2.5e-01
1.7e-01
cases:33.97%
controls:32.34%
cases:32.96%
controls:26.28%
cases:12.14%
controls:5.44%
cases:1.27%
controls:0.29%
cases:7.41%
controls:5.29%
cases:31.81%
controls:26.73%
cases:48.37%
controls:44.26%
1202
11403
2336
23854
1167
9271
2374
26012
430
1920
3111
33363
45
103
3496
35180
262
1862
3272
33338
1094
9147
2345
25072
1455
13134
1553
16544
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
7.5e-02
3.2e-01
8.8e-01
1.5e+00
3.6e-01
2.4e-01
1.7e-01
cases:34.03%
controls:32.37%
cases:32.99%
controls:26.27%
cases:12.14%
controls:5.44%
cases:1.27%
controls:0.29%
cases:7.39%
controls:5.28%
cases:31.75%
controls:26.75%
cases:48.40%
controls:44.25%
1204
11414
2334
23843
1168
9270
2373
26013
430
1918
3111
33365
45
103
3496
35180
261
1858
3273
33342
1092
9154
2347
25065
1456
13133
1552
16545
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
7.3e-02
3.2e-01
8.7e-01
1.5e+00
3.7e-01
2.4e-01
1.6e-01
cases:34.06%
controls:32.43%
cases:33.07%
controls:26.36%
cases:12.17%
controls:5.47%
cases:1.27%
controls:0.29%
cases:7.47%
controls:5.31%
cases:31.84%
controls:26.83%
cases:48.40%
controls:44.35%
1205
11434
2333
23823
1171
9299
2370
25984
431
1931
3110
33352
45
103
3496
35180
264
1868
3270
33332
1095
9182
2344
25037
1456
13161
1552
16517
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
7.3e-02
3.2e-01
8.7e-01
1.5e+00
3.6e-01
2.5e-01
1.7e-01
cases:34.03%
controls:32.41%
cases:33.04%
controls:26.33%
cases:12.14%
controls:5.46%
cases:1.27%
controls:0.29%
cases:7.41%
controls:5.32%
cases:31.87%
controls:26.77%
cases:48.50%
controls:44.29%
1204
11426
2334
23831
1170
9291
2371
25992
430
1928
3111
33355
45
103
3496
35180
262
1871
3272
33329
1096
9161
2343
25058
1459
13144
1549
16534
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
7.5e-02
3.2e-01
8.7e-01
1.5e+00
3.6e-01
2.4e-01
1.6e-01
cases:34.03%
controls:32.38%
cases:32.96%
controls:26.31%
cases:12.14%
controls:5.45%
cases:1.27%
controls:0.29%
cases:7.44%
controls:5.30%
cases:31.81%
controls:26.77%
cases:48.37%
controls:44.28%
1204
11415
2334
23842
1167
9283
2374
26000
430
1924
3111
33359
45
103
3496
35180
263
1865
3271
33335
1094
9162
2345
25057
1455
13140
1553
16538
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
4.3e-01
8.7e-01
1.9e+00
—
—
6.7e-01
6.6e-01
cases:1.27%
controls:0.83%
cases:0.82%
controls:0.35%
cases:0.28%
controls:0.04%
—
—
—
—
cases:0.64%
controls:0.33%
cases:1.66%
controls:0.87%
45
293
3493
34964
29
122
3512
35161
10
15
3531
35268
—
—
22
112
3417
34107
50
258
2958
29420
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
3.5e-01
7.2e-01
1.9e+00
—
1.1e+00
1.6e-01
4.8e-01
cases:4.24%
controls:3.03%
cases:2.12%
controls:1.04%
cases:0.62%
controls:0.10%
—
—
cases:0.28%
controls:0.09%
cases:1.22%
controls:1.04%
cases:5.75%
controls:3.65%
150
1067
3388
34190
75
367
3466
34916
22
34
3519
35249
—
10
32
3524
35168
42
356
3397
33863
173
1082
2835
28596
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
1.8e-01
6.2e-01
1.3e+00
1.2e+00
3.9e-01
4.8e-01
4.0e-01
cases:18.51%
controls:15.92%
cases:16.52%
controls:9.62%
cases:6.58%
controls:1.84%
cases:0.23%
controls:0.07%
cases:2.49%
controls:1.70%
cases:14.66%
controls:9.60%
cases:28.19%
controls:20.77%
655
5613
2883
29644
585
3393
2956
31890
233
649
3308
34634
8
23
3533
35260
88
600
3446
34600
504
3286
2935
30933
848
6164
2160
23514
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.0e-01
6.4e-01
1.2e+00
—
5.9e-01
3.6e-01
4.2e-01
cases:18.20%
controls:15.44%
cases:13.24%
controls:7.47%
cases:3.05%
controls:0.95%
—
—
cases:1.70%
controls:0.95%
cases:10.47%
controls:7.55%
cases:26.96%
controls:19.50%
644
5443
2894
29814
469
2636
3072
32647
108
335
3433
34948
—
60
334
3474
34866
360
2584
3079
31635
811
5787
2197
23891
Disorder of eye and adnexa, unspecified
H57.9 [45552726]
H57.9 [45552726]
1.6e+00
—
—
—
—
—
1.8e+00
cases:0.23%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.05%
8
16
3530
35241
—
—
—
—
—
9
15
2999
29663
Extensive abdominal CT
JN3BD [2001305556]
JN3BD [2001305556]
3.8e-01
1.4e+00
—
1.0e+50
—
1.1e+00
9.1e-01
cases:1.38%
controls:0.96%
cases:0.99%
controls:0.26%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.52%
controls:0.17%
cases:1.66%
controls:0.68%
49
337
3489
34920
35
90
3506
35193
—
14
0
3527
35283
—
18
59
3421
34160
50
201
2958
29477
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
2.6e-01
9.1e-01
1.2e+00
—
5.1e-01
6.5e-01
5.8e-01
cases:4.44%
controls:3.47%
cases:2.68%
controls:1.10%
cases:0.34%
controls:0.10%
—
—
cases:0.17%
controls:0.10%
cases:1.98%
controls:1.04%
cases:7.11%
controls:4.10%
157
1224
3381
34033
95
389
3446
34894
12
35
3529
35248
—
6
36
3528
35164
68
355
3371
33864
214
1218
2794
28460
Electrophysiological examination of eye
XCD10 [2001300413]
XCD10 [2001300413]
7.9e-01
1.7e+00
—
1.0e+50
—
1.7e+00
9.8e-01
cases:0.37%
controls:0.17%
cases:0.25%
controls:0.05%
—
—
cases:0.23%
controls:0.00%
—
—
cases:0.32%
controls:0.06%
cases:0.47%
controls:0.18%
13
59
3525
35198
9
17
3532
35266
—
8
0
3533
35283
—
11
20
3428
34199
14
52
2994
29626
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
7.6e-02
3.4e-01
8.6e-01
1.2e+00
3.5e-01
3.2e-01
2.3e-01
cases:22.07%
controls:20.80%
cases:21.29%
controls:16.12%
cases:7.94%
controls:3.53%
cases:0.68%
controls:0.20%
cases:4.58%
controls:3.29%
cases:21.29%
controls:16.39%
cases:33.54%
controls:28.68%
781
7333
2757
27924
754
5687
2787
29596
281
1247
3260
34036
24
69
3517
35214
162
1157
3372
34043
732
5610
2707
28609
1009
8511
1999
21167
Cryotherapy
ZXC50 [2001311370]
ZXC50 [2001311370]
8.1e-01
1.1e+00
—
1.0e+50
—
2.0e+00
1.3e+00
cases:0.40%
controls:0.18%
cases:0.25%
controls:0.09%
—
—
cases:0.96%
controls:0.00%
—
—
cases:0.67%
controls:0.09%
cases:0.86%
controls:0.23%
14
62
3524
35195
9
30
3532
35253
—
34
0
3507
35283
—
23
32
3416
34187
26
69
2982
29609
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
3.4e-01
7.8e-01
1.4e+00
—
6.6e-01
5.3e-01
5.3e-01
cases:2.94%
controls:2.11%
cases:2.12%
controls:0.99%
cases:0.54%
controls:0.13%
—
—
cases:0.20%
controls:0.10%
cases:1.57%
controls:0.93%
cases:4.45%
controls:2.66%
104
745
3434
34512
75
348
3466
34935
19
45
3522
35238
—
7
36
3527
35164
54
318
3385
33901
134
790
2874
28888
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
2.5e-01
4.2e-01
7.6e-01
2.1e+00
7.1e-01
3.0e-01
2.3e-01
cases:4.92%
controls:3.87%
cases:3.05%
controls:2.03%
cases:0.88%
controls:0.41%
cases:0.25%
controls:0.03%
cases:0.76%
controls:0.38%
cases:2.94%
controls:2.19%
cases:5.52%
controls:4.43%
174
1366
3364
33891
108
718
3433
34565
31
145
3510
35138
9
11
3532
35272
27
133
3507
35067
101
749
3338
33470
166
1316
2842
28362
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
6.7e-01
7.1e-01
8.6e-01
—
8.6e-01
9.7e-01
9.0e-01
cases:1.07%
controls:0.55%
cases:0.82%
controls:0.40%
cases:0.25%
controls:0.11%
—
—
cases:0.25%
controls:0.11%
cases:0.93%
controls:0.36%
cases:1.23%
controls:0.51%
38
194
3500
35063
29
142
3512
35141
9
38
3532
35245
—
9
38
3525
35162
32
122
3407
34097
37
150
2971
29528
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
1.3e-01
5.1e-01
1.8e+00
—
4.6e-01
5.1e-01
4.5e-01
cases:8.17%
controls:7.26%
cases:6.41%
controls:3.95%
cases:3.36%
controls:0.58%
—
—
cases:0.93%
controls:0.59%
cases:6.28%
controls:3.88%
cases:14.13%
controls:9.50%
289
2561
3249
32696
227
1393
3314
33890
119
206
3422
35077
—
33
208
3501
34992
216
1328
3223
32891
425
2820
2583
26858
Day surgery
ZXD20 [2001311388]
ZXD20 [2001311388]
4.5e-01
8.2e-01
2.0e+00
1.0e+50
—
1.2e+00
5.0e-01
cases:1.75%
controls:1.12%
cases:0.54%
controls:0.24%
cases:0.20%
controls:0.03%
cases:0.14%
controls:0.00%
—
—
cases:0.67%
controls:0.21%
cases:1.53%
controls:0.93%
62
395
3476
34862
19
84
3522
35199
7
9
3534
35274
5
0
3536
35283
—
23
71
3416
34148
46
277
2962
29401
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
1.3e-01
5.7e-01
9.5e-01
—
7.6e-01
4.8e-01
4.6e-01
cases:6.59%
controls:5.84%
cases:4.57%
controls:2.63%
cases:0.99%
controls:0.39%
—
—
cases:0.74%
controls:0.35%
cases:4.27%
controls:2.68%
cases:10.87%
controls:7.14%
233
2060
3305
33197
162
928
3379
34355
35
136
3506
35147
—
26
122
3508
35078
147
918
3292
33301
327
2119
2681
27559
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
31017-7 [3019050]
3.1e-01
6.0e-01
2.0e+00
—
7.5e-01
3.4e-01
3.2e-01
cases:4.92%
controls:3.66%
cases:2.17%
controls:1.21%
cases:0.65%
controls:0.09%
—
—
cases:0.20%
controls:0.09%
cases:1.69%
controls:1.21%
cases:6.38%
controls:4.70%
174
1290
3364
33967
77
426
3464
34857
23
32
3518
35251
—
7
33
3527
35167
58
414
3381
33805
192
1395
2816
28283
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
JJ2AT [2001305254]
8.9e-01
—
—
—
—
2.1e+00
1.1e+00
cases:0.34%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.04%
cases:0.47%
controls:0.15%
12
49
3526
35208
—
—
—
—
12
15
3427
34204
14
45
2994
29633
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
2.5e-01
4.9e-01
7.6e-01
1.5e+00
1.1e+00
3.5e-01
2.9e-01
cases:32.39%
controls:27.19%
cases:12.93%
controls:8.34%
cases:2.01%
controls:0.95%
cases:0.23%
controls:0.05%
cases:2.57%
controls:0.90%
cases:11.40%
controls:8.35%
cases:32.15%
controls:26.21%
1146
9585
2392
25672
458
2941
3083
32342
71
336
3470
34947
8
18
3533
35265
91
318
3443
34882
392
2856
3047
31363
967
7778
2041
21900
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
K58.0 [45596336]
3.9e-01
8.5e-01
2.0e+00
—
2.0e+00
1.2e+00
5.0e-01
cases:0.82%
controls:0.56%
cases:0.34%
controls:0.14%
cases:0.17%
controls:0.02%
—
—
cases:0.14%
controls:0.02%
cases:0.38%
controls:0.12%
cases:0.96%
controls:0.59%
29
196
3509
35061
12
51
3529
35232
6
8
3535
35275
—
5
7
3529
35193
13
40
3426
34179
29
174
2979
29504
oxcarbazepine; oral
N03AF02 [21604418]
N03AF02 [21604418]
-1.2e-01
5.2e-01
6.1e-01
—
1.3e+00
9.5e-01
9.0e-01
cases:0.42%
controls:0.48%
cases:0.59%
controls:0.35%
cases:0.20%
controls:0.11%
—
—
cases:0.37%
controls:0.10%
cases:0.90%
controls:0.35%
cases:1.20%
controls:0.49%
15
169
3523
35088
21
125
3520
35158
7
38
3534
35245
—
13
34
3521
35166
31
120
3408
34099
36
146
2972
29532
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
2.0e-01
4.8e-01
4.6e-01
3.2e+00
6.0e-01
5.5e-01
1.4e-01
cases:1.47%
controls:1.21%
cases:1.10%
controls:0.69%
cases:0.28%
controls:0.18%
cases:0.34%
controls:0.01%
cases:0.28%
controls:0.16%
cases:1.25%
controls:0.72%
cases:1.86%
controls:1.62%
52
426
3486
34831
39
242
3502
35041
10
63
3531
35220
12
5
3529
35278
10
55
3524
35145
43
247
3396
33972
56
482
2952
29196
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
77147-7 [46236952]
3.9e-01
7.3e-01
1.6e+00
—
—
7.5e-01
1.7e-01
cases:1.61%
controls:1.10%
cases:0.90%
controls:0.44%
cases:0.42%
controls:0.08%
—
—
—
—
cases:0.93%
controls:0.44%
cases:1.70%
controls:1.44%
57
387
3481
34870
32
154
3509
35129
15
29
3526
35254
—
—
32
151
3407
34068
51
426
2957
29252
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
D01AC20 [21601936]
3.6e-01
5.4e-01
1.2e+00
—
1.0e+00
1.9e-01
2.7e-01
cases:5.09%
controls:3.60%
cases:2.06%
controls:1.21%
cases:0.40%
controls:0.12%
—
—
cases:0.42%
controls:0.15%
cases:1.51%
controls:1.26%
cases:4.99%
controls:3.86%
180
1270
3358
33987
73
428
3468
34855
14
42
3527
35241
—
15
54
3519
35146
52
431
3387
33788
150
1147
2858
28531
Special examination of mouth
SAA04 [2001310277]
SAA04 [2001310277]
7.2e-01
9.8e-01
—
1.0e+50
—
1.5e+00
8.9e-01
cases:0.90%
controls:0.44%
cases:0.23%
controls:0.09%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.29%
controls:0.06%
cases:1.03%
controls:0.43%
32
156
3506
35101
8
30
3533
35253
—
12
0
3529
35283
—
10
22
3429
34197
31
127
2977
29551
Nontoxic multinodular goitre
E04.2 [45576425]
E04.2 [45576425]
9.4e-01
—
—
—
—
1.3e+00
8.7e-01
cases:0.79%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.12%
cases:0.83%
controls:0.35%
28
110
3510
35147
—
—
—
—
15
41
3424
34178
25
104
2983
29574
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
2.7e-01
6.0e-01
1.1e+00
2.3e+00
9.5e-01
4.0e-01
2.3e-01
cases:4.58%
controls:3.53%
cases:3.36%
controls:1.88%
cases:0.76%
controls:0.24%
cases:0.14%
controls:0.01%
cases:0.57%
controls:0.22%
cases:2.97%
controls:2.00%
cases:7.65%
controls:6.17%
162
1245
3376
34012
119
664
3422
34619
27
86
3514
35197
5
5
3536
35278
20
77
3514
35123
102
686
3337
33533
230
1830
2778
27848
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
3.4e-01
6.8e-01
1.0e+00
-1.0e+50
4.5e-01
7.2e-01
3.4e-01
cases:3.65%
controls:2.62%
cases:2.37%
controls:1.22%
cases:0.51%
controls:0.18%
cases:0.00%
controls:0.01%
cases:0.23%
controls:0.14%
cases:2.50%
controls:1.24%
cases:5.22%
controls:3.77%
129
924
3409
34333
84
430
3457
34853
18
65
3523
35218
0
5
3541
35278
8
51
3526
35149
86
423
3353
33796
157
1119
2851
28559
Hematology
82 [38004501]
82 [38004501]
3.2e-01
6.2e-01
9.6e-01
—
3.3e-01
8.3e-01
6.8e-01
cases:1.27%
controls:0.93%
cases:1.16%
controls:0.62%
cases:0.51%
controls:0.20%
—
—
cases:0.28%
controls:0.20%
cases:1.31%
controls:0.57%
cases:2.03%
controls:1.04%
45
327
3493
34930
41
220
3500
35063
18
69
3523
35214
—
10
72
3524
35128
45
196
3394
34023
61
309
2947
29369
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
4.4e-01
6.5e-01
8.8e-01
—
5.9e-01
7.1e-01
4.2e-01
cases:3.99%
controls:2.60%
cases:2.12%
controls:1.12%
cases:0.56%
controls:0.24%
—
—
cases:0.37%
controls:0.20%
cases:2.44%
controls:1.22%
cases:5.22%
controls:3.50%
141
918
3397
34339
75
395
3466
34888
20
83
3521
35200
—
13
72
3521
35128
84
418
3355
33801
157
1039
2851
28639
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
2.8e-01
3.6e-01
9.8e-01
1.0e+50
1.6e+00
1.0e+00
5.0e-01
cases:3.73%
controls:2.84%
cases:1.02%
controls:0.71%
cases:0.23%
controls:0.09%
cases:0.42%
controls:0.00%
cases:0.28%
controls:0.06%
cases:1.60%
controls:0.60%
cases:3.99%
controls:2.46%
132
1002
3406
34255
36
252
3505
35031
8
30
3533
35253
15
0
3526
35283
10
21
3524
35179
55
204
3384
34015
120
730
2888
28948
Lumbar spine extensive MRI examination with high intensity magnet
NA3CG [2001307039]
NA3CG [2001307039]
7.1e-01
1.4e+00
—
—
—
1.7e+00
6.8e-01
cases:0.57%
controls:0.28%
cases:0.34%
controls:0.09%
—
—
—
—
—
—
cases:0.29%
controls:0.06%
cases:0.53%
controls:0.27%
20
98
3518
35159
12
30
3529
35253
—
—
—
10
19
3429
34200
16
80
2992
29598
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
D50.0 [45566697]
6.9e-01
1.2e+00
—
—
—
2.0e+00
1.0e+00
cases:0.37%
controls:0.18%
cases:0.28%
controls:0.09%
—
—
—
—
—
—
cases:0.47%
controls:0.06%
cases:0.57%
controls:0.21%
13
65
3525
35192
10
31
3531
35252
—
—
—
16
21
3423
34198
17
62
2991
29616
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
-6.9e-03
1.2e+00
—
1.0e+50
1.8e+00
7.2e-01
5.4e-01
cases:0.85%
controls:0.85%
cases:0.73%
controls:0.23%
—
—
cases:0.23%
controls:0.00%
cases:0.20%
controls:0.03%
cases:0.52%
controls:0.25%
cases:1.46%
controls:0.86%
30
301
3508
34956
26
81
3515
35202
—
8
0
3533
35283
7
11
3527
35189
18
87
3421
34132
44
255
2964
29423
Cardiology
6 [38004451]
6 [38004451]
1.8e-01
4.6e-01
8.5e-01
1.7e+00
7.7e-01
5.1e-01
4.1e-01
cases:9.47%
controls:8.00%
cases:5.56%
controls:3.60%
cases:1.38%
controls:0.60%
cases:0.14%
controls:0.03%
cases:1.19%
controls:0.55%
cases:5.73%
controls:3.52%
cases:13.30%
controls:9.23%
335
2822
3203
32435
197
1270
3344
34013
49
211
3492
35072
5
9
3536
35274
42
194
3492
35006
197
1203
3242
33016
400
2738
2608
26940
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
2.0e-01
5.0e-01
3.5e-01
8.6e-01
3.2e-01
3.8e-01
5.5e-01
cases:92.31%
controls:90.73%
cases:87.46%
controls:80.82%
cases:51.23%
controls:42.46%
cases:5.11%
controls:2.23%
cases:51.10%
controls:43.11%
cases:86.62%
controls:81.61%
cases:96.41%
controls:93.95%
3266
31988
272
3269
3097
28514
444
6769
1814
14982
1727
20301
181
787
3360
34496
1806
15174
1728
20026
2979
27927
460
6292
2900
27882
108
1796
Localized swelling, mass and lump, lower limb
R22.4 [45597173]
R22.4 [45597173]
7.4e-01
2.0e+00
—
—
—
7.2e-01
9.7e-01
cases:0.37%
controls:0.18%
cases:0.37%
controls:0.05%
—
—
—
—
—
—
cases:0.17%
controls:0.08%
cases:0.53%
controls:0.20%
13
62
3525
35195
13
18
3528
35265
—
—
—
6
29
3433
34190
16
60
2992
29618
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
1.9e-01
8.1e-01
1.1e+00
—
6.6e-01
5.8e-01
4.4e-01
cases:4.27%
controls:3.57%
cases:4.21%
controls:1.92%
cases:1.02%
controls:0.33%
—
—
cases:0.54%
controls:0.28%
cases:3.49%
controls:1.99%
cases:7.55%
controls:5.00%
151
1257
3387
34000
149
679
3392
34604
36
118
3505
35165
—
19
98
3515
35102
120
682
3319
33537
227
1484
2781
28194
calcipotriol; ointment
D05AX02 [21602039]
D05AX02 [21602039]
7.4e-01
1.4e+00
—
—
—
1.5e+00
6.1e-01
cases:0.51%
controls:0.24%
cases:0.28%
controls:0.07%
—
—
—
—
—
—
cases:0.29%
controls:0.06%
cases:0.37%
controls:0.20%
18
86
3520
35171
10
24
3531
35259
—
—
—
10
22
3429
34197
11
59
2997
29619
Body temperature
8310-5 [3020891]
8310-5 [3020891]
2.8e-03
5.8e-01
-1.0e+50
—
1.9e+00
9.9e-01
5.2e-01
cases:0.45%
controls:0.45%
cases:0.37%
controls:0.21%
cases:0.00%
controls:0.02%
—
—
cases:0.20%
controls:0.03%
cases:0.52%
controls:0.20%
cases:1.53%
controls:0.91%
16
159
3522
35098
13
73
3528
35210
0
7
3541
35276
—
7
10
3527
35190
18
67
3421
34152
46
271
2962
29407
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
33718-8 [3043109]
5.5e-01
1.4e+00
—
—
—
1.5e+00
5.6e-01
cases:0.62%
controls:0.36%
cases:0.42%
controls:0.10%
—
—
—
—
—
—
cases:0.32%
controls:0.07%
cases:0.53%
controls:0.30%
22
127
3516
35130
15
37
3526
35246
—
—
—
11
24
3428
34195
16
90
2992
29588
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
1.4e-01
4.3e-01
1.2e+00
—
1.1e+00
6.1e-01
2.8e-01
cases:3.11%
controls:2.71%
cases:1.78%
controls:1.16%
cases:0.48%
controls:0.14%
—
—
cases:0.42%
controls:0.15%
cases:1.92%
controls:1.05%
cases:3.62%
controls:2.77%
110
955
3428
34302
63
409
3478
34874
17
50
3524
35233
—
15
52
3519
35148
66
361
3373
33858
109
823
2899
28855
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.7e-02
4.4e-01
8.6e-01
1.7e+00
8.8e-01
3.7e-01
3.3e-01
cases:7.60%
controls:7.28%
cases:5.93%
controls:3.90%
cases:1.33%
controls:0.57%
cases:0.20%
controls:0.04%
cases:1.30%
controls:0.54%
cases:5.52%
controls:3.88%
cases:12.57%
controls:9.33%
269
2567
3269
32690
210
1377
3331
33906
47
200
3494
35083
7
13
3534
35270
46
191
3488
35009
190
1328
3249
32891
378
2768
2630
26910
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
-8.7e-02
1.1e-01
4.0e-01
2.9e+00
1.4e-01
2.2e-01
-1.9e-02
cases:3.93%
controls:4.27%
cases:2.46%
controls:2.21%
cases:0.71%
controls:0.48%
cases:0.65%
controls:0.04%
cases:0.48%
controls:0.42%
cases:3.05%
controls:2.48%
cases:5.82%
controls:5.92%
139
1505
3399
33752
87
780
3454
34503
25
168
3516
35115
23
13
3518
35270
17
148
3517
35052
105
847
3334
33372
175
1757
2833
27921
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
2.4e-01
7.1e-01
4.4e-01
—
1.2e+00
1.1e+00
1.0e+00
cases:3.45%
controls:2.73%
cases:1.38%
controls:0.68%
cases:0.14%
controls:0.09%
—
—
cases:0.23%
controls:0.07%
cases:1.45%
controls:0.47%
cases:3.66%
controls:1.36%
122
961
3416
34296
49
241
3492
35042
5
32
3536
35251
—
8
24
3526
35176
50
160
3389
34059
110
404
2898
29274
Excision of lesion of eyelid
CBB30 [2001300933]
CBB30 [2001300933]
5.5e-02
—
—
1.0e+50
—
1.7e+00
1.2e+00
cases:0.20%
controls:0.19%
—
—
—
—
cases:0.25%
controls:0.00%
—
—
cases:0.26%
controls:0.05%
cases:0.47%
controls:0.14%
7
66
3531
35191
—
—
9
0
3532
35283
—
9
17
3430
34202
14
42
2994
29636
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
1.9e-01
4.8e-01
6.9e-01
—
9.7e-01
8.5e-01
5.5e-01
cases:4.75%
controls:3.97%
cases:2.23%
controls:1.40%
cases:0.37%
controls:0.18%
—
—
cases:0.57%
controls:0.22%
cases:2.88%
controls:1.26%
cases:6.28%
controls:3.73%
168
1398
3370
33859
79
493
3462
34790
13
65
3528
35218
—
20
76
3514
35124
99
430
3340
33789
189
1107
2819
28571
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
2.1e-01
4.2e-01
7.3e-01
1.3e+00
6.2e-01
4.5e-01
3.9e-01
cases:16.53%
controls:13.78%
cases:9.57%
controls:6.48%
cases:1.98%
controls:0.96%
cases:0.14%
controls:0.04%
cases:1.64%
controls:0.89%
cases:9.94%
controls:6.59%
cases:22.74%
controls:16.68%
585
4858
2953
30399
339
2286
3202
32997
70
338
3471
34945
5
14
3536
35269
58
313
3476
34887
342
2255
3097
31964
684
4950
2324
24728
General Practice Dentistry
1223G0001X [38003675]
1223G0001X [38003675]
4.9e-01
5.4e-01
1.4e+00
1.0e+50
1.7e+00
1.1e+00
4.3e-01
cases:0.76%
controls:0.47%
cases:0.34%
controls:0.20%
cases:0.23%
controls:0.05%
cases:0.59%
controls:0.00%
cases:0.28%
controls:0.05%
cases:0.73%
controls:0.24%
cases:0.96%
controls:0.63%
27
166
3511
35091
12
70
3529
35213
8
19
3533
35264
21
0
3520
35283
10
18
3524
35182
25
82
3414
34137
29
187
2979
29491
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
2.5e-01
7.8e-01
1.5e+00
1.0e+50
1.5e+00
5.2e-01
5.0e-01
cases:2.74%
controls:2.15%
cases:1.47%
controls:0.68%
cases:0.23%
controls:0.05%
cases:0.14%
controls:0.00%
cases:0.28%
controls:0.06%
cases:1.13%
controls:0.68%
cases:3.49%
controls:2.14%
97
757
3441
34500
52
240
3489
35043
8
17
3533
35266
5
0
3536
35283
10
22
3524
35178
39
232
3400
33987
105
635
2903
29043
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
-9.6e-02
-5.2e-02
4.2e-01
2.8e+00
2.4e-01
-1.6e-01
-4.2e-02
cases:2.88%
controls:3.17%
cases:1.61%
controls:1.69%
cases:0.45%
controls:0.30%
cases:0.37%
controls:0.02%
cases:0.37%
controls:0.29%
cases:1.54%
controls:1.81%
cases:4.19%
controls:4.36%
102
1116
3436
34141
57
598
3484
34685
16
105
3525
35178
13
8
3528
35275
13
102
3521
35098
53
620
3386
33599
126
1294
2882
28384
Radiculopathy
M54.1 [45577287]
M54.1 [45577287]
4.9e-01
1.8e+00
—
—
—
6.9e-01
1.0e+00
cases:0.40%
controls:0.24%
cases:0.40%
controls:0.07%
—
—
—
—
—
—
cases:0.17%
controls:0.09%
cases:0.70%
controls:0.25%
14
86
3524
35171
14
24
3527
35259
—
—
—
6
30
3433
34189
21
75
2987
29603
Other malformations of cerebral vessels
Q28.3 [45544086]
Q28.3 [45544086]
2.0e+00
2.8e+00
—
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.23%
controls:0.01%
—
—
—
—
—
—
—
—
—
—
5
7
3533
35250
8
5
3533
35278
—
—
—
—
—
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
1.0e-01
4.7e-01
7.1e-01
1.7e+00
7.8e-01
4.4e-01
3.7e-01
cases:14.13%
controls:12.94%
cases:9.09%
controls:5.88%
cases:1.84%
controls:0.91%
cases:0.17%
controls:0.03%
cases:1.78%
controls:0.83%
cases:8.99%
controls:5.96%
cases:21.18%
controls:15.70%
500
4563
3038
30694
322
2074
3219
33209
65
321
3476
34962
6
11
3535
35272
63
291
3471
34909
309
2041
3130
32178
637
4658
2371
25020
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
D17.1 [45566667]
D17.1 [45566667]
8.3e-01
1.6e+00
—
—
—
1.1e+00
1.2e+00
cases:0.48%
controls:0.21%
cases:0.31%
controls:0.06%
—
—
—
—
—
—
cases:0.26%
controls:0.09%
cases:0.73%
controls:0.23%
17
74
3521
35183
11
22
3530
35261
—
—
—
9
30
3430
34189
22
69
2986
29609
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
5.7e-02
2.5e-01
8.0e-01
1.5e+00
2.8e-01
2.2e-01
1.0e-01
cases:25.27%
controls:24.21%
cases:22.23%
controls:18.17%
cases:7.74%
controls:3.64%
cases:0.85%
controls:0.19%
cases:4.56%
controls:3.48%
cases:21.69%
controls:18.17%
cases:35.17%
controls:32.87%
894
8537
2644
26720
787
6410
2754
28873
274
1286
3267
33997
30
68
3511
35215
161
1225
3373
33975
746
6217
2693
28002
1058
9756
1950
19922
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
8095-2 [3007566]
5.7e-01
1.4e+00
—
—
—
1.4e+00
3.1e-01
cases:0.71%
controls:0.40%
cases:0.54%
controls:0.14%
—
—
—
—
—
—
cases:0.49%
controls:0.13%
cases:0.66%
controls:0.49%
25
141
3513
35116
19
48
3522
35235
—
—
—
17
43
3422
34176
20
145
2988
29533
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
3.7e-01
5.7e-01
9.4e-01
—
1.0e+00
4.8e-01
3.1e-01
cases:6.84%
controls:4.83%
cases:2.49%
controls:1.42%
cases:0.31%
controls:0.12%
—
—
cases:0.42%
controls:0.16%
cases:2.21%
controls:1.38%
cases:6.85%
controls:5.14%
242
1703
3296
33554
88
501
3453
34782
11
43
3530
35240
—
15
55
3519
35145
76
471
3363
33748
206
1524
2802
28154
Epilepsy
G40 [45595935]
G40 [45595935]
-3.0e-01
1.6e+00
—
—
—
1.0e+00
1.1e+00
cases:0.23%
controls:0.31%
cases:0.37%
controls:0.07%
—
—
—
—
—
—
cases:0.26%
controls:0.09%
cases:0.76%
controls:0.25%
8
108
3530
35149
13
26
3528
35257
—
—
—
9
32
3430
34187
23
75
2985
29603
Stomatognathic treatment, basic
SHA02 [2001310406]
SHA02 [2001310406]
7.6e-01
6.6e-01
—
—
-1.0e+50
1.3e+00
6.3e-01
cases:1.38%
controls:0.66%
cases:0.40%
controls:0.20%
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.76%
controls:0.20%
cases:1.46%
controls:0.79%
49
231
3489
35026
14
72
3527
35211
—
—
0
9
3534
35191
26
69
3413
34150
44
233
2964
29445
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
D21.1 [45537899]
D21.1 [45537899]
1.1e+00
—
1.0e+50
—
—
2.7e+00
1.6e+00
cases:0.17%
controls:0.05%
—
—
cases:0.14%
controls:0.00%
—
—
—
—
cases:0.26%
controls:0.02%
cases:0.23%
controls:0.05%
6
19
3532
35238
—
5
0
3536
35283
—
—
9
6
3430
34213
7
14
3001
29664
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.1e-01
3.4e-01
9.4e-01
1.0e+00
2.3e-01
2.2e-01
1.9e-01
cases:30.13%
controls:27.88%
cases:26.80%
controls:20.73%
cases:8.87%
controls:3.66%
cases:0.42%
controls:0.15%
cases:4.39%
controls:3.51%
cases:25.18%
controls:21.29%
cases:43.75%
controls:39.18%
1066
9829
2472
25428
949
7315
2592
27968
314
1292
3227
33991
15
54
3526
35229
155
1234
3379
33966
866
7285
2573
26934
1316
11627
1692
18051
CT of urinary organs
KH1AD [2001306328]
KH1AD [2001306328]
-2.7e-01
1.5e+00
—
—
-1.0e+50
—
1.2e+00
cases:0.20%
controls:0.26%
cases:0.37%
controls:0.08%
—
—
—
—
cases:0.00%
controls:0.01%
—
—
cases:0.76%
controls:0.23%
7
91
3531
35166
13
29
3528
35254
—
—
0
5
3534
35195
—
23
69
2985
29609
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
2.9e-01
6.8e-01
1.2e+00
—
4.7e-01
4.7e-01
3.4e-01
cases:2.80%
controls:2.12%
cases:2.09%
controls:1.07%
cases:0.48%
controls:0.15%
—
—
cases:0.25%
controls:0.16%
cases:1.86%
controls:1.17%
cases:4.42%
controls:3.19%
99
746
3439
34511
74
379
3467
34904
17
52
3524
35231
—
9
56
3525
35144
64
402
3375
33817
133
946
2875
28732
Person consulting for explanation of investigation findings
Z71.2 [45552100]
Z71.2 [45552100]
2.1e-01
4.7e-01
1.3e+00
—
4.0e-01
4.5e-01
4.8e-01
cases:4.27%
controls:3.50%
cases:2.32%
controls:1.46%
cases:0.65%
controls:0.18%
—
—
cases:0.28%
controls:0.19%
cases:2.56%
controls:1.65%
cases:7.91%
controls:5.06%
151
1234
3387
34023
82
516
3459
34767
23
65
3518
35218
—
10
67
3524
35133
88
564
3351
33655
238
1502
2770
28176
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
2.8e-01
6.5e-01
1.1e+00
—
5.1e-01
4.6e-01
4.2e-01
cases:2.66%
controls:2.03%
cases:2.06%
controls:1.09%
cases:0.48%
controls:0.16%
—
—
cases:0.28%
controls:0.17%
cases:2.04%
controls:1.29%
cases:5.22%
controls:3.48%
94
715
3444
34542
73
385
3468
34898
17
55
3524
35228
—
10
60
3524
35140
70
443
3369
33776
157
1034
2851
28644
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
1.2e-01
5.1e-01
1.6e+00
—
5.1e-01
3.0e-01
2.6e-01
cases:14.64%
controls:13.25%
cases:9.71%
controls:6.07%
cases:2.94%
controls:0.62%
—
—
cases:1.13%
controls:0.68%
cases:7.79%
controls:5.87%
cases:20.25%
controls:16.44%
518
4670
3020
30587
344
2141
3197
33142
104
217
3437
35066
—
40
241
3494
34959
268
2010
3171
32209
609
4878
2399
24800
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
1.7e-01
4.5e-01
8.9e-01
1.8e+00
6.2e-01
4.2e-01
2.7e-01
cases:10.12%
controls:8.71%
cases:7.03%
controls:4.61%
cases:1.52%
controls:0.63%
cases:0.17%
controls:0.03%
cases:1.22%
controls:0.66%
cases:7.33%
controls:4.94%
cases:17.35%
controls:13.83%
358
3071
3180
32186
249
1625
3292
33658
54
222
3487
35061
6
10
3535
35273
43
232
3491
34968
252
1691
3187
32528
522
4105
2486
25573
Sequelae of intracerebral haemorrhage
I69.1 [45538404]
I69.1 [45538404]
—
1.3e+00
—
—
—
1.6e+00
1.1e+00
—
—
cases:0.25%
controls:0.07%
—
—
—
—
—
—
cases:0.32%
controls:0.07%
cases:0.47%
controls:0.16%
—
9
24
3532
35259
—
—
—
11
23
3428
34196
14
47
2994
29631
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
1.8e-01
4.6e-01
8.9e-01
1.6e+00
6.1e-01
4.2e-01
2.6e-01
cases:10.12%
controls:8.59%
cases:6.98%
controls:4.54%
cases:1.50%
controls:0.62%
cases:0.14%
controls:0.03%
cases:1.19%
controls:0.65%
cases:7.33%
controls:4.92%
cases:17.05%
controls:13.68%
358
3029
3180
32228
247
1602
3294
33681
53
219
3488
35064
5
10
3536
35273
42
229
3492
34971
252
1682
3187
32537
513
4061
2495
25617
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
1.3e-01
3.3e-01
1.5e+00
—
8.1e-01
5.8e-01
5.2e-01
cases:3.17%
controls:2.79%
cases:1.38%
controls:0.99%
cases:0.48%
controls:0.10%
—
—
cases:0.20%
controls:0.09%
cases:1.54%
controls:0.87%
cases:4.09%
controls:2.46%
112
985
3426
34272
49
351
3492
34932
17
37
3524
35246
—
7
31
3527
35169
53
296
3386
33923
123
731
2885
28947
Unspecified haematuria
R31 [45553726]
R31 [45553726]
2.3e-01
5.5e-01
—
—
2.0e+00
5.6e-01
5.8e-01
cases:0.96%
controls:0.77%
cases:0.42%
controls:0.24%
—
—
—
—
cases:0.20%
controls:0.03%
cases:0.47%
controls:0.27%
cases:1.53%
controls:0.86%
34
270
3504
34987
15
86
3526
35197
—
—
7
9
3527
35191
16
91
3423
34128
46
255
2962
29423
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
1.9e-01
4.6e-01
8.5e-01
1.7e+00
6.2e-01
4.4e-01
2.5e-01
cases:9.98%
controls:8.42%
cases:6.92%
controls:4.46%
cases:1.44%
controls:0.62%
cases:0.14%
controls:0.03%
cases:1.19%
controls:0.64%
cases:7.36%
controls:4.85%
cases:16.79%
controls:13.55%
353
2969
3185
32288
245
1574
3296
33709
51
218
3490
35065
5
9
3536
35274
42
227
3492
34973
253
1660
3186
32559
505
4021
2503
25657
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
3.4e-01
1.3e+00
—
1.0e+50
—
7.9e-01
5.5e-01
cases:0.96%
controls:0.68%
cases:1.44%
controls:0.40%
—
—
cases:0.48%
controls:0.00%
—
—
cases:0.90%
controls:0.41%
cases:2.39%
controls:1.40%
34
241
3504
35016
51
142
3490
35141
—
17
0
3524
35283
—
31
140
3408
34079
72
415
2936
29263
Malignant neoplasm of prostate
C61 [45547509]
C61 [45547509]
3.5e-02
2.2e-01
2.3e-01
2.6e+00
1.2e-01
1.6e-01
2.7e-01
cases:1.27%
controls:1.23%
cases:1.21%
controls:0.97%
cases:0.34%
controls:0.27%
cases:0.31%
controls:0.02%
cases:0.31%
controls:0.28%
cases:1.19%
controls:1.02%
cases:1.86%
controls:1.43%
45
433
3493
34824
43
343
3498
34940
12
95
3529
35188
11
8
3530
35275
11
97
3523
35103
41
348
3398
33871
56
423
2952
29255
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5810-7 [3019150]
1.2e-01
3.5e-01
1.0e+00
—
8.5e-01
3.7e-01
1.8e-01
cases:4.52%
controls:4.01%
cases:3.05%
controls:2.17%
cases:0.73%
controls:0.26%
—
—
cases:0.65%
controls:0.28%
cases:3.29%
controls:2.29%
cases:7.91%
controls:6.71%
160
1415
3378
33842
108
765
3433
34518
26
92
3515
35191
—
23
98
3511
35102
113
785
3326
33434
238
1992
2770
27686
Specialty-specific consultation based on referral by dentist or doctor
WZC05 [2001310886]
WZC05 [2001310886]
5.2e-01
9.5e-01
—
1.0e+50
—
1.6e+00
1.0e+00
cases:0.68%
controls:0.40%
cases:0.20%
controls:0.08%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.49%
controls:0.10%
cases:1.00%
controls:0.37%
24
142
3514
35115
7
27
3534
35256
—
14
0
3527
35283
—
17
34
3422
34185
30
110
2978
29568
Surface analgesia on skin or mucosa
WX105 [2001310765]
WX105 [2001310765]
4.0e-02
3.3e-01
1.8e+00
—
-1.0e+50
5.0e-01
7.5e-01
cases:1.13%
controls:1.09%
cases:0.51%
controls:0.37%
cases:0.20%
controls:0.03%
—
—
cases:0.00%
controls:0.03%
cases:0.49%
controls:0.30%
cases:2.26%
controls:1.08%
40
383
3498
34874
18
129
3523
35154
7
11
3534
35272
—
0
10
3534
35190
17
103
3422
34116
68
321
2940
29357
Telephone prescription or other care instructions
WZB00 [2001310884]
WZB00 [2001310884]
1.5e-01
2.5e-01
6.3e-01
—
1.7e+00
6.4e-01
2.9e-01
cases:4.21%
controls:3.66%
cases:1.50%
controls:1.17%
cases:0.28%
controls:0.15%
—
—
cases:0.62%
controls:0.12%
cases:2.09%
controls:1.11%
cases:5.49%
controls:4.15%
149
1290
3389
33967
53
414
3488
34869
10
53
3531
35230
—
22
42
3512
35158
72
380
3367
33839
165
1232
2843
28446
Helicobacter pylori Ag [Presence] in Stool
31843-6 [3013139]
31843-6 [3013139]
3.0e-01
1.0e+00
—
—
—
9.3e-01
6.2e-01
cases:1.47%
controls:1.09%
cases:0.79%
controls:0.28%
—
—
—
—
—
—
cases:0.70%
controls:0.28%
cases:2.09%
controls:1.14%
52
385
3486
34872
28
99
3513
35184
—
—
—
24
95
3415
34124
63
338
2945
29340
Calculus of gallbladder without cholecystitis
K80.2 [45552951]
K80.2 [45552951]
3.8e-01
8.5e-01
1.7e+00
1.0e+50
1.3e+00
5.4e-01
3.2e-01
cases:1.53%
controls:1.05%
cases:0.68%
controls:0.29%
cases:0.25%
controls:0.05%
cases:0.45%
controls:0.00%
cases:0.17%
controls:0.05%
cases:0.49%
controls:0.29%
cases:1.33%
controls:0.97%
54
371
3484
34886
24
103
3517
35180
9
16
3532
35267
16
0
3525
35283
6
17
3528
35183
17
99
3422
34120
40
287
2968
29391
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
2.5e-01
4.0e-01
1.2e+00
—
8.3e-01
5.9e-01
4.1e-01
cases:4.49%
controls:3.53%
cases:2.51%
controls:1.69%
cases:0.65%
controls:0.20%
—
—
cases:0.48%
controls:0.21%
cases:3.11%
controls:1.74%
cases:7.55%
controls:5.16%
159
1244
3379
34013
89
597
3452
34686
23
72
3518
35211
—
17
74
3517
35126
107
596
3332
33623
227
1530
2781
28148
Ultrasound elastography of liver
JJ1LE [2001305253]
JJ1LE [2001305253]
1.4e+00
—
—
—
—
2.6e+00
—
cases:0.17%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.02%
—
—
6
15
3532
35242
—
—
—
—
9
7
3430
34212
—
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
2.5e-01
9.3e-01
—
—
—
1.6e+00
4.5e-01
cases:1.84%
controls:1.44%
cases:0.65%
controls:0.26%
—
—
—
—
—
—
cases:1.05%
controls:0.21%
cases:1.50%
controls:0.96%
65
506
3473
34751
23
91
3518
35192
—
—
—
36
72
3403
34147
45
284
2963
29394
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
19113-0 [3005322]
1.1e-01
8.8e-01
1.5e+00
—
—
1.0e+00
6.3e-01
cases:1.10%
controls:0.99%
cases:0.71%
controls:0.29%
cases:0.14%
controls:0.03%
—
—
—
—
cases:0.76%
controls:0.28%
cases:2.26%
controls:1.21%
39
349
3499
34908
25
104
3516
35179
5
11
3536
35272
—
—
26
95
3413
34124
68
360
2940
29318
Total thyroidectomy
BAA60 [2001300753]
BAA60 [2001300753]
2.2e-01
—
—
—
—
2.5e+00
5.9e-01
cases:0.20%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.32%
controls:0.03%
cases:0.20%
controls:0.11%
7
56
3531
35201
—
—
—
—
11
9
3428
34210
6
33
3002
29645
Incomplete excision of soft tissue tumour of wrist or hand
NDR20 [2001307741]
NDR20 [2001307741]
—
2.1e+00
—
1.0e+50
—
2.5e+00
7.2e-01
—
—
cases:0.14%
controls:0.02%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.32%
controls:0.03%
cases:0.17%
controls:0.08%
—
5
6
3536
35277
—
11
0
3530
35283
—
11
9
3428
34210
5
24
3003
29654
Metanephrine [Moles/volume] in Serum or Plasma
25473-0 [3009340]
25473-0 [3009340]
1.1e+00
9.6e-01
—
—
—
1.5e+00
1.4e+00
cases:0.51%
controls:0.18%
cases:0.17%
controls:0.07%
—
—
—
—
—
—
cases:0.23%
controls:0.05%
cases:0.50%
controls:0.12%
18
62
3520
35195
6
23
3535
35260
—
—
—
8
17
3431
34202
15
36
2993
29642
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
3.7e-01
5.6e-01
6.9e-01
—
4.1e-01
4.4e-01
4.2e-01
cases:10.97%
controls:7.85%
cases:6.75%
controls:3.98%
cases:1.67%
controls:0.84%
—
—
cases:1.30%
controls:0.87%
cases:6.14%
controls:4.03%
cases:11.84%
controls:8.13%
388
2767
3150
32490
239
1403
3302
33880
59
298
3482
34985
—
46
305
3488
34895
211
1378
3228
32841
356
2413
2652
27265
levocetirizine; oral
R06AE09 [21603498]
R06AE09 [21603498]
5.8e-01
6.3e-01
9.5e-01
—
—
7.2e-01
5.2e-01
cases:3.25%
controls:1.85%
cases:1.61%
controls:0.86%
cases:0.40%
controls:0.15%
—
—
—
—
cases:1.77%
controls:0.87%
cases:2.96%
controls:1.78%
115
653
3423
34604
57
304
3484
34979
14
54
3527
35229
—
—
61
299
3378
33920
89
527
2919
29151
Other specified rheumatoid arthritis
M06.8 [45543441]
M06.8 [45543441]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.23%
controls:0.02%
—
—
—
—
—
—
7
6
3001
29672
Extensive MRI of small bowel
JF1CG [2001304816]
JF1CG [2001304816]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.23%
controls:0.02%
—
—
—
—
—
—
7
6
3001
29672
combinations of corticosteroids
D07XB30 [21602188]
D07XB30 [21602188]
3.1e-01
5.0e-01
9.6e-01
—
4.6e-01
3.9e-01
2.8e-01
cases:13.34%
controls:10.13%
cases:5.62%
controls:3.48%
cases:0.99%
controls:0.38%
—
—
cases:0.74%
controls:0.47%
cases:5.12%
controls:3.53%
cases:13.90%
controls:10.90%
472
3573
3066
31684
199
1228
3342
34055
35
134
3506
35149
—
26
164
3508
35036
176
1207
3263
33012
418
3234
2590
26444
combinations of corticosteroids
D07AB30 [21602118]
D07AB30 [21602118]
3.1e-01
5.0e-01
9.6e-01
—
4.6e-01
3.9e-01
2.8e-01
cases:13.34%
controls:10.13%
cases:5.62%
controls:3.48%
cases:0.99%
controls:0.38%
—
—
cases:0.74%
controls:0.47%
cases:5.12%
controls:3.53%
cases:13.90%
controls:10.90%
472
3573
3066
31684
199
1228
3342
34055
35
134
3506
35149
—
26
164
3508
35036
176
1207
3263
33012
418
3234
2590
26444
Biopsy of lip
TEA00 [2001301899]
TEA00 [2001301899]
—
—
—
1.0e+50
—
2.4e+00
1.5e+00
—
—
—
—
—
—
cases:0.37%
controls:0.00%
—
—
cases:0.23%
controls:0.02%
cases:0.20%
controls:0.04%
—
—
—
13
0
3528
35283
—
8
7
3431
34212
6
13
3002
29665
Congenital non-neoplastic naevus
Q82.58 [2000503507]
Q82.58 [2000503507]
—
2.4e+00
—
—
—
—
1.3e+00
—
—
cases:0.25%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.17%
controls:0.05%
—
9
8
3532
35275
—
—
—
—
5
14
3003
29664
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
AA1DG [2001300120]
2.7e-01
1.4e+00
—
—
—
1.5e+00
9.7e-01
cases:0.28%
controls:0.22%
cases:0.31%
controls:0.07%
—
—
—
—
—
—
cases:0.20%
controls:0.05%
cases:0.53%
controls:0.20%
10
76
3528
35181
11
26
3530
35257
—
—
—
7
16
3432
34203
16
60
2992
29618
Hyperlipidaemia, unspecified
E78.5 [45537986]
E78.5 [45537986]
5.7e-02
4.1e-01
1.6e+00
—
8.3e-01
8.0e-01
3.5e-01
cases:1.02%
controls:0.96%
cases:0.62%
controls:0.41%
cases:0.25%
controls:0.05%
—
—
cases:0.17%
controls:0.07%
cases:0.93%
controls:0.42%
cases:2.03%
controls:1.44%
36
339
3502
34918
22
146
3519
35137
9
18
3532
35265
—
6
26
3528
35174
32
144
3407
34075
61
426
2947
29252
ranitidine bismuth citrate; oral
A02BA07 [21600088]
A02BA07 [21600088]
3.4e-01
9.3e-01
6.9e-01
—
9.8e-01
8.8e-01
5.7e-01
cases:2.54%
controls:1.83%
cases:1.30%
controls:0.52%
cases:0.20%
controls:0.10%
—
—
cases:0.23%
controls:0.09%
cases:1.16%
controls:0.49%
cases:2.19%
controls:1.25%
90
645
3448
34612
46
182
3495
35101
7
35
3534
35248
—
8
30
3526
35170
40
167
3399
34052
66
372
2942
29306
ranitidine; oral, parenteral
A02BA02 [21600083]
A02BA02 [21600083]
3.4e-01
9.3e-01
6.9e-01
—
9.8e-01
8.8e-01
5.7e-01
cases:2.54%
controls:1.83%
cases:1.30%
controls:0.52%
cases:0.20%
controls:0.10%
—
—
cases:0.23%
controls:0.09%
cases:1.16%
controls:0.49%
cases:2.19%
controls:1.25%
90
645
3448
34612
46
182
3495
35101
7
35
3534
35248
—
8
30
3526
35170
40
167
3399
34052
66
372
2942
29306
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
1.2e-01
8.7e-01
1.2e+00
—
—
7.9e-01
7.0e-01
cases:0.90%
controls:0.80%
cases:0.79%
controls:0.33%
cases:0.23%
controls:0.07%
—
—
—
—
cases:0.79%
controls:0.36%
cases:1.86%
controls:0.93%
32
283
3506
34974
28
117
3513
35166
8
23
3533
35260
—
—
27
122
3412
34097
56
276
2952
29402
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
5.7e-01
8.1e-01
2.1e+00
—
—
1.0e+00
7.6e-01
cases:1.36%
controls:0.77%
cases:0.56%
controls:0.25%
cases:0.14%
controls:0.02%
—
—
—
—
cases:0.73%
controls:0.26%
cases:1.66%
controls:0.79%
48
271
3490
34986
20
89
3521
35194
5
6
3536
35277
—
—
25
89
3414
34130
50
233
2958
29445
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
1.1e-01
5.6e-01
—
—
—
1.6e+00
7.9e-01
cases:0.42%
controls:0.38%
cases:0.37%
controls:0.21%
—
—
—
—
—
—
cases:0.44%
controls:0.09%
cases:0.96%
controls:0.44%
15
134
3523
35123
13
74
3528
35209
—
—
—
15
31
3424
34188
29
131
2979
29547
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
G40.22 [2000502141]
2.6e-01
7.4e-01
—
—
—
1.2e+00
1.2e+00
cases:0.31%
controls:0.24%
cases:0.25%
controls:0.12%
—
—
—
—
—
—
cases:0.47%
controls:0.15%
cases:1.06%
controls:0.32%
11
85
3527
35172
9
43
3532
35240
—
—
—
16
50
3423
34169
32
96
2976
29582
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
2742-5 [3034780]
3.9e-01
1.2e+00
1.4e+00
—
—
1.2e+00
5.6e-01
cases:0.93%
controls:0.64%
cases:0.85%
controls:0.26%
cases:0.14%
controls:0.03%
—
—
—
—
cases:0.64%
controls:0.20%
cases:1.30%
controls:0.75%
33
224
3505
35033
30
93
3511
35190
5
12
3536
35271
—
—
22
68
3417
34151
39
222
2969
29456
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
7.1e-01
9.8e-01
—
—
—
8.0e-01
6.6e-01
cases:0.99%
controls:0.49%
cases:0.48%
controls:0.18%
—
—
—
—
—
—
cases:0.41%
controls:0.18%
cases:1.20%
controls:0.62%
35
173
3503
35084
17
64
3524
35219
—
—
—
14
63
3425
34156
36
184
2972
29494
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
1.0e-01
4.1e-01
1.3e+00
—
9.1e-01
6.5e-01
3.8e-01
cases:3.96%
controls:3.59%
cases:2.09%
controls:1.39%
cases:0.54%
controls:0.14%
—
—
cases:0.42%
controls:0.17%
cases:2.24%
controls:1.19%
cases:5.35%
controls:3.71%
140
1266
3398
33991
74
491
3467
34792
19
51
3522
35232
—
15
60
3519
35140
77
406
3362
33813
161
1101
2847
28577
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
7.7e-02
5.6e-01
9.0e-01
—
5.7e-01
4.1e-01
4.6e-01
cases:4.55%
controls:4.23%
cases:3.36%
controls:1.94%
cases:0.68%
controls:0.28%
—
—
cases:0.42%
controls:0.24%
cases:3.11%
controls:2.08%
cases:8.24%
controls:5.34%
161
1491
3377
33766
119
686
3422
34597
24
98
3517
35185
—
15
85
3519
35115
107
712
3332
33507
248
1586
2760
28092
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
5.0e-01
5.1e-01
—
—
—
8.7e-01
9.6e-01
cases:1.58%
controls:0.96%
cases:0.54%
controls:0.32%
—
—
—
—
—
—
cases:0.76%
controls:0.32%
cases:2.36%
controls:0.92%
56
339
3482
34918
19
114
3522
35169
—
—
—
26
109
3413
34110
71
273
2937
29405
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
-2.4e-02
4.7e-01
1.8e+00
—
6.9e-01
4.7e-01
5.2e-01
cases:1.84%
controls:1.88%
cases:1.10%
controls:0.69%
cases:0.40%
controls:0.07%
—
—
cases:0.14%
controls:0.07%
cases:0.90%
controls:0.56%
cases:2.93%
controls:1.75%
65
663
3473
34594
39
245
3502
35038
14
23
3527
35260
—
5
25
3529
35175
31
193
3408
34026
88
520
2920
29158
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
1.3e-01
5.5e-01
8.7e-01
—
3.9e-01
4.4e-01
4.4e-01
cases:5.48%
controls:4.83%
cases:3.95%
controls:2.31%
cases:0.85%
controls:0.36%
—
—
cases:0.45%
controls:0.31%
cases:3.84%
controls:2.50%
cases:9.74%
controls:6.50%
194
1702
3344
33555
140
815
3401
34468
30
126
3511
35157
—
16
108
3518
35092
132
854
3307
33365
293
1930
2715
27748
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
3209-4 [3019250]
8.8e-02
6.5e-01
—
—
—
1.4e+00
9.3e-01
cases:0.45%
controls:0.41%
cases:0.37%
controls:0.19%
—
—
—
—
—
—
cases:0.38%
controls:0.10%
cases:1.00%
controls:0.39%
16
146
3522
35111
13
68
3528
35215
—
—
—
13
33
3426
34186
30
117
2978
29561
Melanocytic naevi of other and unspecified parts of face
D22.3 [45542687]
D22.3 [45542687]
9.8e-01
2.3e+00
—
—
—
—
6.8e-01
cases:0.34%
controls:0.13%
cases:0.28%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.27%
controls:0.13%
12
45
3526
35212
10
10
3531
35273
—
—
—
—
8
40
3000
29638
Phlebitis and thrombophlebitis of other sites
I80.8 [45601087]
I80.8 [45601087]
5.4e-01
2.3e+00
—
—
—
—
5.6e-01
cases:0.14%
controls:0.08%
cases:0.20%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.20%
controls:0.11%
5
29
3533
35228
7
7
3534
35276
—
—
—
—
6
34
3002
29644
Melaena
K92.1 [45533624]
K92.1 [45533624]
5.3e-01
1.1e+00
2.3e+00
1.0e+50
—
8.8e-01
6.2e-01
cases:0.59%
controls:0.35%
cases:0.34%
controls:0.11%
cases:0.17%
controls:0.02%
cases:0.17%
controls:0.00%
—
—
cases:0.23%
controls:0.10%
cases:0.76%
controls:0.41%
21
124
3517
35133
12
40
3529
35243
6
6
3535
35277
6
0
3535
35283
—
8
33
3431
34186
23
122
2985
29556
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
16135-6 [3018658]
16135-6 [3018658]
8.8e-01
—
—
—
—
2.3e+00
—
cases:0.20%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.17%
controls:0.02%
—
—
7
29
3531
35228
—
—
—
—
6
6
3433
34213
—
Weight loss
T08 [2002001071]
T08 [2002001071]
8.6e-01
—
—
—
—
2.3e+00
6.8e-01
cases:0.14%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.17%
controls:0.08%
5
21
3533
35236
—
—
—
—
6
6
3433
34213
5
25
3003
29653
Other excision or repair of lesion of skin of trunk
QBE99 [2001309861]
QBE99 [2001309861]
8.0e-01
1.4e+00
—
1.0e+50
—
2.3e+00
5.3e-01
cases:0.23%
controls:0.10%
cases:0.14%
controls:0.03%
—
—
cases:0.25%
controls:0.00%
—
—
cases:0.17%
controls:0.02%
cases:0.17%
controls:0.10%
8
36
3530
35221
5
12
3536
35271
—
9
0
3532
35283
—
6
6
3433
34213
5
29
3003
29649
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
8.6e-02
4.2e-01
1.0e+00
—
4.5e-01
7.0e-01
5.3e-01
cases:1.47%
controls:1.35%
cases:1.13%
controls:0.75%
cases:0.45%
controls:0.16%
—
—
cases:0.17%
controls:0.11%
cases:1.28%
controls:0.64%
cases:3.16%
controls:1.89%
52
476
3486
34781
40
264
3501
35019
16
56
3525
35227
—
6
38
3528
35162
44
218
3395
34001
95
561
2913
29117
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
21573-1 [3003031]
2.4e-02
5.4e-01
2.2e+00
—
—
1.5e-01
1.7e-01
cases:2.15%
controls:2.10%
cases:1.24%
controls:0.73%
cases:0.48%
controls:0.05%
—
—
—
—
cases:0.79%
controls:0.68%
cases:2.59%
controls:2.21%
76
740
3462
34517
44
258
3497
35025
17
18
3524
35265
—
—
27
231
3412
33988
78
655
2930
29023
Cervical disc disorder with radiculopathy
M50.1 [45596588]
M50.1 [45596588]
4.1e-01
1.1e+00
—
—
—
1.2e+00
4.1e-01
cases:0.57%
controls:0.38%
cases:0.40%
controls:0.13%
—
—
—
—
—
—
cases:0.38%
controls:0.12%
cases:0.60%
controls:0.40%
20
133
3518
35124
14
47
3527
35236
—
—
—
13
41
3426
34178
18
118
2990
29560
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
1.7e-01
3.2e-01
9.4e-01
—
8.8e-01
4.1e-01
1.8e-01
cases:4.27%
controls:3.61%
cases:2.85%
controls:2.08%
cases:0.73%
controls:0.29%
—
—
cases:0.65%
controls:0.27%
cases:3.37%
controls:2.26%
cases:7.25%
controls:6.12%
151
1274
3387
33983
101
735
3440
34548
26
102
3515
35181
—
23
95
3511
35105
116
774
3323
33445
218
1817
2790
27861
Consultation of another employee
SPAT1260 [2001700361]
SPAT1260 [2001700361]
3.3e-01
2.8e-01
1.6e+00
—
—
6.0e-01
2.1e-01
cases:3.02%
controls:2.20%
cases:1.07%
controls:0.82%
cases:0.34%
controls:0.07%
—
—
—
—
cases:1.31%
controls:0.72%
cases:3.06%
controls:2.49%
107
774
3431
34483
38
288
3503
34995
12
24
3529
35259
—
—
45
246
3394
33973
92
739
2916
28939
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2353
18662
1.63
48.02
6.6
6.7
10.97
11.39
umol/l
1.00
2245
17816
1535
11332
1.58
39.61
2.8
2.7
62.76
67.45
u/l
0.27
1444
10535
3102
27038
1.66
37.35
9.2
8.4
78.51
79.07
u/l
0.22
2981
25760
146
483
3.10
34.25
2.0
2.7
7.21
119.81
u/ml
0.73
146
474
1952
15707
1.47
30.94
13.9
14.5
1.20
1.23
inr
1.48
1654
13080
2985
26442
1.51
26.91
5.0
4.5
10.72
11.63
mm/h
3.47
2831
24892
2133
17852
1.42
25.12
7.7
7.5
1.21
1.21
mmol/l
0.06
1877
15546
1909
15873
1.39
22.22
5.6
5.2
36.24
35.92
g/l
1.81
1834
14926
1990
16686
1.38
21.88
2.9
2.8
—
—
estimate
—
0
0
2407
20832
1.39
21.77
5.2
5.1
6.48
6.62
mmol/l
3.41
2287
19723
2196
18765
1.38
21.20
6.9
6.6
0.57
0.57
e9/l
0.90
1934
16147
2199
18799
1.38
21.15
6.9
6.6
0.04
0.04
e9/l
0.55
1935
16163
2257
19407
1.37
20.76
7.1
6.8
0.19
0.19
e9/l
0.11
2020
16982
3672
34613
1.74
20.32
18.1
15.7
22.61
23.24
mg/l
0.55
3071
28423
2230
19178
1.37
20.25
7.0
6.6
1.91
1.95
e9/l
0.37
1996
16931
2403
20924
1.37
20.11
9.7
9.8
3.92
4.06
e9/l
2.35
2134
18158
3698
34962
1.76
19.77
20.0
18.0
139.69
139.68
mmol/l
0.11
3647
34298
236
1247
1.95
19.65
2.5
3.5
67.10
3484.70
u/ml
0.91
203
1067
3700
35036
1.74
18.99
20.2
18.2
3.95
3.96
mmol/l
1.97
3641
34307
1516
12376
1.36
18.69
3.6
3.3
28.80
33.96
u/l
3.22
1441
11723
3075
28058
1.41
18.25
5.0
4.6
14.74
14.69
pmol/l
0.51
2861
25991
3486
32620
1.53
17.75
6.2
5.5
1.87
1.89
mu/l
0.13
3280
30499
2202
19141
1.33
17.35
4.4
3.9
0.00
4.71
estimate
3.24
467
4052
2212
19258
1.33
17.15
4.4
3.9
2.21
0.09
estimate
0.47
453
3817
515
3531
1.53
16.41
3.6
4.2
21.21
22.70
ug/l
0.05
404
2830
2171
18938
1.32
16.15
4.4
3.9
0.00
0.00
estimate
0.28
465
3966
692
5059
1.44
15.97
2.7
2.5
125.73
124.78
ug/g
0.03
575
4063
2692
24326
1.33
14.95
3.8
3.4
47.66
45.84
u/l
0.41
2580
22995
1141
9166
1.34
14.79
4.7
4.2
93.75
90.97
%
3.57
1109
8966
1133
9121
1.34
14.40
1.4
1.4
1.47
1.71
u/ml
0.22
277
2457
1939
16828
1.30
14.18
2.8
2.5
78.31
77.12
nmol/l
1.03
1786
15407
2578
23249
1.31
13.97
5.2
4.7
1368.57
1922.88
e6/l
0.30
35
312
1993
17383
1.29
13.92
7.0
6.6
56.93
56.87
%
0.08
1913
16650
2023
17715
1.29
13.54
7.1
6.7
28.24
28.34
%
0.16
1931
16841
588
4292
1.43
13.52
3.0
2.9
7.05
7.75
umol/l
0.40
508
3773
1849
16018
1.29
13.43
6.9
6.9
1.21
1.21
mmol/l
0.24
1720
14900
1389
11601
1.30
13.35
3.7
3.4
112.21
79.07
e6/l
0.16
1055
8817
1022
8192
1.33
13.17
2.1
1.9
1.21
1.18
mg/l
0.10
790
6293
991
7923
1.33
12.97
1.6
1.5
2.26
2.34
g/l
0.67
608
4918
3795
36607
1.71
12.68
22.9
19.9
74.85
75.20
umol/l
0.28
3755
36201
1215
10034
1.30
12.52
3.4
3.3
0.31
0.41
e6/l
1.48
902
7334
139
723
1.96
12.21
2.7
3.5
41.97
793.57
u/ml
1.35
126
666
418
2923
1.48
11.97
2.8
3.0
10.57
10.50
g/l
0.13
389
2714
246
1529
1.65
11.87
3.7
5.4
1.59
1.59
%
0.00
237
1444
1564
13438
1.27
11.54
4.4
4.0
61.05
94.21
e6/l
1.81
1122
9341
699
5392
1.36
11.44
2.3
2.3
29.55
29.61
s
0.07
678
5255
1652
14337
1.26
11.05
4.3
3.8
1.37
0.08
estimate
0.48
374
3251
1243
10434
1.28
10.97
3.3
2.9
0.00
0.04
1.70
23
218
794
6306
1.32
10.60
3.0
2.9
1.00
1.22
e6/l
0.88
437
3331
223
1397
1.63
10.46
3.8
5.7
0.88
0.88
%
0.01
214
1318
3870
37689
1.82
10.39
27.9
23.8
254.15
255.29
e9/l
0.50
3813
36999
3870
37696
1.81
10.29
27.8
23.7
90.81
90.89
fl
0.54
3841
37345
3870
37699
1.81
10.24
28.3
24.2
40.27
40.50
%
0.72
3838
37327
3870
37700
1.81
10.22
27.8
23.7
4.50
4.49
e12/l
0.69
3800
36907
3870
37703
1.81
10.18
27.9
23.8
6.66
6.71
e9/l
0.64
3801
36903
3870
37710
1.80
10.07
28.1
23.9
135.02
134.87
g/l
0.27
3842
37361
399
2859
1.44
10.04
2.8
2.5
0.31
0.45
e6/l
0.83
381
2723
482
3573
1.40
10.01
2.6
2.4
0.22
0.21
g/l
0.79
457
3353
1500
12989
1.25
9.90
4.0
3.7
84.28
96.87
ng/l
0.07
987
8618
1274
10842
1.26
9.77
2.2
2.2
143.77
214.65
u/l
3.92
1209
10305
833
6729
1.30
9.74
4.0
3.8
338.40
435.06
ng/l
0.31
593
5005
1761
15544
1.24
9.69
2.2
2.1
97.21
97.02
pmol/l
0.06
931
8205
38
124
3.08
9.35
1.2
1.4
92.05
90.09
%
0.11
20
66
38
125
3.06
9.22
1.2
1.2
92.79
91.50
%
0.08
19
66
376
2720
1.42
8.97
1.6
1.5
—
—
—
0
0
3752
36373
1.51
8.87
13.9
12.1
25.51
25.90
u/l
0.79
3681
35459
185
1158
1.63
8.75
3.1
2.9
3.34
3.54
g/l
1.28
175
1105
719
5770
1.30
8.74
3.3
3.1
3.52
2.87
e6/l
0.59
358
2789
344
2465
1.43
8.65
3.4
3.5
4.47
4.51
pmol/l
0.34
317
2219
326
2317
1.44
8.57
2.0
1.9
1.32
1.36
g/l
0.18
310
2142
1438
12546
1.23
8.49
3.4
3.5
2.36
2.36
mmol/l
0.11
1328
11473
180
1130
1.62
8.42
3.0
2.9
166.82
187.64
%
2.85
170
1084
752
6110
1.28
8.27
2.8
2.7
13.26
13.33
umol/l
0.09
701
5720
998
8393
1.25
8.22
4.6
4.0
1.02
1.38
kg/l
0.80
680
5579
3450
33042
1.32
8.22
17.0
15.0
83.53
82.95
ml/min/173m2
0.91
3200
30514
704
5685
1.29
8.11
2.8
2.6
2.41
2.34
g/l
2.56
659
5275
3520
33829
1.34
8.02
5.3
4.9
1.48
1.48
mmol/l
0.21
3321
31731
1986
17970
1.21
7.93
3.7
3.2
101.55
113.16
ug/l
2.00
1884
16904
228
1533
1.52
7.93
3.4
3.4
25.63
25.31
mmol/l
0.84
223
1478
1047
8891
1.24
7.85
2.6
2.4
—
—
—
0
0
3443
33006
1.31
7.83
5.4
5.0
5.86
5.88
mmol/l
0.41
3225
30581
1157
9944
1.23
7.73
3.2
3.2
1085.34
1219.40
ng/l
0.53
977
8521
3370
32245
1.29
7.56
4.5
4.2
1.27
1.28
mmol/l
0.22
3155
29988
512
4005
1.32
7.45
4.0
4.5
234.61
246.85
u/l
0.88
488
3803
175
1126
1.58
7.43
1.5
1.4
292.65
285.17
ug/g
0.20
108
643
1117
9615
1.22
7.27
2.9
2.4
2.88
2.76
mg/l
0.76
990
8353
3567
34427
1.33
7.24
6.0
5.6
2.74
2.75
mmol/l
0.13
3377
32329
3367
32250
1.28
7.24
6.6
6.1
38.67
38.90
mmol/mol
0.94
3195
30395
945
8002
1.24
7.18
2.8
2.8
5.18
6.17
e6/l
1.68
872
7279
3096
29402
1.23
6.99
22.0
19.1
13.61
13.56
%
1.14
3077
29026
1194
10380
1.21
6.99
3.7
3.3
0.67
0.13
estimate
0.39
378
3150
640
5215
1.27
6.78
2.8
2.7
22.57
22.85
%
0.20
594
4868
1152
10010
1.21
6.73
1.7
1.7
21.19
20.44
nmol/l
0.93
991
8543
165
1078
1.55
6.59
1.4
1.2
123.53
95.00
titre
0.34
17
100
183
1226
1.52
6.53
2.7
2.7
95.42
93.40
%
0.66
175
1188
27
91
2.98
6.37
1.1
1.4
105.11
105.34
%
0.01
27
86
835
7060
1.23
6.35
2.9
2.9
2.44
2.45
mmol/l
0.35
758
6344
3521
34027
1.29
6.27
5.4
5.0
4.67
4.68
mmol/l
0.17
3341
32096
341
2582
1.35
6.19
1.6
1.7
—
—
—
0
0
794
6717
1.23
5.97
1.4
1.3
5.87
10.07
u/ml
1.48
323
2660
3098
29570
1.21
5.88
22.7
19.7
332.17
332.24
g/l
0.17
3084
29413
395
3090
1.31
5.73
3.6
3.7
4.66
4.61
kpa
0.13
389
3011
140
913
1.55
5.69
1.2
1.2
—
—
—
0
0
495
3994
1.27
5.66
6.6
8.1
0.89
0.89
mmol/l
0.00
404
3295
459
3679
1.28
5.53
2.4
2.3
365.26
374.91
nmol/l
0.53
425
3415
422
3348
1.29
5.51
7.4
9.0
120.23
121.75
g/l
0.80
414
3274
335
2580
1.33
5.44
2.8
3.1
146.47
186.91
ng/l
1.32
306
2352
457
3673
1.28
5.39
3.9
4.3
5.87
5.83
kpa
0.39
450
3583
1061
9308
1.19
5.38
2.8
2.7
331.73
334.26
umol/l
0.35
955
8288
363
2833
1.31
5.37
4.1
4.1
82.33
85.00
ng/l
0.24
319
2463
109
680
1.62
5.36
2.1
2.0
5.20
5.00
mmol/24h
0.26
104
601
20
64
3.14
5.18
2.5
2.8
5.75
4.97
ug/l
0.19
20
64
220
1601
1.40
5.15
2.3
2.0
41.69
39.42
u/l
0.77
203
1451
1777
16304
1.16
5.11
12.7
11.3
0.00
0.00
e9/l
2.97
1453
13239
109
690
1.60
5.07
3.8
8.1
10.62
11.29
mmol/l
2.01
101
619
109
691
1.59
5.05
3.8
8.1
105.50
105.30
mmol/l
0.20
101
620
492
4028
1.25
4.97
6.8
8.2
5.15
5.10
kpa
0.51
478
3883
492
4028
1.25
4.97
6.8
8.2
13.19
12.53
kpa
1.82
478
3881
338
2641
1.31
4.97
2.5
2.4
19.66
20.83
au/ml
0.08
25
304
87
525
1.67
4.91
1.2
1.1
1.41
1.50
g/l
1.30
82
476
836
7233
1.20
4.90
1.4
1.3
22.63
29.06
iu/ml
1.40
241
2184
211
1540
1.39
4.87
2.2
2.2
8616.34
5302.04
u/l
0.53
74
592
158
1095
1.46
4.86
1.2
1.3
—
—
—
0
0
1169
10427
1.17
4.77
4.6
4.1
0.00
0.00
estimate
2.14
436
3722
441
3582
1.26
4.77
7.0
8.6
95.83
95.72
%
0.12
426
3471
847
7362
1.19
4.70
1.7
1.6
—
—
—
0
0
274
2096
1.33
4.70
6.5
7.1
24.43
24.49
mmol/l
0.10
265
2005
189
1368
1.40
4.60
1.7
1.7
—
—
—
0
0
232
1737
1.36
4.59
4.2
3.3
1.02
1.02
ratio
0.03
209
1569
990
8741
1.18
4.55
4.3
3.8
0.45
0.15
0.37
11
81
145
1009
1.45
4.40
1.0
1.1
4.62
5.38
eliau/ml
0.08
14
131
378
3046
1.27
4.38
2.6
2.7
68.77
70.04
e9/l
0.29
286
2213
286
2228
1.31
4.33
1.5
1.4
28.48
28.36
iu/l
0.02
251
1900
2454
23214
1.15
4.26
3.3
3.1
—
—
—
0
0
271
2105
1.31
4.20
1.1
1.0
—
—
—
0
0
681
5863
1.19
4.18
1.9
1.9
—
—
—
0
0
309
2444
1.29
4.17
1.3
1.3
28.70
52.72
au/ml
1.90
13
159
833
7302
1.18
4.14
1.7
1.7
37266614.76
31298883.39
pmol/l
0.12
695
6192
335
2680
1.27
4.13
1.3
1.3
156.79
230.69
u/ml
0.98
315
2493
433
3584
1.23
3.97
4.0
4.3
1.87
1.81
mmol/l
0.14
383
3104
38
190
2.01
3.97
1.4
1.4
—
—
—
0
0
358
2905
1.26
3.93
3.0
2.8
67.17
66.51
g/l
0.96
326
2690
698
6063
1.18
3.86
3.6
3.7
0.82
0.82
mmol/l
0.03
657
5732
190
1421
1.35
3.84
2.7
2.4
3.58
3.69
g/l
0.38
178
1312
190
1422
1.35
3.82
2.7
2.4
7.39
7.36
g/l
0.08
178
1311
38
195
1.96
3.72
1.4
1.3
—
—
—
0
0
189
1422
1.35
3.69
2.7
2.4
4.25
4.23
g/l
0.12
177
1311
86
563
1.54
3.57
1.1
1.1
114.45
117.03
%
0.28
73
519
190
1439
1.34
3.56
1.7
1.6
8.27
15.31
u/ml
1.49
47
341
137
985
1.40
3.55
2.5
2.1
9.66
11.58
mg/l
2.31
129
917
253
1998
1.28
3.50
8.1
10.8
16.20
16.04
%
0.39
244
1928
132
946
1.41
3.49
1.4
1.3
18.06
3.17
u/ml
0.44
14
61
145
1061
1.38
3.40
1.2
1.3
—
—
—
0
0
165
1234
1.35
3.38
1.8
1.8
1.17
1.19
g/l
0.33
156
1175
426
3585
1.21
3.34
2.8
2.5
38.82
53.09
u/l
0.51
372
3026
82
540
1.53
3.34
1.0
1.1
1.72
3.35
eliau/ml
1.51
32
247
973
8767
1.15
3.29
5.9
5.4
2.26
2.69
ug/l
1.24
893
7959
228
1793
1.29
3.28
2.3
2.1
0.00
0.44
estimate
0.51
78
582
1234
11298
1.13
3.27
4.3
4.2
22.20
8.62
mg/mmol
0.45
765
7024
200
1549
1.31
3.23
1.7
1.9
1.50
1.54
g/l
0.22
182
1355
162
1219
1.34
3.20
2.6
2.5
10.28
10.26
g/l
0.02
149
1103
129
936
1.39
3.20
1.2
1.1
2.88
2.38
u/ml
0.16
74
517
640
5605
1.17
3.19
1.7
1.7
1174.20
1159.07
nmol/l
0.15
491
4296
1214
11120
1.13
3.18
3.5
3.5
43.30
47.15
mg/l
0.27
758
7051
79
523
1.52
3.16
1.4
1.3
—
—
—
0
0
560
4855
1.18
3.16
5.8
6.5
1.02
1.06
mmol/l
2.48
522
4517
60
373
1.62
3.14
5.7
5.1
29.01
70.06
u/ml
1.09
20
113
77
508
1.53
3.13
1.5
1.3
63.02
57.98
u/ml
—
6
30
506
4375
1.18
2.96
1.7
1.8
—
—
—
0
0
94
655
1.45
2.95
1.9
1.7
—
—
—
0
0
114
823
1.40
2.94
1.1
1.1
2.94
5.09
u/ml
1.32
59
455
174
1343
1.31
2.91
2.9
2.5
2.82
2.91
g/l
0.54
162
1234
73
485
1.51
2.90
1.4
1.3
0.16
0.22
nmol/l
0.90
56
377
111
802
1.39
2.86
1.1
1.1
1.00
1.13
u/ml
0.08
52
370
40
230
1.75
2.82
7.4
7.0
18.95
99.33
ug/l
0.52
27
140
196
1544
1.28
2.82
1.3
1.3
0.67
1.21
u/ml
0.52
11
119
107
771
1.40
2.81
1.1
1.1
0.86
1.63
u/ml
1.67
60
408
156
1193
1.32
2.80
1.8
1.8
0.22
0.23
g/l
1.02
145
1136
72
482
1.50
2.78
2.2
2.4
6.84
6.94
umol/l
0.02
56
351
55
347
1.59
2.76
1.6
1.2
—
—
—
0
0
87
607
1.44
2.74
1.3
1.3
—
—
—
0
0
712
6357
1.15
2.73
1.6
1.5
—
—
—
0
0
160
1234
1.31
2.72
1.4
1.3
48.00
37.13
u/ml
—
8
70
72
485
1.49
2.71
1.4
1.3
374.37
337.83
pmol/l
0.30
65
422
85
592
1.45
2.70
1.3
1.3
7.41
4.36
u/ml
0.69
32
272
8
19
4.22
2.67
1.0
1.1
—
—
—
0
0
1598
14989
1.11
2.66
2.0
1.9
1.34
1.36
mmol/l
0.41
1380
12794
337
2841
1.20
2.64
3.4
2.7
69.72
67.83
ml/min/173m2
0.40
151
1200
27
141
1.92
2.60
1.3
1.2
0.29
0.29
g/l
0.02
19
116
23
114
2.02
2.55
2.0
2.9
28.12
30.26
umol/l
0.38
15
80
38
223
1.71
2.53
1.1
1.1
1.07
1.06
ratio
0.21
27
184
49
309
1.59
2.49
1.1
1.2
113.53
108.54
pmol/l
0.28
49
309
226
1842
1.24
2.48
2.7
3.2
0.67
0.62
%
1.64
226
1835
92
663
1.40
2.46
1.1
1.1
10.80
4.53
u/ml
0.42
46
339
1302
12127
1.11
2.43
3.5
3.5
7.51
7.50
mmol/l
0.03
1122
10384
69
473
1.47
2.41
1.4
1.5
3.52
3.98
ug/l
0.18
57
418
35
204
1.72
2.40
1.1
1.1
—
—
—
0
0
25
131
1.91
2.40
1.5
1.4
—
—
—
0
0
25
131
1.91
2.40
1.5
1.4
—
—
—
0
0
151
1179
1.29
2.38
5.8
5.1
1.45
1.47
mg/l
0.12
142
1093
148
1154
1.29
2.36
1.4
1.3
21.61
3.13
u/ml
0.46
16
105
10
33
3.04
2.35
2.1
1.8
—
—
—
0
0
42
259
1.63
2.35
1.2
1.2
—
—
—
0
0
123
938
1.32
2.31
1.4
1.2
63.47
41.96
u/ml
0.49
12
97
331
2823
1.19
2.31
1.2
1.2
104.81
143.05
u/ml
1.43
128
1048
148
1158
1.29
2.31
2.5
2.7
—
—
—
0
0
19
92
2.07
2.26
1.2
1.2
0.26
12.59
u/ml
—
10
63
42
262
1.61
2.26
1.2
1.2
—
—
—
0
0
226
1863
1.23
2.26
2.7
3.3
1.31
1.24
%
0.41
226
1853
774
7033
1.12
2.25
5.0
4.4
23.15
21.69
%
1.77
394
3365
0
59
0.00
2.24
0.0
1.2
—
—
—
0
0
471
4144
1.15
2.23
1.7
1.9
—
—
—
0
0
32
187
1.72
2.20
1.5
1.5
35.84
33.96
nmol/l
0.12
27
160
84
610
1.39
2.18
1.1
1.1
5.78
4.82
u/ml
0.15
40
284
154
1221
1.27
2.18
2.0
1.9
—
—
—
0
0
8
24
3.34
2.18
1.5
1.2
—
—
—
0
0
326
2794
1.18
2.16
3.8
4.0
1.23
1.23
mmol/l
0.40
296
2428
155
1233
1.27
2.14
2.9
2.5
1.12
0.97
g/l
0.15
133
1074
11
42
2.62
2.14
1.0
1.0
—
—
—
0
0
34
204
1.67
2.14
1.2
1.2
—
—
—
0
0
146
1156
1.27
2.10
1.5
1.3
13.29
7.33
u/ml
0.24
19
171
166
1339
1.25
2.05
2.1
2.0
—
—
—
0
0
64
449
1.43
2.04
1.3
1.2
—
—
—
0
0
272
2309
1.19
2.03
2.0
1.9
—
—
—
0
0
285
2431
1.19
2.02
4.8
4.4
5.12
5.15
kpa
0.32
269
2339
28
162
1.73
2.01
1.1
1.1
—
—
—
0
0
154
1236
1.26
2.00
1.4
1.3
—
—
—
0
0
186
1526
1.23
1.98
1.6
1.5
12.43
15.58
iu/ml
—
6
36
42
273
1.54
1.94
1.3
1.1
17.79
1.88
u/ml
0.47
16
81
62
437
1.43
1.94
1.0
1.1
96.61
98.13
%
0.15
56
416
141
1126
1.26
1.92
1.4
1.5
9.66
10.54
u/l
0.33
115
903
13
58
2.25
1.90
2.2
2.1
—
—
—
0
0
12
53
2.27
1.80
2.3
2.2
—
—
—
0
0
108
842
1.29
1.80
2.0
2.3
132.41
129.75
g/l
0.45
79
663
7
23
3.05
1.80
1.0
1.1
—
—
—
0
0
155
1263
1.24
1.79
1.5
1.5
23.59
6.47
iu/ml
0.32
31
217
151
1227
1.24
1.79
3.3
3.4
24.58
24.71
mmol/l
0.22
146
1208
302
2620
1.17
1.77
2.7
2.3
12.14
12.90
nmol/l
0.92
279
2387
458
4097
1.13
1.74
2.1
2.1
—
—
—
0
0
9
36
2.50
1.74
2.8
2.2
1.68
1.46
mg/l
—
9
30
32
201
1.60
1.74
1.1
1.1
1706.52
1469.05
miu/ml
0.68
32
201
5
13
3.85
1.71
1.2
3.4
4.12
4.51
mmol/l
—
5
13
316
2763
1.16
1.68
2.2
2.1
—
—
—
0
0
25
149
1.68
1.66
1.3
1.2
—
—
—
0
0
130
1049
1.25
1.66
2.8
2.4
0.13
0.02
g/l
0.40
119
951
189
1586
1.20
1.65
1.8
1.7
0.34
0.31
mg/l
0.35
76
745
26
157
1.66
1.65
1.0
1.1
93.05
93.81
%
0.04
19
124
499
4504
1.12
1.65
1.8
1.8
1.46
1.45
%
0.15
441
3986
243
2090
1.17
1.61
4.8
4.4
1.75
1.68
mmol/l
0.12
178
1554
80
610
1.32
1.60
1.3
1.2
3.29
3.72
u/ml
0.08
31
217
136
1109
1.23
1.59
1.5
1.4
—
—
—
0
0
62
455
1.37
1.59
1.4
1.3
—
—
—
0
0
11
50
2.20
1.56
1.2
1.4
—
—
—
0
0
12
57
2.11
1.55
1.1
1.2
12.18
7.21
u/ml
—
7
49
172
1442
1.20
1.54
1.7
1.7
269.23
294.73
mu/l
0.81
157
1308
429
3858
1.13
1.52
7.0
6.6
—
—
—
0
0
78
598
1.31
1.52
1.1
1.1
—
—
—
0
0
42
291
1.45
1.50
2.0
2.2
—
—
—
0
0
11
218
0.50
1.50
18.5
14.3
821.73
6703.72
nmol/l
0.50
11
212
101
804
1.26
1.48
1.5
1.6
—
—
—
0
0
52
376
1.39
1.48
3.0
3.0
11.02
10.51
mmol/l
0.42
52
370
52
377
1.38
1.46
1.3
1.2
56.08
65.39
u/l
0.71
46
338
361
3224
1.13
1.44
7.3
8.1
1.27
1.33
mmol/l
0.58
356
3169
309
2733
1.14
1.43
2.3
2.3
4.70
7.11
ug/l
2.76
265
2440
58
430
1.35
1.43
1.4
1.4
—
—
—
0
0
84
658
1.28
1.41
1.3
1.2
112.00
464.91
titre
—
5
53
163
1374
1.19
1.40
2.0
2.0
0.79
2.05
ug/l
2.43
144
1228
12
225
0.53
1.39
29.3
18.5
1732.92
1424.59
nmol/l
0.71
12
219
58
432
1.35
1.39
1.4
1.4
—
—
—
0
0
238
2072
1.16
1.39
2.3
3.5
202.96
61.06
u/ml
0.53
231
2002
163
1378
1.19
1.36
5.3
4.7
24.82
24.72
mmol/l
0.17
155
1292
123
1012
1.22
1.36
2.8
2.4
0.00
0.00
g/l
-0.00
108
894
84
662
1.27
1.36
1.3
1.3
—
271.67
—
0
12
24
151
1.59
1.34
2.5
2.4
—
—
—
0
0
121
997
1.22
1.33
1.2
1.2
—
—
—
0
0
96
772
1.25
1.32
2.9
3.0
30.08
35.69
umol/l
1.66
86
708
38
266
1.43
1.32
1.5
1.7
—
—
—
0
0
45
325
1.39
1.31
1.0
1.1
5.91
8.82
iu/ml
—
8
89
123
1018
1.21
1.30
4.5
3.6
3.82
3.10
ratio
0.18
64
583
47
344
1.37
1.28
1.2
1.1
—
—
—
0
0
91
731
1.25
1.27
2.3
2.4
94.30
106.03
ug/min
0.11
45
444
60
457
1.32
1.26
1.4
1.4
—
—
—
0
0
151
1282
1.18
1.23
2.0
1.8
—
30.85
—
0
5
11
56
1.97
1.22
2.2
3.5
22.48
28.88
mg/l
—
5
11
89
719
1.24
1.20
1.5
1.5
—
—
—
0
0
17
101
1.69
1.19
2.1
3.4
9.59
10.55
kpa
1.17
17
101
17
101
1.69
1.19
2.0
3.4
4.72
4.91
kpa
0.48
17
101
120
1004
1.20
1.16
1.2
1.2
—
—
—
0
0
0
34
0.00
1.16
0.0
2.6
—
0.68
—
0
34
56
429
1.31
1.15
1.4
1.4
—
—
—
0
0
113
944
1.20
1.12
2.8
2.4
0.00
0.00
g/l
-0.00
108
893
73
582
1.26
1.12
1.1
1.1
0.35
0.64
u/ml
0.30
25
200
83
674
1.24
1.09
1.4
1.4
0.26
0.39
nmol/l
1.53
60
514
43
320
1.35
1.09
1.2
1.2
—
—
—
0
0
135
1150
1.18
1.09
4.7
3.7
38.14
65.83
mg/l
0.96
110
985
58
451
1.29
1.09
1.4
1.4
—
—
—
0
0
7
32
2.19
1.08
1.6
1.2
—
—
—
0
0
58
454
1.28
1.04
1.4
1.4
—
—
—
0
0
127
1082
1.18
1.03
2.2
2.0
2.75
9.44
iu/l
0.70
56
447
5
22
2.27
1.03
1.0
1.1
—
—
—
0
0
5
22
2.27
1.03
1.0
1.0
12.03
0.17
u/ml
—
5
16
106
890
1.20
1.02
1.4
1.6
1390.81
1259.48
e6/l
0.04
86
696
73
590
1.24
1.02
1.4
1.4
30.78
27.94
u/l
0.23
59
484
28
196
1.43
1.02
1.2
1.2
9.46
8.99
mm/h
0.11
28
196
134
1149
1.17
1.02
4.7
3.7
44.45
56.21
mg/l
0.62
109
983
5
107
0.47
1.01
1.0
1.1
—
—
—
0
0
354
3235
1.10
1.00
7.4
8.2
8.66
9.42
mmol/l
1.46
344
3112
104
875
1.19
0.99
1.4
1.6
19.25
31.34
e6/l
0.35
76
646
43
326
1.32
0.99
1.2
1.2
—
—
—
0
0
9
49
1.84
0.98
1.6
1.6
—
—
—
0
0
11
61
1.81
0.98
1.1
1.1
—
—
—
0
0
566
5289
1.08
0.98
3.4
3.2
0.71
0.75
ug/l
0.79
375
3379
85
703
1.21
0.97
1.2
1.3
—
—
—
0
0
85
703
1.21
0.97
1.2
1.3
—
—
—
0
0
13
77
1.69
0.95
1.3
1.3
835.30
158.84
ug/l
—
5
36
485
4512
1.09
0.94
2.2
2.2
—
—
—
0
0
14
85
1.65
0.94
2.1
2.2
17.59
17.99
umol/l
0.05
14
85
17
109
1.56
0.93
2.1
1.6
9.58
8.62
ug/l
0.31
17
109
380
3500
1.09
0.93
3.5
3.4
—
—
—
0
0
41
312
1.32
0.93
3.6
2.7
—
—
—
0
0
20
134
1.49
0.91
1.5
1.5
77.75
336.89
nmol/24h
0.65
20
134
86
718
1.20
0.90
3.3
3.6
16.34
27.02
mg/l
4.43
56
492
18
118
1.53
0.90
1.4
1.2
—
—
—
0
0
58
465
1.25
0.89
1.3
1.3
—
—
—
0
0
96
811
1.19
0.89
6.3
6.1
168.07
503.95
iu/ml
1.17
15
110
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
86
720
1.20
0.88
1.4
1.5
160.89
147.18
au/ml
0.54
25
221
337
3096
1.10
0.88
1.7
1.7
3.44
3.49
mmol/l
0.31
231
2114
50
395
1.27
0.87
1.2
1.2
—
—
—
0
0
186
1656
1.13
0.87
1.8
1.9
9.44
6.87
iu/ml
0.46
48
392
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
8
43
1.86
0.87
1.1
1.1
1.65
0.34
u/ml
—
8
43
43
334
1.29
0.86
1.2
1.1
—
—
—
0
0
30
221
1.36
0.85
1.4
1.3
4.18
4.94
umol/l
0.53
24
198
43
335
1.29
0.84
1.2
1.2
—
—
—
0
0
6
31
1.94
0.84
3.5
3.6
—
—
—
0
0
35
265
1.32
0.84
1.1
1.3
—
—
—
0
0
28
206
1.36
0.81
1.6
1.1
—
—
—
0
0
59
481
1.23
0.81
5.5
6.6
11.30
12.07
mg/l
0.67
54
453
93
795
1.17
0.78
1.4
1.5
—
20.55
—
0
17
119
1038
1.15
0.78
4.9
4.8
8.48
8.52
kpa
0.09
113
1012
5
98
0.51
0.77
1.0
1.1
—
—
—
0
0
26
191
1.36
0.76
2.0
1.7
509.68
783.64
pmol/l
—
5
28
6
34
1.77
0.76
5.7
4.2
—
—
—
0
0
24
175
1.37
0.74
1.5
1.4
142.13
156.45
mmol/24h
0.35
24
175
437
4095
1.08
0.74
5.0
4.8
32.81
32.50
%
0.23
303
2767
42
334
1.26
0.73
3.3
3.9
—
—
—
0
0
196
1780
1.11
0.69
1.5
1.5
—
—
—
0
0
234
2144
1.10
0.69
1.8
1.7
—
—
—
0
0
33
257
1.29
0.68
1.8
2.6
235.35
212.96
e6/l
0.31
26
213
86
742
1.16
0.67
1.7
1.7
—
—
—
0
0
124
1099
1.13
0.67
1.2
1.1
3.18
4.28
0.88
19
141
17
238
0.71
0.67
2.5
2.1
—
—
—
0
0
93
808
1.15
0.67
1.4
1.3
263.76
256.14
u/ml
0.08
67
489
28
214
1.31
0.66
1.6
1.4
206.83
204.39
pmol/l
0.02
28
214
54
448
1.21
0.66
1.6
1.6
340.11
353.71
mu/l
0.13
44
358
441
4157
1.07
0.65
2.1
1.9
3.47
3.46
ratio
0.06
329
3152
112
989
1.14
0.65
1.5
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
123
1094
1.13
0.64
3.3
3.6
0.39
0.35
iu/ml
0.62
68
604
53
441
1.20
0.63
2.5
2.4
55.88
33.99
iu/ml
—
5
44
54
452
1.20
0.61
1.5
1.3
7.60
7.27
mmol/l
0.31
47
403
0
20
0.00
0.60
0.0
4.1
—
—
—
0
0
21
278
0.75
0.60
1.4
1.2
—
—
—
0
0
8
52
1.54
0.59
2.1
1.5
110.63
143.37
ug/l
—
8
46
47
391
1.20
0.58
1.5
1.4
2486.11
2177.50
e6/l
0.21
37
268
7
112
0.62
0.58
1.0
1.1
—
—
—
0
0
100
887
1.13
0.56
1.2
1.4
3.78
3.71
mmol/l
0.26
93
844
31
385
0.80
0.55
1.8
1.5
—
—
—
0
0
82
719
1.14
0.55
1.9
1.8
—
—
—
0
0
57
486
1.18
0.55
1.4
1.6
—
—
—
0
0
146
1329
1.10
0.53
1.5
1.5
—
—
—
0
0
7
45
1.56
0.49
1.1
4.2
42.00
43.18
umol/l
—
7
37
155
1424
1.09
0.48
1.5
1.5
—
—
—
0
0
7
110
0.64
0.48
1.0
1.1
—
—
—
0
0
16
211
0.76
0.47
1.3
1.3
—
—
—
0
0
7
48
1.46
0.46
1.9
1.8
—
—
—
0
0
39
328
1.19
0.46
2.6
3.2
15.33
13.32
index
0.20
18
204
17
221
0.77
0.46
1.4
1.6
—
—
—
0
0
31
255
1.22
0.45
1.5
2.5
412.35
553.51
e6/l
1.06
23
200
11
77
1.43
0.45
1.3
1.9
0.26
0.17
nmol/l
—
6
55
16
121
1.32
0.44
1.1
1.3
—
—
—
0
0
30
247
1.22
0.44
2.2
2.4
745.36
618.70
ml
0.76
22
171
34
284
1.20
0.43
2.6
2.5
17.91
29.40
mg/l
1.65
22
199
111
1011
1.10
0.43
1.2
1.5
472.39
542.12
mg/l
0.97
106
967
123
1340
0.92
0.42
1.1
1.1
0.67
0.64
ratio
0.36
24
176
6
93
0.64
0.42
1.0
1.2
—
—
—
0
0
5
32
1.56
0.42
1.2
1.7
82.20
45.41
umol/l
—
5
32
0
15
0.00
0.41
0.0
1.2
—
2.67
—
0
15
82
739
1.11
0.40
1.1
1.1
10.92
16.13
au/ml
0.42
21
164
49
427
1.15
0.40
1.1
1.1
—
—
—
0
0
8
61
1.31
0.39
1.0
1.7
34.34
41.27
pmol/l
—
8
54
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
25
206
1.21
0.37
2.0
2.0
29.12
28.72
umol/l
0.07
25
190
74
666
1.11
0.37
1.5
1.7
—
—
—
0
0
55
486
1.13
0.37
1.5
1.7
—
—
—
0
0
35
300
1.17
0.36
1.3
1.5
1.13
1.22
promille
0.11
26
241
199
1878
1.06
0.35
1.4
1.4
—
—
—
0
0
69
623
1.11
0.34
1.5
1.5
56.97
59.86
ug/l
0.29
69
623
136
1268
1.08
0.34
2.2
2.2
357.76
559.62
ug/l
0.55
127
1188
17
136
1.25
0.33
1.1
1.1
7.50
11.87
u/ml
—
9
97
30
256
1.17
0.33
1.3
1.5
16.67
22.05
u/ml
—
6
42
133
1423
0.93
0.32
1.1
1.1
1.54
1.55
g/l
0.07
133
1423
40
455
0.88
0.32
1.4
1.8
—
1222.86
—
0
14
39
342
1.14
0.31
1.5
1.4
93043.04
81077.09
e6/l
0.06
26
184
7
53
1.32
0.30
1.0
1.0
—
—
—
0
0
138
1296
1.07
0.30
1.3
1.3
263.97
218.70
miu/ml
0.61
66
624
20
166
1.21
0.29
3.0
2.5
20.20
66.49
ug/l
0.49
20
151
64
582
1.10
0.29
1.2
1.1
2.73
3.09
0.13
14
90
19
157
1.21
0.29
1.3
1.1
—
—
—
0
0
44
392
1.12
0.29
1.0
1.1
—
49.20
—
0
5
7
57
1.23
0.29
1.3
1.2
41.71
67.58
ug/l
—
7
57
19
227
0.84
0.28
1.4
1.6
—
—
—
0
0
66
603
1.10
0.28
1.3
1.2
44.59
30.94
u/l
0.49
55
519
21
248
0.85
0.28
1.3
1.5
—
—
—
0
0
8
64
1.25
0.27
2.5
1.6
—
—
—
0
0
47
423
1.11
0.27
1.1
1.1
—
—
—
0
0
104
973
1.07
0.26
1.5
1.6
—
—
—
0
0
17
141
1.21
0.26
1.1
1.1
—
—
—
0
0
9
73
1.23
0.25
1.1
1.3
—
—
—
0
0
80
743
1.08
0.25
1.9
2.3
0.99
0.86
nmol/l
0.84
71
626
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
198
1.16
0.24
1.0
1.1
—
—
—
0
0
6
84
0.71
0.24
12.0
7.0
6.32
5.96
kpa
—
6
76
15
124
1.21
0.24
1.1
1.4
—
—
—
0
0
97
911
1.07
0.23
1.3
1.5
81.05
178.01
pmol/l
2.43
97
892
17
143
1.19
0.23
2.1
1.6
41.39
40.63
g/l
0.22
17
143
35
313
1.12
0.23
1.4
1.5
—
—
—
0
0
35
313
1.12
0.23
1.4
1.5
—
—
—
0
0
35
313
1.12
0.23
1.4
1.5
—
—
—
0
0
15
179
0.84
0.23
1.1
2.7
128.40
147.18
umol/l
—
5
100
41
371
1.11
0.22
1.0
1.1
—
—
—
0
0
5
40
1.25
0.22
1.8
5.0
1.20
2.31
mg/l
—
5
31
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
31
276
1.12
0.22
1.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
7.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
76
712
1.07
0.20
1.4
1.5
—
—
—
0
0
27
240
1.13
0.20
1.5
1.5
75.44
80.42
umol/l
0.58
27
240
25
221
1.13
0.20
1.2
1.2
0.55
0.58
ratio
0.29
15
131
57
614
0.93
0.20
1.1
1.1
142.25
1012.24
iu/ml
—
6
135
9
113
0.80
0.20
1.3
1.1
—
—
—
0
0
12
144
0.83
0.19
1.8
1.8
—
—
—
0
0
33
298
1.11
0.19
1.1
1.1
12.72
16.63
u/ml
0.43
14
119
128
1223
1.05
0.19
1.3
1.3
—
—
—
0
0
144
1380
1.05
0.18
1.6
1.8
4.21
4.49
mg/l
0.10
106
1032
17
147
1.16
0.18
3.5
4.0
0.85
1.20
%
0.81
17
147
44
406
1.08
0.17
2.0
2.2
20.93
21.15
mg/l
0.01
21
154
19
216
0.88
0.17
1.4
1.5
—
—
—
0
0
11
91
1.21
0.17
2.5
3.5
125.33
149.26
ng/l
—
6
51
92
968
0.95
0.17
1.6
1.5
84.91
60.00
ug/l
0.94
79
798
90
855
1.05
0.17
1.4
1.5
—
—
—
0
0
15
129
1.16
0.17
1.0
1.1
—
—
—
0
0
54
576
0.94
0.16
1.3
1.5
—
—
—
0
0
8
73
1.10
0.15
1.1
1.4
—
0.68
—
0
6
8
73
1.10
0.15
1.0
1.4
1.19
1.17
mmol/l
—
8
73
8
73
1.10
0.15
1.1
1.2
—
—
—
0
0
6
76
0.79
0.15
11.8
7.2
4.62
5.38
kpa
—
6
76
69
729
0.95
0.15
1.3
1.4
—
—
—
0
0
9
79
1.14
0.15
1.0
1.1
—
—
—
0
0
18
159
1.13
0.15
1.0
1.1
74.86
341.04
ng/l
—
7
43
16
140
1.14
0.15
2.0
1.8
—
—
—
0
0
23
207
1.11
0.15
2.2
2.8
43.28
42.60
%
0.06
17
110
105
1007
1.04
0.14
1.5
1.6
—
—
—
0
0
22
244
0.90
0.14
1.0
1.0
49.30
41.44
ng/l
0.48
17
162
15
131
1.15
0.14
2.2
3.1
—
117.34
—
0
25
10
118
0.85
0.14
1.0
1.3
21.74
16.83
umol/l
—
10
101
34
314
1.08
0.14
1.4
1.4
23670.41
86077.79
e6/l
1.00
17
213
8
99
0.81
0.13
1.0
1.0
30.26
38.16
iu/ml
—
8
99
22
242
0.91
0.13
1.0
1.0
653.38
718.70
ng/l
0.37
16
160
101
972
1.04
0.12
3.0
3.2
1.88
2.07
index
0.10
50
515
84
805
1.04
0.12
1.6
1.6
—
—
—
0
0
44
415
1.06
0.11
1.0
1.1
—
4.24
—
0
5
174
1696
1.03
0.11
1.6
1.6
1004.10
1010.10
mu/l
0.03
150
1412
12
136
0.88
0.11
1.4
1.0
—
—
—
0
0
45
426
1.06
0.10
1.6
1.5
282.51
278.94
mosm/kgh2o
0.57
35
328
92
888
1.04
0.10
1.8
1.7
14327.22
11941.88
e6/l
0.34
63
607
86
891
0.96
0.10
1.6
1.4
—
—
—
0
0
32
300
1.07
0.10
1.6
1.2
602.00
148.18
titre
—
5
55
28
261
1.07
0.10
2.0
2.2
0.38
1.64
u/field
4.04
13
143
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
24
223
1.08
0.09
1.0
1.1
0.99
1.13
u/l
—
10
101
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
27
288
0.94
0.08
1.4
1.6
—
—
—
0
0
12
107
1.12
0.08
1.5
1.2
7.84
8.99
pmol/l
—
7
44
10
113
0.88
0.08
1.9
2.0
8914.80
21248.32
e6/l
—
5
63
31
328
0.94
0.08
1.1
1.0
—
—
—
0
0
7
65
1.08
0.08
5.7
7.8
—
471.17
—
0
6
7
68
1.03
0.07
3.0
2.1
—
—
—
0
0
7
68
1.03
0.07
1.4
3.2
2731.14
2582.95
u/l
—
7
62
29
307
0.94
0.07
1.2
1.5
39.49
33.26
%
0.40
19
177
19
204
0.93
0.07
1.4
2.2
10.16
8.43
mmol/l
0.51
19
204
8
91
0.88
0.06
1.0
1.3
—
—
—
0
0
88
902
0.98
0.06
1.6
1.5
0.97
0.95
ratio
0.15
54
535
88
902
0.98
0.06
1.6
1.5
1.23
1.18
ratio
0.20
55
538
13
142
0.92
0.06
1.8
1.8
—
—
—
0
0
13
142
0.92
0.06
1.8
1.8
—
—
—
0
0
9
100
0.90
0.06
1.0
1.1
—
—
—
0
0
88
900
0.98
0.05
1.6
1.5
1.26
1.13
ratio
0.59
54
533
83
812
1.02
0.05
2.4
3.5
61.23
61.93
%
0.10
83
807
18
191
0.94
0.04
1.2
1.7
—
—
—
0
0
18
191
0.94
0.04
1.2
1.7
—
—
—
0
0
14
130
1.08
0.04
3.4
2.7
0.62
0.62
mmol/l
0.03
14
130
10
91
1.10
0.04
1.2
1.2
—
—
—
0
0
23
220
1.05
0.03
1.6
1.5
3.53
6.02
u/l
0.57
15
182
23
220
1.05
0.03
1.8
1.8
—
—
—
0
0
20
191
1.05
0.03
1.9
1.6
—
—
—
0
0
52
510
1.02
0.02
1.7
1.5
—
—
—
0
0
39
381
1.02
0.02
1.7
1.7
—
—
—
0
0
20
208
0.96
0.02
1.3
1.3
141.09
131.75
nmol/l
0.47
20
208
94
930
1.01
0.02
1.6
1.4
—
—
—
0
0
15
157
0.96
0.01
1.9
3.1
1.72
1.34
ug/l
0.16
15
148
18
186
0.97
0.00
1.6
1.7
—
—
—
0
0
18
186
0.97
0.00
1.6
1.7
—
—
—
0
0
18
186
0.97
0.00
1.6
1.7
—
—
—
0
0
18
186
0.97
0.00
1.6
1.7
—
—
—
0
0
30
294
1.02
0.00
1.5
1.6
—
—
—
0
0
22
215
1.02
0.00
1.0
1.1
—
—
—
0
0
32
318
1.01
0.00
1.5
1.3
—
—
—
0
0
39
392
0.99
0.00
1.4
1.6
44.72
59.65
%
1.86
25
238
11
115
0.96
0.00
1.2
1.6
0.46
0.47
e9/l
0.08
11
115
63
635
0.99
0.00
3.2
3.4
0.82
0.82
nmol/l
0.01
54
515
16
158
1.01
0.00
4.5
4.5
—
—
—
0
0
30
295
1.02
0.00
1.0
1.1
267.38
270.08
mg/l
0.01
24
259
31
307
1.01
0.00
1.2
1.1
39.47
41.21
mg/l
0.07
23
259
32
325
0.98
0.00
1.3
1.3
7.02
2.65
u/ml
0.35
14
187
17
172
0.99
0.00
1.6
1.6
2.18
3.25
u/field
0.35
11
128
25
246
1.02
0.00
1.4
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
1.28
—
0
6
0
8
0.00
0.00
0.0
10.6
—
109.25
—
0
8
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
92
0.98
-0.00
1.0
1.1
—
—
—
0
0
42
418
1.00
-0.00
1.6
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
1.0
1.5
—
—
—
0
0
6
61
0.98
-0.00
9.0
5.9
8.17
8.18
%
—
6
61
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA | 0.963 [0.86, 1.08] | 0.536 |
| Birth year | 0.995 [0.99, 1.0] | 0.208 |
During the follow-up period (1.1.1998 — 31.12.2019), 979 out of 13789 females with CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA | 1.126 [1.0, 1.27] | 0.046 |
| Birth year | 0.987 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 1156 out of 9406 males with CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.066% | 0.222% |
| 5 | 0.478% | 1.371% |
| 10 | 1.339% | 3.372% |
| 15 | 2.605% | 6.383% |
| 20 | 4.503% | 10.786% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA – Haemangioma and lymphangioma, any site
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data